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ABSTRACT
Nicotinic acetylcholine receptors (nACliRs) are ligand-gated ion channels that have 
been implicated in a variety of brain functions as well as pathological states. In the 
liippocampus, nACliRs appear to modulate both excitatory and inliibitory circuits. 
The numerous subunits that make up nAChRs result in a gr eat diversity of functional 
receptors, equipping them with different pharmacological and biophysical properties. 
It has recently been foimd that certain forms of epilepsy may arise from mutation in 
the genes responsible for encoding of riACliR subunits. Moreover, many reports have 
shown that high doses o f nicotine induce seizures in animals, which are blocked by 
different nACliR antagonists. However, the mechanism underling the role of nACliRs 
in patterning epileptiform activity is poorly understood. This project aims to establish 
the role that nAChRs may play in experimental models of epilepsy and to assess 
whether pharmacological agents acting at these receptors might represent a novel 
avenue for developing future anticonvulsants.
To assess the possible modulatory influence of iiACliRs on epileptifomi activity, a 
range o f nAChR ligands were applied during experimentally induced epileptifoim 
activity in hippocampal slices prepared from wistar rats (2-6 weeks). Extracellular 
recordings were obtained in the stratum pyramidale of the area CA3 (n==280). Initial 
experiments investigated the effects o f nACliR ligands on 4-aminopyridine (4AP)~ 
induced epileptiform activity, Bath application of 4AP (10-50 pM) resulted in the 
development of spontaneous epileptiform bursting activity in area CA3 (n=250 of 
280) occuiTing regularly at a frequency of 0.4 ± 0.02Hz, Subsequent co-application of 
the selective nAChR agonists dimethylphenylpiperazinium iodide (DMPP; 0.3-300 
pM, n=31 of 37), choline (0.3-10 inM, n=23 of 33) and lobeline (3-30 pM, n=8 of 
10) produced sustained and concentration-dependent increases in burst frequency 
with maximal frequency potentiation of 37 ± 5%, 27 ± 5% and 24 ± 11%,
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respectively. The increase in burst frequency induced by nAChR activation was 
accompanied by a decrease in the duration of individual bm'st events. These effects 
were reversed upon subsequent washout of nAChR agonist or upon co-application of 
selective nAChR antagonists including dihydro-beta-erytliroidine (DHBE, 10-30 pM, 
11=6 of 8), alpha-bungarotoxin (a-Bgt, 100 nM, n=8) and mecamylamine (50-200 pM, 
11=7 of 9).
To assess whether iiAChR activation has a modulatory influence over epileptifoim 
activities more generally we examined the action of DMPP on two additional 
pharmacological paradigms. Following bath application of bicuculline (20 pM) or by 
incubating slices in a low magnesium medium, spontaneous intermittent events 
occurred at a mean hequency of 0.146 ± 0.02Hz and 0.165 ± 0.02Hz, respectively. 
Subsequent co-application of DMPP (10-30 pM, n=24) produced a significant 
increase in both bicuculline and low magnesiiun-induced burst frequency with a 
mean maximal frequency potentiation of 248 ± 76% and 110 ± 37%, respectively. 
These effects were reversed upon subsequent washout of DMPP or upon co­
application of DHpE (20-40 pM, n=7 o f 10). These results suggest that nAChRs may 
have a general role in regulating a range of pathological neiuonal discharges.
The work presented in the rest of the thesis was focused to establish the mechanisms 
by which nAChRs mediate their pro-epileptogenic actions. To identify possible 
excitatory circuits involved in nACliRs-induced pro-epileptogenic effects, we 
investigated the effect o f DMPP on evoked glutamatergic synaptic transmission in 
area CA3. Bath application of DMPP (30 pM) resulted in a sustained and reversible 
enhancement of glutamate afferent evoked fEPSP amplitude by 15.7 ±5.1%  (mean ± 
SEM; f =0.007, n=8 of 12) suggesting that glutamatergic tiansmission is enlianced by 
iiAChR activation in the CA3 region of the hippocampus. In a further set of 
experiments we investigated the action of DMPP on epileptiform activity when 
glutamate receptors were blocked to uncover possible contribution of glutamate 
receptors in the pro-epileptogenic action of nAChRs. In these experiments application
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of NMDA receptor blocker CGP40116 (50pM) resulted in a depression of burst 
frequency but did not affect the ability of subsequent DMPP application to potentiate 
epileptifonn burst frequency. On the other hand, application of the AMPA/Kainate 
receptor antagonist NBQX (2 pM) completely abolished epileptiform activity 
suggesting that these receptors are crucial for supporting such activity. Moreover, 
subsequent co-application of DMPP failed to reintroduce extracellular field activity. 
However, slices preincubated with a lower concentration of NBQX (0.2 pM), which 
results in a partial blockade of AMPA/Kainate receptor-mediated synaptic 
transmission, were still able to exhibit burst fi’equency potentiation upon DMPP 
application. These results suggest that NMDA receptor activation is not necessary in 
the DMPP-induced burst frequency potentiation and when these receptors are blocked 
DMPP can potentiate epileptiform activity through activation of AMPA/Kainate 
receptor-mediated circuitry.
Functional nicotinic receptor-mediated responses are most prominently observed in 
hippocampal inteineurones and thus it is likely that the pro-epileptogenic action of 
nAChRs is mediated in part tlnough GABAergic circuits. However, such an action of 
nAChRs appears to be independent of fast GABAergic transmission since it is 
resistant to the blockade of GABAa receptors. To identify possible contribution of 
the GAB An receptor in the nAChR-induced effect a set o f experiments was carried 
out in the presence of GABAb receptor antagonist CGP55845A. Slices pre-incubated 
with IpM  CGP55845A were not able to exhibit burst frequency potentiation o f 4AP- 
induced epileptiform activity upon DMPP application (-8.3 ± 7%, n = ll) . Similarly, 
in the presence of IpM  CGP55845A, slices exhibited negligible burst frequency 
potentiation of bicuculline-induced (20pM) epileptiform activity upon DMPP 
application (27.6 ± 18%, n=9), in comparison to those observed in the absence of 
CGP55845A (248 ± 76 %, n=14). These data suggests that nAChRs may regulate the 
excitability of hippocampal networks through GABAb receptor-mediated 
mechanisms.
In conclusion, this study demonsti'ates that nAChRs regulate epileptiform discharges 
generated by a number of different pharmacological manipulations. The cellular 
mechanisms generating each pattern of epileptiform activity are quite distinct 
involving complex interactions between synaptic and non-synaptic elements of 
different neuronal circuits. Since iiACliRs produce a similar phenotype of modulation 
in each epileptifomi model it is possible that iiACliRs target a common cellular 
mechanism that is prevalent in each model and which mediates the increase in buist 
frequency in these models.
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GENERAL INTRODUCTION
1.1 Epilepsy
Epilepsy is a very common neurological disease which affects more than 0.5% of 
the world’s population (Kaneko et ah, 2002). Epilepsy has been defined as an 
“episodic disorder o f the nervous system arising from the excessively 
synchronous and sustained discharge o f a group o f neurones”(Jackson, 1890). 
During epilepsy, brain function is interrupted by usually transient episodes of 
abnormal neuronal activity. The term epilepsy refers to recurrent and numerous 
episodes o f seizures with a sudden and unpredictable onset. Seizures are 
characterised by excessive bursts o f activity o f CNS neurones and are not 
necessarily epileptic. At the level o f the single neurone, epileptic discharges are 
associated with very rapid bursts o f action potentials, which in turn are associated 
with abrupt depolarisations o f the membrane potential (Lockard, 1980). 
Epilepsies may be caused by many factors: trauma, cerebrovascular disease, 
tumours, infection, toxic states and genetically inherited factors, e.g., Autosomal 
Dominant Nocturnal Frontal Lobe Epilepsy (ADNFLE). In about half o f the 
patients, however no specific causative factors are found (idiopathic epilepsy) and 
the underlying cellular mechanisms are not well understood (Sandercock and 
Mumford, 1996).
1.1.1 Forms of epilepsy
Epilepsies come in many forms and display a variety o f symptoms, which range 
from vacant stares in absence seizures, to loss o f consciousness accompanied by
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muscle spasm and thence jerking of the limbs which is characteristics of tonic- 
clonic seizures. Seizures are initially characterised into two groups depending on 
whether the abnormal discharge remains localised in a brain region, partial 
seizures, or whether it spreads rapidly, generalised seizures.
1.1.2 Pathophysiology
Two sets o f changes can determine the epileptogenic properties o f neuronal 
tissues: hyperexcitahility and hypersynclrrony. Abnormal neuronal excitability is 
thought to occur as a result o f disruption o f the depolarisation and repolarisation 
mechanisms o f the cell, which is teimed the "excitability o f neuronal tissue". 
Aberrant neuronal networks that develop abnormal synchronisation o f  a group of 
neurones can result in the development and propagation o f  an epileptic seizure 
which is termed the "synclii'onisation o f neuronal tissue" (Engel, 1989).
The excitability o f individual neurones is affected by:
• Cell membrane properties (selective ion permeability and ionic pumps).
• Intracellular processes (hitracellular Ca^^ changes, receptor functions, 
transmitter release and ionic channels).
• Structural features o f neuronal elements (the cerebral neocortex and the 
hippocampus are particularly prone to the generation o f epilepsy).
• Intemeuronal connections (release o f neurotransmitter into the synaptic cleft 
and the postsynaptic membrane, resulting in excitatory or inliibitory 
postsynaptic potentials).
A hyperexcitability o f neurones that results in random firing o f cells, by itself, 
may not lead to propagation o f an epileptic seizure. Indeed, patterns o f behaviour 
require a certain degree o f synclironisation o f firing in a population o f neurones 
for normal brain function. It is only when this synchronisation becomes excessive 
or uncontrolled that epileptic seizure originates.
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In general seizines can be generated in response to a loss o f balance between 
excitatory and inhibitory influences.
1,1.3 Diagnosis
Electroencephalogram (EEG) recording is commonly used in the investigation 
and diagnosis o f epilepsies since different forms o f epilepsy exhibit distinct EEG 
signatines. Bursts o f action potentials and synchronisation ai*e particularly 
prominent during seizures, but they can also be seen at other times, as the “inter- 
ictal EEG spike” which is often used as a diagnostic for patients likely to suffer 
epilepsy (Jefferys, 1993).
hiterictal discharges are electrical events occurring in vivo between seizures 
(Dichter and Spencer, 1969), which are not especially troublesome in patients but 
form a useful diagnostic indicator. Ictal discharges refer to the patterns o f 
electrical activity that occur during a seizure. The extent o f depolarisation and 
speed of activity is prolonged and more diverse when compared to interictal 
events thus producing a full blown seizure. Interictal bursts are approximately 
100-200ms in duration and are localised to restricted brain regions, whereas ictal 
discharges last for seconds to minutes and spread to large regions o f the brain.
Interictal-like and ictal-like discharges can also occur in vitro in the slice 
preparation (Schwartzkroin and Prince, 1978). Interictal spikes in the slice 
preparation are similar to those occurring in vivo in their spontaneous periodic 
occurrence, extracellular field potential, and intracellular bursting, which is 
coiTelated with the extracellularly recorded event (Traub and Wong, 1982).
Electrophysiological recordings fi*om hippocampal slices and computer simulation 
data have revealed that key cellular and synaptic properties in the generation o f 
interictal bursts are intrinsic burst firing and activation o f ionotropic glutamate 
receptors at recurrent synapses between pyi*amidal cells (Miles et ah, 1984; Traub 
and Wong, 1982; Wong et al., 1986). In contrast, the critical factors that
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precipitate seizures and that are involved in the maintenance o f ictal discharges 
remain to he elucidated (Lee et ah, 2002).
The background o f the spontaneous epileptiform process is a synchronised 
activity o f all neurones in which a paroxysmal depolarisation shift (PDS) develops 
(Prince, 1968). PDS is a period of spontaneous cellular depolarisation on top of 
which the cell generally displays spiking activity. PDS represents the cellular 
correlate o f inteietal spikes seen on the electroencephalogram of epileptic patients 
(Matsmuoto and Marsan, 1964) and probably represents the huge EPSP resulting 
in synchronous activation of recurrent axonal collaterals (Ayala et ah, 1973).
1.1.4 Current therapy
Many classes o f pharmacological agents are ciuTently available to control 
epilepsy. For most epilepsy patients, drug intervention is successful in preventing 
seizures almost continually. Most anti epileptic drugs (AEDs) are thought to 
operate tlirough two main mechanisms (Jefferys, 1994): (1) suppressing 
membrane excitability through ion channel blockade, with selectivity either for 
sodium (e.g. phenytoin and valproate), or calcium (e.g. ethosuximide), or by (2) 
enhancing GABA-mediated synaptic inhibition (e.g. the benzodiazepines and 
barbiturates). Also included in this second class o f drugs interacting with the 
GABAergic system there is a range o f  newer AEDs including vigabatrin (an 
inliibitor o f GABA transaminase), gabapentine (a GAB A analogue) and tiagabine 
(a GABA uptake blocker). Other new drugs such as topiramate appear to have 
multiple mechanisms o f action including Na"  ^channel blockade, enhancing GABA 
actions, blocking AMP A receptors and inliibiting carbonic anliydrase. Moreover, 
there is a new group o f potential anticonvulsants that can reduce excitatory 
glutamatergic neurotransmission (e.g. MK-801 and phencyclidine) but are not 
used clinically partially due to adverse psychological effects associated with their 
use. Other compounds have yet unspecified or multiple actions.
Seizures are well controlled with a single anticonvulsant in most patients with 
epilepsy. However, approximately 20% of patients with primary generalised
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epilepsy and 35% o f patients with focal epilepsy have medically intractable 
seizures (Reutens and Berkovic, 1995; Spencer et al., 1981). Clearly there remains 
the need to develop new and more effective AEDs. For this, the pharmaceutic 
industry and academic labs are trying towards investigating novel targets and 
transmitter systems in order to identify new AEDs. The focus o f the current 
research was to identify the possible role o f acetylcholine receptors in 
epileptogenesis. Indeed, there is some evidence that the therapeutic action o f some 
novel and some classical AEDs, is in part due to their effects on the cholinergic 
system (Loscher et ah, 2003). Identifying new therapeutic agents focusing on 
these neurotransmitter systems may suggest novel and improved strategies in 
controlling epileptiform activities based upon pharmacological targeting o f 
defined microcircuits as opposed to generalised suppression o f excitability or 
enhanced inliibition.
1.2 Neuronal receptors and neurotransmitter systems
1.2.1 The cholinergic system
1.2.1.1 Acetylcholine
Acetylcholine (ACh) is a major neurotransmitter in the central and peripheral 
nervous systems (Reviewed by Caulfield, 1993). Acetylcholine was first 
described back in 1906 (Hunt and Taveau, 1906) and was the first substance 
shown to be a neurotransmitter (Dale, 1934; Dale, 1938; Dale et ah, 1936). 
Chemically it is composed o f choline and an acetyl group, synthesised in the axon 
terminal by the enzyme choline acetyltransferase (CliAT) where it is subsequently 
taken up into vesicles for storage and release. It is released from presynaptic 
tenninals to act on postsynaptic acetylcholine receptors generating an excitatory 
postsynaptic response that can be detected as excitatory voltage (EPSP) or current
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(EPSC) deflections. The response is tenninated when acetylcholine is broken 
down by the enzyme acetylcholinesterase (AChE) back to choline and acetate.
1.2.1.2 Muscarinic acetylcholine receptors (mAChRs)
inACliRs play key roles in regulating the activity o f many important fimctions o f 
the central and peripheral nervous system. Central niACliRs are involved in 
regulating an extraordinarily large number o f cognitive, behavioural, sensory, 
motor, and autonomic functions (Eglen et al., 1999; Felder et al., 2000). Reduced 
or increased signalling tlnough distinct mAChR subtypes has been implicated in 
the pathophysiology o f several major diseases o f the CNS, including Alzheimer's 
and Parkinson's disease, depression, schizophrenia, and epilepsy (Eglen et al., 
1999; Felder et al., 2000).
mACliRs are members o f the superfamily o f G protein-coupled receptors and act 
indirectly tlnough guanine nucleotide-binding proteins. Agonist binding triggers a 
conformational change, which leads to the activation o f specific G-proteins. The 
activated G-protein then stimulates or inhibits one o f many effector systems. The 
ultimate outcome o f agonist binding depends on the type o f G-protein activated 
and the effector system targeted. Due to this additional step o f G-protein 
activation mAChR mediate slower neurotransmission than the nicotinic ligand- 
gated ion chamiels.
The muscarinic actions o f ACh are mediated by five molecularly distinct mACliR 
subtypes (M1-M5) (Caulfield, 1993; Caulfield and Birdsall, 1998), which are 
encoded by five distinct inACliR genes (Bomier et al,, 1987; Bonner et al., 1988; 
ICubo et al., 1986). Based on their ability to activate different classes of 
heterotrimeric G proteins, the five mAChR subtypes can be subdivided into two 
major functional classes. The M2 and M 4 receptors selectively couple to G 
proteins o f the Gj family, which leads to the inhibition o f the enzyme Adenylate 
Cyclase and a decrease o f the intracellular messenger cyclic adenosine 5 ’ 
monophosphate (cAMP). The Mi, M3, and M5 receptors selectively couple to G
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proteins o f the Gq class (Caulfield, 1993; Caulfield and Birdsall, 1998) which 
activates the enzyme Phospholipase C (PLC), leads to release the intracellular 
messengers inositol triphosphate (IP3) and DAG.
mAChR proteins have differential cellular distributions within individual regions 
o f the brain. In the hippocampus M l and M3 receptors are expressed in pyramidal 
neurones and M2 and M4 receptors expressed in non-pyramidal neurones (Levey 
et al., 1995).
mACliR activation produces a variety o f responses in CNS depend on the circuit 
involved, the neurotransmitter concentration (Segal, 1991), and the location and 
the subtype o f receptor. Muscarinic stimulation causes a sustained depolarisation 
associated with an increased input resistance. These effects are attributed to a 
cholinergic-induced depression o f four potassium conductances, including the M- 
cuiTent (7m) (Halliwell and Adams, 1982; Madison et al., 1987), a fast inactivating 
current (7a ) (Nakajima et ah, 1986), a slow Ca^^-activated current (7a h p ) (Benardo 
and Prince, 1982; Madison et al., 1987), and a backgiound leak current (7l e a k ) 
(Madison et al., 1987). Voltage-dependent Ca^ "** channels are also modulated by 
cholinergic stimulation (Misgeld et al., 1986; Toselli et al., 1989).
1.2.1.3 Nicotinic acetylcholine receptors (nAChRs)
General
Nicotinic acetylcholine receptors are cationic channels whose opening is 
controlled hy acetylcholine and nicotinic receptor agonists. They belong to the 
large family o f  ligand-gated ion channels that also includes the GABAa, glycine, 
and 5-HT3 type receptors. Nicotinic receptors are key molecules in cholinergic 
transmission at the neuromuscular junction o f striated muscles, at the synapse in 
the autonomous peripheral ganglia, and in several brain areas (Changeux and 
Edelstein, 1998; Clementi et al., 2000; Gotti et al., 1997; Sargent, 1993). Our
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Icnowledge o f neuronal nicotinic receptors started in 1889 with the publication of 
the famous paper hy Langley and Dickinson, who first reported that nicotine 
could block neuronal transmission in the superior cervical ganglion. The concept 
o f the presence o f nicotinic receptors in central nervous system developed in 
subsequent papers published hy Langley in 1905-1906 (Langley, 1905). Until 
only a few years ago, laiowledge o f neuronal nicotinic receptors remained 
confined to the ganglia and more recently neuronal nicotinic receptors have been 
investigated systematically. Although, much is known ahout nACliRs in 
ganglionic transmission, neuromuscular jimction and peripheral autonomic system 
their real function in the brain are still unclear (Reviewed by Clementi et ah, 
2000).
Nicotinic acetylcholine receptors are distributed widely in human brain and 
ganglia and foim a family of receptors with a variety o f different subtypes, each of 
which has a specific physiology and pharmacology. Recent progress in 
neurochemical and pharmacological methods indicates that the major effect o f 
nAChRs is often slow neromodulation rather than processing o f fast synaptic 
transmission (Reviewed hy Vizi and Lendvai, 1999).
Structure o f  neuronal nicotinic receptors
The receptor and associated ion channel consists of five subunits ( a , (3,5,y and s), 
all o f which arrange a large structure inserted into the membrane and suiTOund a 
central aqueous channel (Figure 1.1-1.2). nACliRs exist as a variety o f subtypes 
due to the diversity o f genes encoding acetylcholine nicotinic receptor subunits 
(Clementi et al., 2000). Earlier binding studies have detected only two subtypes in 
the hrain: (1) a low affinity receptor labelled by a-bungarotoxine, and (2) a high 
affinity receptor labelled by nicotine or acetylcholine (Clarke et al., 1985; Marks 
et al., 1986). However, sixteen iiAChR subunit genes have so far been cloned ( a l  
to a9 , p i to P4, 0,y and s) (Le Novere and Changeux, 1995). The subunits have 
several common structural features, a large extracellular N-terminal domain, four 
putative transmembrane sequences (M l -  M4), a short C-tenninal extracellular
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Figure 1.1. The structure of neuronal nicotinic acetylcholine receptors (nAChRs). 
Diagram adapted from Laviolette and Van der kooy 2004. A. Each nAChR is 
composed of five subunits arranged in either homomeric or heteromeric complexes of 
a or A subunit arrangements. Different subunit combinations confer unique functional 
properties to the ubiquitously distributed nAChRs throughout the brain. B. The 
schematic shows the transmembrane topology of a single nAChR subunit. The 
transmembrane domains are labelled M1-M4. The larger amino-terminal domain 
contains the acetylcholine-binding site, whereas the M2 domain determines the ionic 
selectivity of the receptor and faces the inside of the channel pore. C. nAChRs are 
located on axons, presynaptic terminals and on all postsynaptic sites (dendrites and 
soma). This widespread localization confers the receptor with a wide range of 
functions, influencing neuronal signalling at the pre- and postsynaptic levels.
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sequence, and an intracellular loop o f varying length, depending on the subunit, 
joining the third and fourth transmembrane domain which is very important for 
the regulation of receptor function (Reviewed by Clementi et ah, 2000; Laviolette 
and van der Kooy, 2004) ( Figure L I B  and 1.2 B).
Nicotinic receptors can be subdivided into tlnee sub-families according to the 
amino acid sequences o f the subunits (Figure 1.2 C): The first subfamily consists 
o f heteromeric muscle nicotinic acetylcholine receptors which have a pentameric 
subunit composition ( a l ) 2p iy l81 in the foetal form and ( a l ) 2P ls l§ l in  the mature 
form. The second one consists o f  heteromeric neuronal acetylcholine nicotinic 
receptors, which do not bind a-bungarotoxin. These neuronal nACliRs have a 
pentameric structure formed fi'om combination o f a 2 ,a 3 ,a 4 ,a 6  with either p2 or 
P4 subunits and sometimes also with a5  or p3 subunits. The last subfamily 
consists o f neuronal homoligomeric acetylcholine nicotinic receptors that are 
formed by the a7  or a 8 or a 9  subunits and bind a-bungarotoxin.
The a  subunits participate in the formation o f agonist binding sites and the p 
subunits are considered stmctural subunits (Gotti et al., 1997). In the heteromeric 
muscle and neuronal iiACliRs, the acetylcholine binding site is located in the large 
extracellular N-term inal domain, at the interface between the a  and non-a subunit 
(Clementi et al., 2000). The homoligomeric a7  or a 8 receptors have five identical 
acetylcholine binding sites per receptor molecule, one in each subunit (Changeux 
and Edelstein, 1998). As indicated earlier, a7 ,a8  and a9  are the subunits that can 
form homomeric receptors, whereas a 2 ,a 3 ,a 4  and a 6 always need to be co­
expressed with p2 or p4 in order to form functional channels.
Receptor distribution
N icotinic receptors are distributed widely in human brain and ganglia and are key 
molecules in cholinergic transmission at the neuromuscular junction o f striated 
muscles, at the synapse in the autonomous peripheral ganglia and in several brain
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Figure 1.2. Subunit organization and ligand binding loops for nicotinic receptors. 
Diagram adapted from clementi et al, 2000, original drawing by Changeux and 
Edelestein, 1998. (A) Vertical section of the putative transmembrane organisation 
of the muscle nicotinic acetylcholine receptor. The black areas indicate the 
acetylcholine binding sites and rings the charged areas that control the channel 
permeability. (B) Putative transmembrane organisation of the nicotinic 
acetylcholine receptor subunit. (0) Subunit arrangement of muscle-type receptors. 
Two agonist binding sites are indicated by the dashed circles. (D) Subunit 
arrangement of heteropentameric neuronal receptors with 2 or 3 subunit types. 
Two agonist binding sites are indicated by the dashed circles. The a in quotation 
marks indicates that, unlike other a subunits, o5 may not directly contribute to 
agonist binding. (E) Subunit arrangement of homopentameric receptors. Agonist 
binding sites are indicated by the dashed circles; all five are equivalent, but one is 
enlarged to show the contributions of loops A-F.
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areas (Sargent, 1993). In the CNS, they are mainly located in various cortical 
areas, the periacqueductal gi'ay matter, the basal ganglia, the thalamus, the 
hippocampus, the cerebellum and the retina (Reviewed by Clementi et a l ,  2000). 
Although the hippocampus contains a3 , a4 , a5 , a7 , (32, (33 and (34 subunits 
(Jones et al., 1999), tlu'ee subtypes o f nACliRs have been shown to be present on 
the most hippocampal neurones; (1) an a l  bearing nACliR that gives rise to fast- 
desensitising, a~bungarotoxin-sensitive nicotinic cuirents (named as type lA  
current), (2) an a4(32-containing nACliR that subserves slowly desensitising, 
DHBE-sensitive nicotinic currents (named as type II current), and (3) an a3p4- 
bearing iiAChR that accounts for very slowly desensitising, mecamylamine- 
sensitive nicotinic currents (named as type III current) (Albuquerque et a l ,  1997; 
Albuquerque et a l ,  1995; Alkondon and Albuquerque, 1993).
Hippocampal nAChRs are expressed on GABAergic inhibitory intemeurones 
(Alkondon et a l ,  1997; Frazier et a l , 1998a; Frazier et a l ,  1998b; Freedman et a l, 
1993; Freund and Buzsaki, 1996; Jones and Yakel, 1997; McQuiston and 
Madison, 1999b), on the excitatory glutamatergic pyramidal cells (Albuquerque et 
a l ,  1997; Alkondon et a l ,  1997; Ji et a l ,  2001) and also on the granule neurones, 
so both inhibitory and excitatory synapses are directly modulated by nAChR 
activity. Nicotinic receptors do not only exist on neuronal cell bodies and 
dendrites but are also located on axon term inals and involved in modulation o f 
multiple transmitter releases (W ilkie et a l ,  1996; Wonnacott et a l ,  1989). 
Receptors in the presynaptic localisation can function as synaptic or non-synaptic 
receptors. The tenn o f preterm inal receptors has been assigned to nonsynaptic 
receptors (Wonnacott, 1997). Postsynaptic receptors may also be localised in 
synaptic and non-synaptic areas o f the neurone. However, the postsynaptic 
responses after activation o f these receptors have to be summed at the axon 
tenninal to prompt action potential.
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Receptor functions
Although much is Imown about the role o f nAChRs in ganglionic transmission 
and control the function o f the peripheral autonomic system, their true Rinctions 
in the brain are still unclear. They are known to be involved in various complex 
cognitive functions, such as attention, learning, memory, control the locomotor 
activity, pain perception and body temperature regulation (Reviewed by Gotti et 
ah, 1997). The majority o f these effects are due to the presynaptic nicotinic 
receptors that modulate the release o f a number o f neurotransmitters (Womiacott,
1997). However, postsynaptic nicotinic receptors also play important roles in 
controlling o f ganglionic transmission and fast ACh-mediated synaptic 
transmission as reported in the hippocampus and in sensory cortex (Reviewed by 
Clementi et ah, 2000).
i
Put in the simplest terms, ACh binds iiACliRs and ion chamiel opens for several
milliseconds. Then the receptor/channel closes again to the initial state or enters
an inactivated phase that is unresponsive to ACh or other agonists (Dani, 2000).
.The speed o f activation, the intensity o f the depolarisation, the size o f the calcium 
signal, the rate o f desensitisation and recovery and the pharmacology o f the ACh 
response w ill all depend on the nACliRs subunit composition as well as other 
local factors (Reviewed by Alkondon and Albuquerque, 2004; Dani, 2000).
Different receptor subtypes are involved in different neurone functions. For 
example, the (32 subtype is important in the control o f presynaptic GABA release
■
(Lu et ah, 1998) where as dopamine release from brain dopaminergic neurones is 
partially controlled by an a4-containing subtype (Le Novere and Changeux,
1995). It is also reported that the release o f glutamate from glutamatergic inputs to 
the ventral lateral geniculate nucleus in chick brain slices is mainly controlled by 
an a7-containing subtype (Guo et ah, 1998) while in the hippocampal CAl region 
an a3(34 subtype contributed to the modulation of glutamate release onto CAl 
stratum radiatum  intemeurones (Alkondon and Albuquerque, 2004; Alkondon et 
ah, 2003). The presence o f the a7  subunit greatly increase Ca2+ permeability 
(Seguela et ah, 1993) and thus may be important to trigger intracellular second
11
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messenger systems (Chiodini et al., 1999). Moreover, nicotine and also a novel 
nicotinic agonist, 2,4-dimethoxybenzylidene anabaseine (DMXB), possibly via 
the a l  subtype, can induce long-term potentiation in the hippocampus in a 
micromolar concentration range, possibly due to the high Ca^^ permeability o f the 
a l  subunit (Hunter et ah, 1994; Mann and Greenfield, 2003).
In the cerebral cortex and in the hippocampus, cholinergic afferents project in a 
diffuse manner (Mesulam et ah, 1983; Schafer et al., 1998; Woolf, 1991). 
However, in both regions, unlike the glutamatergic and GABAergic afferents, 
cholinergic fibres form direct synaptic contacts with only a minor fraction o f the 
total number o f tenninals present (Mrzljak et ah, 1995; Umbriaco et ah, 1995). 
These anatomical data are consistent with the physiological observations that a 
direct nicotinic synaptic transmission has only been demonstrated in a few brain 
regions (Alkondon et ah, 1998; Frazier et ah, 1998a; Frazier et ah, 1998b). In the 
hippocampus, fast nicotinic transmission has been found only onto GABAergic 
intemeurones (Alkondon et ah, 1997; Frazier et ah, 1998a) and not glutamatergic 
pyramidal cells (Frazier et al., 1998b; Jones and Yakel, 1997), but in developing 
visual cortex, stimulation has evoked nAChR-mediated synaptic responses in both 
pyramidal cells and intemeurones (Roerig et al., 1997). Because nicotinic 
synapses are o f low density and difficult to detect experimentally, fast nicotinic 
transmission may be present at low densities in more neuronal area than the few 
that have been reported (Dani, 2000). Where it has been reported, fast nAChR- 
mediated transmission is a minor component o f the excitatory input, which is 
overwhelm ingly glutamatergic. Therefore, direct nicotinic excitation o f a neurone 
usually dose not predominate, but it could influence the excitability o f a group o f 
neurones ow ing to the broad cholinergic projections into area (Dani, 2000).
nAChR activation is reported to produce a variety o f responses in hippocampal 
intemeurones which depend on the type and the location o f intemeurones and also 
nAChR subtypes expressed (Reviewed by Alkondon and Albuquerque, 2004). 
The majority o f intemeurones show a fast depolarisation mediated by a l  subunit 
containing receptors (Frazier et al., 1998a; McQuiston and Madison, 1999b).
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However McQuiston and Madison also reported a subset o f intemeurones that 
showed a fast depolarisation in combination with a slower response. Alkondon 
(1997) reported similar response in some intemeurones but also intemeurones 
which displayed only a slow response probably due to the activation of a4[32 
nACliR. Three different responses modulated by at least tliree distinct iiACliR 
subtypes have also been reported in a single type o f interneurone (e.g. CAl 
stratum radiatum  intemeurone) (Alkondon and Albuquerque, 2004). 
Intemeurones showing no nicotinic response at all have also been obseived 
(McQuiston and Madison, 1999b).
It is possible that the difficulty in detecting fast excitatory nicotinic synapses in 
the brain reflect the participation of neuronal nAChRs in modulation rather than 
the mediation o f synaptic transmission per se (Lapchak et al., 1989; Lena et al., 
1993; McGehee et al., 1995; McMahon et a l ,  1994). nAChRs at presynaptic sites 
can modulate synaptic transmission by regulating the extent o f transmitter release 
(see below).
nAChRs also have roles during development. The density o f nAChRs varies 
during the course o f development. In addition, short-tenn and long-term 
regulation o f nACliR number and function is likely to be important for modulating 
synaptic efficacy. These regulatory and developmental factors are particularly 
important when considering the development o f epilepsy. Alterations in nAChRs 
could exert their effects directly and immediately to alter excitability, or there 
could be indirect and /or developmental consequences o f mutations in nAChR 
genes that subsequently produce the epilepsy (Dani, 2000).
Interaction between nAChRs and other neuronal transmitters
An important function o f neuronal nicotinic acetylcholine receptors in the CNS 
appears to be their involvement in neurotransmitter release (Womiacott, 1990). 
Strong neurochem ical evidence indicates that presynaptic nAChRs are involved in 
the enhanced release o f a number of transmitters, including norepineplirine,
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dopamine, serotonin, acetylcholine, GABA and glutamate (Gray et ah, 1996; 
Lapchak et ah, 1989; Lena et ah, 1993; McGehee et ah, 1995; Vidal and 
Changeux, 1993). It is hypothesised that activation of calcium-penneable 
presynaptic nicotinic receptors enliances transmission directly by elevating 
presynaptic calcium levels (Gray et ah, 1996). According to Vizi and Lendvai 
(1999), interacellular mechanisms leading to release o f transmitters in response to 
nAChRs stimulation are initiated by axonal firing, or directly induce Na"  ^and Ca^^ 
influx followed by a depolarisation sufficient to activate local voltage-sensitive 
Ca^^ channels, as a result transmitter o f vesicular origin will be released (Figure
1.3).
However, some other studies were unable to evoke an increase in presynaptic 
calcium levels w ith local application o f nicotinic receptor agonists suggesting an 
indirect synaptic modulation could arise from nicotinic excitation (Vogt and 
Regehr, 2001).
Moreover, some o f the nAChR agonists such as DMPP and lobeline, besides their 
effects on presynaptic nAChRs, at higher concentrations are able to inliibit the 
uptake o f NE and 5-HT into nerve term inals, thereby their transmitter releasing 
effects are extended in time and space (Vizi and Lendvai, 1999) (see Figure 1.3). 
The effect on the uptake process is not being sensitive to nAChR antagonism, but 
can be prevented by selective uptake blockers or reduced temperature.
Tetrodotoxin (TTX) is a neurotoxin that blocks voltage dependent Na^ chaimels, 
thereby blocking axonal conduction. It has been suggested by different authors 
(Clarke and Reuben, 1996; Sacaan et ah, 1995), that the sensitivity or resistance to 
TTX indicates the pre-, or postsynaptic localisation o f nAChRs. The TTX- 
insensitive part o f transmitter release evoked by iiACliR agonists has been taken 
as evidence of presynaptic receptor localisation (Womiacott, 1997). It is likely 
that TTX reduces that portion o f transmitter release in which Na^-influx has been 
involved. TTX-dependence o f nACliR-induced neurotransmitter release can be 
very different across brain regions, for example, nicotine-induced dopamine
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Figure 1.3. Putative intracellular mechanisms for nicotinic receptor activation- 
induced release.
Diagram adapted from Vizi and lendvai, 1999. (1) Integral ion-channel function - the 
calcium entry via presynaptic nAChR channel directly triggers exocytosis, (2) 
activation of voltage-dependent ion channels by the local depolarization (excitatory 
postsynaptic potentials) due to nAChR activation, calcium enters via VDCCs and 
induces vesicle fusion (calcium channel blocker-sensitive part of nAChR 
stimulation-evoked release), (3) reversal of membrane uptake carrier to release NE 
from the cytoplasm.
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release lias been found TTX-sensitive in the striatum but not in the cortex using in 
vivo microdialysis (Marshall et al., 1996; 1997). Moreover the hippocampal 
release o f NE evoked by iiACliR stimulation was completely inhibited by TTX 
(Sershen et al., 1997), whereas, in chick sympathetic neurones release o f NE and 
increase in [Ca^’^ 'ji evoked by nAChR stimulation can be still elicited in the 
presence o f TTX (Dolezal et al., 1996). These results can easily be explained by 
different localisation of presynaptic nAChRs in the very varicose dopaminergic 
and noradrenergic fibres w ith a dominance o f receptor far from the actual release 
site or closer (Vizi and Lendvai, 1999).
As mentioned earlier, the release o f these transmitters can be modulated by 
different nACliR subtypes. The release o f glutamate is mainly controlled by an a l  
or aSp4 - containing subtypes (Alkondon et al., 2003; Guo et al., 1998). However, 
a study in mice, indicated that the P2 subtype is important in the control of 
presynaptic GABA release (Poth et al., 1997). It seems likely that presynaptic 
iiACliRs on raonoaminergic fibres are composed o f a3  or a4  subunits in 
combination with the P2 subunit (Vizi and Lendvai, 1999). This is supported by 
the obseiwation that nAChR agonists have no presynaptic effect on transmitter 
release in loiockout mice lacking thep2 nACliR subunit gene.
1.2.2 The GABAergic system
1.2.2.1 Gamma-aminobutyric acid (GABA)
The neutral amino acid y-aminobutyiic acid (GABA) is the main inliibitory 
neurotransmitter in vertebrates as roughly 40% o f all cerebral synapses are 
GABAergic (Reviewed by Ure and Perassolo, 2000). GABA is synthesised from 
glutamate in neurones expressing the enzyme glutamic acid decarboxylase 
(GAB). It is released horn presynaptic term inals to act on postsynaptic GABA 
receptors generating an inhibitory postsynaptic response that can be detected as 
voltage (IPSP) or current (IPSC) deflections. Teniiination o f action is due to 
uptake into neurones and surrounding glial cells by GABA transporters (GAT 1-3)
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and the breakdown o f GABA by transaminase (Reviewed by Soudijn and van 
Wijngaarden, 2000).
Early work with the neurotransmitter GABA indicated that it produced inhibitory 
hyperpolarising postsynaptic responses in neurones (Krnjevic and Schwartz, 
1967), which could be blocked by the alkaloid bicuculline (Curtis et al., 1970). 
During the 1970s Bowery and colleagues showed that GABA could inliibit 
noradrealine release in the heart (Bowery et al., 1981; Bowery and Hudson, 1979). 
However this response was not blocked by bicuculline and ultimately lead to the 
classification o f two pharmacologically distinct GABA receptors named GABAa 
and GAB As (Hill and Bowery, 1981). This novel GABAb receptor was also 
shown to be present in the brain (Bowery et al., 1980b; Bowery et al., 1987) and is 
activated by the specific agonist baclofen (Bowery et al., 1980b; Hill and Bowery, 
1981). More recently the existence o f a third type o f GABA receptor has been 
confirmed (Jolmston, 1996). Jolmston’s original work on GABA analogues 
identified a GABA receptor insensitive to bicuculline (Johnston et al., 1975). 
These analogues were later shown not to effect binding o f the GABAe agonist 
baclofen and as such a third subclass o f GABA receptor was suggested and named 
GAB Ac (Drew et al., 1984). Fast inhibitory neurotransmission is mediated by the 
GABAa receptor and the GAB Ac receptor, both o f which are ligand-gated Cl" 
channels. Slow inhibitory neurotransmission is mediated by the G protein-coupled 
GABAb receptor.
1,2.2.2 GABAa receptors
GABAa receptors are ionotropic receptors, which open channels permeable to CP 
and are blocked by picrotoxin and bicuculline. The action o f GABA on ionotropic 
receptors is both a hyperpolarisation and a reduction o f excitation, each of which 
can be considered inhibitory. GABAa receptors mediating most inhibitory 
synaptic transmission in the CNS belong to the ligand-gated ion channel 
superfamily (Schofield et al., 1987). As with all others members of this 
superfamily they have a pentameric architecture (Nayeem et ah, 1994) with the
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exact subunit composition conferring discrete functional characteristics 
(Reviewed by Sieghait, 1995; Sieghart et al., 1999). Five subunits are aiTanged 
within the plasma membrane to form a chamiel that is mainly selective for 
chloride and bicarbonate ions (Bormami et al., 1987). The first two receptors 
subunits identified (a and (3) were cloned by Schofield in 1987. Currently, 20 
GABAa receptor subunits have been identified in mammalian tissue, including six 
a , four P, tliree Y, one 5, one s, one tt, one 9, and thi'ee Psubunits (Reviewed by 
Sieghart et al., 1999). At least one a , (3 and y subunit is required to form a fully 
functional chamiel (Pritchett et al., 1989). The most common formation is two a l 
subunits in combination with two (32 subunits and a single y2 subunit which 
accounts for approximately 43% of GABAa receptors (McKernan and Whiting,
1996). A large diversity o f GABAa receptor subtypes are found within the 
hippocampus (Wisdeii et al., 1992).
1.2.2.3 GABAb receptors
GABAb receptors are metabotropic receptors and belong to the G-pi'otein coupled 
receptor superfamily (Reviewed by Bowery et al., 2002). The heterodimeric 
nature o f the GABAe receptor was not initially appreciated when this receptor was 
first cloned by Kaupmami et a i  in 1997. Subsequent studies (Marshall et al., 
1999) revealed that functionally expressed the GABAe receptor was not a single 
protein but instead existed as a heterodimer with the subunits designated 
GABAbRI and GABAbICZ, neither o f which was functional on its own (Reviewed 
by Bowery et a l ,  2002). Agonist binding occurs at the GABAbRI subunit, 
whereas no ligand binding is detectable on the R2 subunit (Kniazeff et al., 2002). 
Conversely, the R1 subunit is not able to activate effector systems, whereas the 
R2 subunit is responsible for G protein coupling (Duthey et al., 2002).
GABAb receptors are activated by agonists GABA and (-)baclofen (Bowery et al., 
1981; Bowery et al., 1980b; Hill and Bowery, 1981) and antagonised by saclofen 
as well as a range o f more recently developed selective and potent antagonists
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including CGP55845A (3-A-[l-(S)-(3,4-dichlorophenyl)ethyl] amino-2- 
hydroxypropyl-P-benzyl-pliosphinic acid) (Davies et al., 1993).
Effector mechanisms associated with neural GABAb receptors are the adenylate 
cyclase system and Ca^ "^  and ion chamiels (Reviewed by Bowery et al., 2002). 
When activated, GABAb receptors open chamiels on both the pre and 
postsynaptic sides o f the synapse (Dutar and Nicoll, 1988) and increase 
conductance. In the postsynaptic cell this leads to a hyperpolarisation o f the 
membrane potential which has a slower onset and slower decay than the GABAa 
response. In the presynaptic tenninal, activation o f GABAe receptors reduces 
transmitter release by an Inliibition o f Ca^^ conductance. It depresses transmitter 
release o f virtually all transmitters investigated including glutamate and GABA. 
Therefore, effects of GABAb receptors can be complex and are not always 
inhibitory (Freund and Buzsaki, 1996). Electrophysiological data indicate that 
GABAb receptors are present at both pre- and postsynaptic sites within the 
hippocampus (Dutar and Nicoll, 1988).
1.2.3 The glutamatergic system
1.2.3.1 Glutamate
L-Glutamate is the major excitatory neurotransmitter within the adult central 
neiwous system and was the first excitatory amino acid to be so recognised (Curtis 
et al., 1959). It is one o f the quantitatively more important neurotransmitters in 
mammalian CNS (Curtis and Jolmston, 1974). Glutamate is synthesised in and 
released from the presynaptic tenninal by Ca^^ dependant exocytosis (Nicholls,
1989) and acted on specific glutamate postsynaptic receptors to elicit excitatory 
postsynaptic responses (EPSPs or EPSCs) (Curtis and Watkins, 1960; 1963). The 
postsynaptic action o f glutamate is terminated by glutamate uptake carriers 
present in the plasma membrane o f  glial cells and neurones (Rotlnnan et al., 
1987).
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Once again, the action o f glutamate is on two main types of receptors, ionotropic 
and metabotropic:
1.2.3.2 Ionotropic glutamate receptors
The ionotropic glutamate receptors consist primarily o f three types named after 
their selective agonists, hydroxy-5-methyl-4-isoxazole propionic acid (AMPA), 
kainate and A-Methyl-D-aspartate (NMDA) receptors (Reviewed by McLennan, 
1983; Westbrook, 1994). AMP A and kainate receptors mediate fast EPSPs 
whereas NMDA receptors mediate slower-rising and slower-decaying EPSPs. 
AMP A and kainate receptors are often referred to as non-NMDA receptors but in 
fact represent different classes o f receptors with discrete functional, 
pharmacological properties and distributions. Under normal conditions 
transmission within the hippocampus is carried out by non-NMDA receptors 
(Collingridge et al., 1982; 1983).
More recent molecular biological studies o f glutamate receptors have revealed 
that each o f these tlnee subgroups is encoded by a number o f different genes, 
including G luRl-4  for AMP A receptors, GluR5-7, K A l and KA2  for kainate 
receptors and NM D ARl and NMDAR2A-D  (also known as N R l and NR2A-D) for 
NMDA receptors (Reviewed by Barnes and Henley, 1992; Hollmami and 
Heinemaim, 1994). Different subunits generated by these genes are o f a wide 
variety and exhibit varying electrophysiological and pharmacological properties, 
depending upon the combination o f subunits expressed (McCormick, 1998). All 
ionotrophic glutamate receptor subunits differ from the nicotinic acetylcholine 
receptor subunits in their transmembrane topology by having only three 
membrane spanning domains.
Activation o f excitatory amino acid receptors underlies fast glutamatergic 
excitatory postsynaptic potentials (EPSPs). The postsynaptic potentials mediated 
by AMP A and kainate receptors, like those associated with nicotinic channels, are 
caused by an increase in a mixed cation conductance (mainly Na"*^  and K^, but
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sometimes as well) such that the reversal potential is approximately 0 mV 
(Hollmann and Heinemami, 1994). These synaptic potentials have a very short 
delay from the anival o f the action potentials at the presynaptic terminal, and a 
rapid rate o f rise. The falling phase is much slower, being determined in large part 
by the membrane properties o f the neurone.
In contrast to the fast PSPs mediated by AMPA/kainate receptors, the action of 
glutamate through NMDA receptors is more complicated. Stimulation o f NMDA 
receptors results in the activation o f a voltage-dependent current that is earned not 
only by Na^ and K"*" but also importantly by Ca^^. The voltage-dependent nature 
o f this NMDA-mediated current is due to the differential block o f the ionic 
chamiel by magnesium ions (Mg^" )^ at more hyperpolarised membrane potentials 
(Mayer et al., 1984). High calcium penneability o f NMDA receptors is important 
in initiating intracellular processes including long-term metabolic or stmctural 
changes.
1.2.3.3 Metabotropic glutamate receptors (mGluRs)
mGluRs represent a family o f G protein-coupled receptors, which can trigger 
long-lasting intracellular processes and ‘metabolic’ changes and mediate synaptic 
plasticity (Neugebauer, 2002). Eight niGluR subtypes have been cloned to date 
and are classified into groups I (mGluRs 1 and 5), II (mGluRs 2 and 3) and III 
(mGluRs 4, 6, 7, and 8) based on their sequence homology, signal transduction 
mechanisms, and pharmacological profile (Reviewed by Anwyl, 1999; Gasparini 
et al., 2002; Schoepp et al., 1999).
A major distinction between group I mGluRs and groups II and III mGluRs is that 
group I couple through Gq/u proteins to the activation of phospholipase C (PLC), 
resulting in phosphoinositide (PI) hydrolysis, release o f calcium from intracellular 
stores, and protein kinase C (PKC) activation. In contrast, groups II and III 
mGluRs are negatively coupled to adenylyl cyclase (AC) tlmough Gi/Go proteins, 
thereby inhibiting cyclic AMP (cAMP) formation and cAMP-dependent protein
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kinase (PKA) activation (Reviewed by Anwyl, 1999; Gasparini et al., 2002; 
Schoepp et al., 1999). In general, it appears that the predominant effect o f group I 
mGluR activation is enhanced neuronal excitability and synaptic transmission 
whereas activation o f groups II and III typically produces inhibitory effects, 
although exceptions exist.
Activation o f the inGluR has a very diverse range o f electrophysiological effects. 
These include inhibition o f potassium and calcium currents, activation of 
potassium, calcium and non-specific cation currents, mediation o f slow excitatory 
postsynaptic potentials, presynaptic inliibition o f transmitter release, potentiation 
o f AMP A and NMDA receptor synaptic responses and involvement in the 
generation o f oscillatory and epileptifonn activity (Reviewed by Anwyl, 1999). 
Members o f each mGluR subgroup can presynaptic ally inhibit excitatory 
(glutamatergic) as well as inhibitory (GABAergic) synaptic transmission and 
transmitter release, which appears to be modulated by groups II and III mGluRs. 
Group I mGluRs can facilitate excitatory and inhibitory synaptic transmission. 
Importantly, inhibition o f GABA release by groups II and III inGluRs might 
actually increase neuronal excitability tlirough disinhibition whereas facilitation of 
GABAergic transmission by group I mGluRs would strengthen the inliibitory tone 
(Reviewed by Neugebauer, 2002).
Although group I mGluRs can be found presynaptically, they are localised 
primarily on the postsynaptic membrane. Group III mGluRs represent 
predominantly presynaptic receptors, whereas group II mGluRs have been 
detected both pre- and postsynaptically (Reviewed by Neugebauer, 2002).
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1.3 Neurotransmitters and epilepsy
The normal functioning o f the brain rests on maintaining a fine balance between 
excitation and inliibition. Disruption in this balance within interconnected 
neuronal networks may lead to a predisposition for the generation o f uncontrolled 
and hypersynchronous dischaiges as occurs in epilepsies.
1.3.1 GABA
Reduction o f inliibition by GABA antagonists generates epileptiform activity both 
in vivo and in vitro models raising the possibility that epilepsy can arise from a 
loss o f GABA-mediated inliibition (Ameri et al., 1997; Coloiii and Saggau, 1994; 
Gulyas-Kovacs et al., 2002; Herron et al., 1985; ICnowles et ah, 1987; Koln and 
Heinemami, 1990). Decreased concentrations o f GABA were found in tissue 
removed from epileptic patients when compared to normal concentrations 
determined from non-epileptic patients (Van Gelder et al., 1972). The use of in 
vivo micro-dialysis found lower GABA levels in the epileptic compared with the 
non- epileptic hippocampus (During and Spencer, 1993). Ininiunohistochemistry 
revealed a decreased number o f GABA-ininiunoreactive neurones in epileptic 
tissue (Ribak et al., 1986). The induction o f status epilepticus in animals results in 
a loss o f GABA binding sites in the rat forebrain (Kapur et al., 1994). However, a 
clear reduction in either GABA concentration or in the activity o f  GABAergic 
neurones is not the significant underlying cause that it was initially thought to be. 
GABAergic inliibition is not impaired in some epilepsy models such as exposure 
to low magnesium (Tancredi et al., 1990), 4-aminopyiidine (Rutecki et al., 1987) 
and high h'equency tetanic stimulation (Higashima, 1988). In the 4AP model, 
epileptiform activity occurs despite the presence o f normal or even enhanced 
synaptic inhibition (Chesnut and Swami, 1988; Rutecki et al., 1987). A preserved 
GABAergic inhibitory postsynaptic potential in sclerotic, epileptic hippocampi 
has also been reported (see Schwartzkroin, 1994 for review). Although some 
alteration in inliibitory process may cause or result from seizures, the exact nature 
and extent o f this involvement remains unclear.
2 2
Chapter 1
1.3.2 Glutamate
The alternative explanation o f increased excitability is enhanced activity through 
excitatory circuits, which probably involves glutamate. The role o f glutamate as a 
convulsant and excitotoxic agent is well documented (Reviewed by Ure and 
Perassolo, 2000). Glutamate is also a precursor o f the powerful inhibitor G ABA 
and thus it has been suggested that the glutamate/GAB A ratio might exert the 
most crucial influence in the generation o f paroxysmal neuronal discharges (Ure 
and Perassolo, 2000). A major contention in the theory that enlianced glutamate 
levels are responsible for seizures are the conflicting reports regarding the 
concentration of glutamate before and during seizures. In epileptic patients 
undergoing surgery, an increase in glutamate levels was detected in samples o f 
extracellular fluid extracted by microdialysis (During and Spencer, 1993; Romie- 
Engstrom et ah, 1992) although no change was apparent in seizures induced in 
animals by kainate, bicuculline, picrotoxin or electrical stimulation (Lehmami et 
ah, 1985; Obrenovitch et ah, 1996). A reduced concentration o f glutamate in 
epileptic foci (Van Gelder et ah, 1972) and in CSF from epileptic patients with 
normal values o f other aminoacids (Mutani et ah, 1974) has also been reported. 
Thus it is proposed that seizures and raised glutamate levels are not necessarily 
related.
Enhanced excitability can be attributed to other mechanisms apart from elevated 
glutamate levels. An increased density o f NMDA and kainate receptors in the 
entorhinal cortex and hippocampal CA l region (Geddes et ah, 1990; McDonald et 
ah, 1991) and an increase in AMP A  receptor density in the dentate gyrus (Hosford 
et ah, 1991) has been shown in tissue removed from epileptic patients.
Raised NMDA receptor activation may contribute to hippocampal 
hyperexcitability in some models. Kindling, the repeated stimulation o f a pathway 
at intervals until seizures are initiated, is highly dependent on NM DA receptor 
activation (Cain et ah, 1988; Mody et ah, 1988; Robinson, 1991). The main 
trigger o f long-lasting potentiation is the Ca^^ influx initiated by glutamate and 
mediated by NMDA receptors. It has also been reported an increased binding in
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the hippocampus (McDonald et ah, 1991) and dentate gyrus (Roper et ah, 1992) 
o f  ligands to NMDA receptors in the cortex removed from patients with temporal 
epilepsy, as well as an increase in NMDA receptor density (Geddes et ah, 1990; 
McDonald et ah, 1991).
Glutamate receptor agonists, NMDA, AMPA and kainate are convulsants 
producing seizures both in vivo (Chiamulera et ah, 1992; Koek and Colpaert,
1990) as well as epileptifonn activities in vitro (Fisher and Alger, 1984). 
Glutamate receptor antagonists are also good at inliibiting seizures in models 
where the involvement o f either NMDA or non-NMDA receptors is clear. For 
example, NMDA receptor antagonists totally or partially block epileptiform 
activity induced by lowering magnesium levels (Gulyas-Kovacs et ah, 2002; 
Home et ah, 1986; Mody et ah, 1987; Schneiderman and MacDonald, 1987; 
Tancredi et ah, 1990), while have no or little effect on the epileptiform discharges 
seen with other models such as GABAa receptor blockade by bicuculline and 
picrotoxin (Gulyas-Kovacs et ah, 2002; Neuman et ah, 1988; Thomson and West, 
1986). AMPA/Kainate receptor antagonist significantly affect epileptifonn 
activity in BIC model (Avoli et ah, 1993; Gulyas-Kovacs et ah, 2002; Perreault 
and Avoli, 1991; Traub et ah, 1993), while have only a minor influence in the 
generation o f epileptiform discharges in low magnesium model (Gulyas-Kovacs 
et ah, 2002). In fact, there are significant alterations in contribution o f NMDA and 
AMPA/Kainate glutamate receptors to the development and maintenance of 
epileptiform activity in the different convulsants. It has also been reported that 
4AP-induced epileptiform activity is mediated tlrrough the activation o f 
AMPA/Kainate receptors (Avoli et ah, 1993; Perreault and Avoli, 1991). 
However, the finding o f Avoli et a l, (1996) and Gulyas-Kovacs et a l, (2002) are 
contrary to this suggesting that in 4AP model, both types o f ionotropic excitatory 
amino acid receptors are overactivated and contribute to seizure initiation and 
propagation. While data related to the relevance o f each of these receptors in focal 
epileptogenesis are contradictory, there is a noticeable trend towards a strong 
activation o f both NMDA and AMPA/Kainate receptors during epileptifonn
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activity (Lee and Hablitz, 1991; Siniscalclii et al., 1997; Valenzuela and Benardo, 
1995).
Metabotropic glutamate receptors have also been shown to be critically involved 
in modulating ictal activity during seizures in animal models o f epilepsy (Dalby 
and Thomsen, 1996; Tizzano et ah, 1995). mGluR agonists have also been 
reported to induce epileptifonn discharges in vitro (Cobb et ah, 2000; Merlin et 
ah, 1995; Merlin and Wong, 1997).
1.3.3 Acetylcholine
Acetylcholine may play a role during epilepsy. An increase in ACh synthesising 
and degrading enzymes in the epileptic cortex of patients undergoing anterior 
temporal lobectomy has been reported (Kish et ah, 1988), but discussion persists 
as regards the exact significance o f such changes (Ure and Perassolo, 2000).
1.3.3.1 mAChRs and epilepsy
In spite o f  the conflicting data in the literature, there may be only a pro- 
epileptogenic action for nACliRs (see below), while muscarine receptors may play 
an excitatory or suppresor role, depending both on the circuits involved and on the 
neurotransmitter concentration (Segal, 1991). However, it has been reported that 
endogenous ACh may enhance epileptogenesis in immature hippocampus 
(Psarropoulou and Dallaire, 1998) and neocoilex (Potier and Psarropoulou, 2001; 
Potier and Psarropoulou, 2004) via activation o f muscarinic receptors.
1.3.3.2 nAChRs and epilepsy
Wliilst the exact functional significance o f different populations o f nACliRs in 
modulating hippocampal dependent physiological processes is unclear there is 
increasing evidence that nAChRs may also be involved in disease states
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(Reviewed by Jones et al., 1999). It has been claimed that neuronal nicotinic 
receptors are involved in a number o f brain diseases such as epilepsy, 
schizophrenia, dementia and Alzheimer’s disease and are currently the subject of 
intense research interest with respect to their therapeutic potential in these series 
o f  neurological and psychiatric conditions (Decker et ah, 1998; Elmslie et al., 
1997; Freedman et al., 1997; Hodgkiss and Kelly, 2001; James and Nordberg, 
1995; Lena and Changeux, 1997; Lena and Changeux, 1998; Mambio et al., 1999; 
Phillips et al., 1998; Steinlein et al., 1995). Recent studies have indicated that 
specific iiACliR subtypes are selectively responsible for certain brain diseases 
(Reviewed by d em en ti et ah, 2000). For example, the number o f receptors 
containing a 4  subunit is decreased in Alzheimer's disease (Martin-Ruiz et ah, 
1999). However, the sensory gating defect in schizophrenia seems to be 
associated with an abnormal expression o f the a 7  subunit (Leonard et ah, 1996).
The association between a particular form o f genetically transmissible epilepsy 
and mutations in genes coding for iiAClrR subunits constituted the first 
demonstration o f the contribution o f a neurotransmitter-activated receptor in 
epilepsy and the first identification o f the role o f neuronal iiACliRs in human 
brain dysfunction (Reviewed by Raggenbass and Bertrand, 2002). This epilepsy 
was termed Autosomal Dominant Nocturnal Frontal Lobe Epilepsy (ADNFLE), 
because of its autosomal dominant mode o f transmission, its occurrence during 
sleep and its frontal origin. In 1995, Phillips et al, found that ADNFLE is a 
genetic disease whose gene is located in chi'omosome 20q 13.2-q 13.3, the region 
that also contains the gene o f the a 4  nicotinic subunit (Phillips et ah, 1995). On 
the basis o f this information Steinlein et al. (1995) studied the sequence o f the a4  
gene and found a mutation that replaces serine with phenylalanine and inserts a 
leucine, this mutation is present in all affected siblings but not in normal subjects 
(Steinlein et ah, 1995). The serine-to-phenylanaline substitution mainly speeds 
desensitisation and slows its recovery, and the leucine insertion increases ACh 
affinity and alters the signal-channel conductance (Dani, 2000). The possible 
mechanism linking this form o f epilepsy is due to a decrease in a4  receptor 
function that lowers the seizure threshold (Gotti et ah, 1997). It is also
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hypothesised that decreased iiACliR function leads to decrease in G ABA release, 
with an accompanying increase in excitability (Jones et ah, 1999). Several other 
mechanisms have also been proposed to contribute to ADNFLE. For example, 
mutant nicotinic receptors may display an increased acetylcholine sensitivity with 
respect to normal receptors (Bertrand et ah, 2002; Bertrand et ah, 1998). The 
increase ACh sensitivity may produce a faster response o f the cortical or thalamic 
neurones and thereby unbalance this phase sensitive network. The thalamus and 
cortex are strongly innervated by cholinergic afferents from the pons and basal 
forebrain and ACh exert modulatory actions on thalamic and cortical neurones by 
acting via either nicotinic or muscarinic acetylcholine receptors (McCoimick, 
1992). Neuronal synchronisation could occur by a small but significant shift 
between cortical and thalamic activity. Other possibility is that ACh indirectly can 
act on presynaptic terminals by enliancing other neurotransmitter release and 
thereby causing the unbalance between excitation and inliibition (Raggenbass and 
Bertrand, 2002). Therefore, single amino acid changes produce effects that are 
potent enough presumably to disrupt proper functioning o f these receptors and, in 
certain cases, provoke the unbalance o f excitation versus inliibition that is at the 
origin o f epileptic seizures (Dani, 2000; Raggenbass and Bertrand, 2002).
Other epilepsies due to mutations in the genes encoding the a?  and (33 nAChR 
subunits have also been reported (Dumer et al., 1999; Elmslie et al., 1997; 
Neubauer et al., 1998; Phillips et al., 1998)
In addition to the genetic studies mentioned above reporting an involvement of 
nAChRs in epilepsy, some in vivo studies have also demonstrated that high does 
o f nicotine induce clonic-tonic convulsions in animals after systemic and 
intracerebral injections (Dixit et ah, 1971; Miner et ah, 1985). 
Electrophysiological studies have indicated that nicotine-induced seizures 
originate in the hippocampus (Floris et ah, 1964). Moreover, it has been indicated 
that mice with large numbers o f brain a-bungarotoxin binding sites are more 
prone to develop seizures in response to nicotine (Marks et ah, 1989). Thus, a7- 
receptor subtype may underlie nicotine-induce seizures because the a7  subunit is
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thought to be the major a-bungarotoxin binding site in the mammalian brain 
(McLane et ah, 1992). Nevertheless, the pharmacological mechanisms involved in 
the convulsive effect o f nicotine are poorly understood.
In 1999, Damaj et al, extended the pharmacological characterisation o f nicotine- 
induced seizures by examining the role o f nACliRs subtypes in mediating this 
effect after systemic and central administration o f several nicotinic agonists in 
mice (Damaj et ah, 1999). In addition, different nAChR antagonists were used in 
combination with nACliR selective agonists. According to this study, nicotine- 
induced seizures are centrally mediated and involve the activation o f a7  along 
with other nAChRs subunits. MLA, a a l-  antagonist, blocked the effects o f 
nicotine and mecamylamine, a non-competitive antagonist, blocked nicotine- 
induced bursting more potently than MLA. Although these results did not 
eliminate the involvement o f a4p2- receptors, they suggested that this receptor 
subtype dose not play a major role in nicotine- induced seizures. This study also 
suggests that nicotine entrances the release o f glutamate either directly or 
indirectly. Glutamate release in turn stimulates NMDA receptors, thus triggering 
the cascade o f events leading to nitric oxide formation and possibly seizure 
production (Damaj et ah, 1999).
Despite these links to epilepsy, infonnation regarding the role o f  nAChRs in 
patterning epileptiform activity is extremely sparse. The aim o f  this thesis, 
therefore, was to address this gap in our knowledge by investigating the effects of 
nAChR ligands on pharmacologically-induced epileptiform activity in rat 
hippocampal slices.
As all studies were carried out in the hippocampal slice, I w ill provide a brief 
account o f the hippocampal formation and its importance in epilepsy research.
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1,4 The Hippocampus
1.4.1 General
The hippocampus is a region o f the temporal lobe, which has long been loiown to 
play a crucial role in important brain functions such as learning and memory. In 
pioneering studies, memory impairment was been reported in patient having 
undergone a bilateral temporal lobectomy for the treatment o f severe epilepsy 
(Scoville and Milner, 1957) whilst more recent studies have shown similar deficits 
in patients with bilateral damage restricted to the hippocampus (Zola-Morgan et 
al., 1986). In the past two decades this brain region became a major focus o f 
neuroscience research. Interest in this stincture stems from its importance in 
normal cognitive functions as well as involvement in some major neurological 
disorders such as Alzheimer’s disease and temporal lobe epilepsy (Robbins and 
Kumar, 1987).
1.4.2 Anatomy
The hippocampus is a bilateral and banana-shaped structure found within the 
forebrain located beneath the posterior and temporal neocortex. The hippocampus 
proper is coimected to cortical regions o f the brain tlnough the perforant pathway 
and numerous subcortical regions such as raphe nucleus and medial septum, 
through the fornix. It is one o f a group o f structures within the limbic system 
typically called the hippocampus form ation  that includes the dentate gyrus, the 
hippocampus, the subiculiun and the entorhinal cortex. Division o f the 
hippocampus into the regio superior and regio inferior was based on differences 
in cell morphology and fibre projections (Cajal, 1911). However, in 1934, Lorente 
de No divided the hippocampus into four field described as cornu ammonis (CA) 
1-4 (Figure 1.4) based on the size and appearance o f the neurones (Jolmston and 
Amaral, 1998). He also noted a variety o f subtle differences in the dendritic 
organisation o f pyramidal cells in different parts o f CA3 and C A l and used these 
distinctions, in part, to further subdivide these fields into three subareas each
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(CA3a,b,c; CAla,b,c). He also used the term CA4, referred to the region occupied 
by the polymorphic layer o f the dentate gyrus. The CA l and the CA3 regions 
constitute most o f the hippocampus. In addition to differences in the size o f cells 
in CA3 and C A l, there is a clear-cut coimectional difference. The CA3 pyramidal 
cells receive a mossy fibre input from the dentate gyrus and the C A l pymmidal 
cells do not. The CA2 field has been a matter o f some controversy. It is a narrow 
zone of cells interposed between CA3 and C A l that have large cell bodies like 
CA3 but do not receive mossy fibre inneiwation like C A l. In many respects, CA2 
resembles a terminal portion o f the CA3 field. In other ways, however, CA2 is 
quiet distinct from either CA3 or CA l (Amaral and Witter, 1995). The CA2 and 
CA4 regions are less well defined which leads to these regions being generally 
ignored.
Both the dentate gyrus and the hippocampus are tlnee-layered cortices (Figure
1.4). The three fundamental layers o f the dentate gyms are the polymorphic layer 
(the hilus) containing the granule cell axons, the gmnular layer (the stratum  
granulosum) containing the granule cell bodies and the molecular layer {stratum 
moleculare) containing the granule cell dendrites. The dentate granule cell layer, 
with the local circuitry in the hilus, act as a gate controlling the sensory input to 
the hippocampus fi'om the entorhinal cortex (Jefferys, 1993).
The hippocampus also consists o f a polymorphic layer (the stratum oriens), a 
pyramidal layer (the stratum pyramidale) and a molecular layer (the stratum  
radiatum  and stratum lacunosum-moleculare). The polymoiphic layer contains 
the basal dendrites o f the pyramidal cells, the pyramidal layer consists mainly o f 
the pyi'amidal cell bodies and the molecular layer contains distal apical dendrites. 
The white coat o f the hippocampus is produced by the axons o f the pyramidal 
cells, which are grouped to fonn the alveus. As described above the pyramidal 
cell layer has been divided into four regions designated CA1-CA4 (Lorente de 
No, 1934) based on the size and appearance o f the neurones.
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Figure 1.4. The hippocampal formation.
Diagram adapted from Brown and Zador, 1990, original drawing by Raymon y Cajal, 
1911. Each region of the hippocampal formation is indicated, dentate gyrus, entorhinal 
cortex, subiculum with the hippocampus proper separated into CAl-CA4 regions. All 
principal cell types are illustrated and the direction of the arrows represents the flow of 
information throughout the hippocampal formation. The circled numbers 1-4 indicate 
the different strata of the hippocampus; ^-stratum oriens, 2-stratum pyramidale, 3- 
stratum radiatum, 4- stratum iacunosum-moiecuiare. Also shown are the certain 
excitatory pathways including the Perforant path, the mossy fibers and Schaffer 
collaterals.
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1.4.3 Cytology
1.4.3.1 Principal neurones
The pyram idal cells are the principal cells and the most numerous classes o f 
neurones o f the hippocampus proper. The cell bodies o f the hippocampal 
pyramidal neurones are aiTanged, 3-6 cells deep, in the pyramidal cell layer. These 
neurones have elaborate dendritic trees extending perpendicularly to the cell layer 
in both directions and are thus considered to be bipolar neurones. The dendrites of 
pyramidal cells are highly spineous and such spines are known to represent 
functional micro domains o f the cell which receive discrete synaptic inputs. The 
morphology o f pyramidal cells varies gi*adually from region CA3 to region C A l, 
the cell bodies become smaller and the apical dendrites longer and more slender 
(Figure 1.5 B, Brown and Zador, 1990). The apieal dendrites are longer than the 
basal and extended from the apex o f the pyramidal cell body toward the center of 
the hippocasmpus. The basal dendrites extend form the base o f  the pyi'amidal cell 
body fanning out tlnough stratum oriens.
The principal cells o f the dentate gyrus are the granule cells. They have small, 
spherically shaped cell bodies that are arranged 4-6 cells thick in the gi'anule cell 
layer. They are the most numerous neuronal type in the hippocampal fonnation 
and their soma are densely packed within stratum granulosum. They are 
monopolar with dendrites extending into the molecular layer.
1.4.3.2 Interneurones
There are also many different morphological types o f inliibitory interneurones in 
the hippocampus and dentate gyi'us. Although the interneuron/principal cell ratio 
in the hippocampus is only 1:10-1:12 (Woodson et al., 1989), interneurones have 
a much higher structural and functional diversity than pyramidal or granule cells 
(Freund and Buzsaki, 1996). All hippocampal interneurones are thought to be 
GABAergic and inhibitory in simple terms. Their diversity is manifested in their
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Figure 1.6. Structure of the transverse hippocampal slice and the trisynaptic circuit.
A. A slice cut perpendicular to the long axis of the hippocampus shows several regions 
of the hippocampal formation and indicating the principal intrinsic connections. B. 
Diagram shows typical principal cells within each region of the hippocampus and their 
connectivity by outlining the three major synapses in the hippocampus. Fibres of the 
perforant path (pp) synapse onto dentate gyrus granule cells. The granule cells send 
their major axons to synapse onto the CA3 pyramidal cells via mossy fibres (mf). The 
CA3 pyramidal cells send a major axon collateral, the Schaffer collaterals (Sch), to 
synapse onto the CA1 pyramidal cells. To complete the circuit CA1 pyramidal cells 
send their axons back to the deep layers of the entorhinal cortex partially via the 
subicular complex. Note that the morphology of pyramidal cells varies gradually from 
region CA3 to region CA1, the cell bodies become smaller and the apical dendrites 
longer and more slender.
Chapter 1
anatomical, neurochemical, electrophysiological and phamiacological properties 
(Freund and Buzsaki, 1996).The vast majority o f intemeurones do indeed have 
locally restricted target regions, generally lack spines, and are GABAergic 
(Freund and Buzsaki, 1996). The best studied interneuron is the basket cells which 
form inhibitory contacts onto CAl pyi'amidal cells and receive excitatoiy input 
from these same CAl pyramidal cells (Buhl et al., 1995). These interneurones 
thus appear to mediate both feedforward and feedback inhibition o f pyramidal 
neurones (Brown and Zador, 1990).
The glutamatergic principal (pyramidal and gi'anule) cells along with the divers 
population o f GABAergic intemeurones as well as a poorly defined population o f 
mossy cells and cholinergic intemeurones (Frotscher et al., 1986; 2000), make up 
the hippocampal neuronal network. It is proposed that pattemed signalling o f the 
principal cells coupled with changes in synaptic strength known as plasticity at the 
glutamatergic synapses may underlie hippocampal dependent tasks including 
adaptive processes such as learning and memory. However the intemeurones o f 
the hippocampus are extremely important in that they act to govern principal cell 
properties such as action potential generation, firing patterns and membrane 
potential oscillations, while also regulating other intemeurones. Overall, it is 
suggested that they set conditions for synaptic plasticity (Paulsen and Moser, 
1998) and have role in the synchronisation and patteming o f principal cell activity 
(Cobb et al., 1995; Freund and Buzsaki, 1996).
1.4.4 Hippocampal connectivity
The major input into the hippocampus is from the entorhinal cortex in the fomi o f 
the perforent path. The perforant path originates in the superficial layers o f medial 
and lateral entorhinal cortex and teiminate in either the hippocampus or dentate 
gyi'us (Lorente de No, 1934; Raisman et al., 1966). The perforent path input to the 
dentate gi'anule cells is particularly strong. The dentate gyrus in turn sends a 
projection, the mossy fibre projection, which selectively imiei-vates CA3 
pyi'amidal cells o f proximal dendritic sites. This selective input fomis the lamina
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stratum lucidum. The CA3 pyi'amidal cells in turn give rise to highly 
collateralised axons that distribute fibres both within the hippocampus as well as 
sending fibres to contralateral hippocampus and also to subcortical regions such 
as the lateral septal nucleus. The projections within hippocampus from CA3 
pyramidal cells to the CAl field are among the most intensively studied pathways 
in the brain and are known as the Schaffer collaterals. Within the CA3 region, 
CA3 pyramidal cells give rise to a high degi'ee o f recurrent (feedback) collaterals, 
which form what is referred to as the associational pathway. It is this high degree 
o f recurrent excitatory comiectivity that is suggested to be the basis for the 
hippocampus to be a particularly seizure prone brain structure (see below). Unlike 
the CA3 field, pyi'amidal cells in CA l do not appear to give rise to a major set o f 
collaterals that distribute within CA l (Amaral et al., 1991; Tamamaki et al.,
1987). The CA l field rather gives rise to a projection to the entorhinal cortex, by 
way of the adjacent subiculum (Amaral et al., 1991). A small number o f CAl 
neurones may project to the contralateral CA l (van Groen and Wyss, 1990). As 
the CA l axons extend in the alveus or in stratum oriens towards the subiculum, 
occasional collaterals arise and terminate on the dendrites o f other CA l cells 
(Deuchars and Thomson, 1996), but the massive associational network which is 
so apparent in CA3 is largely missing in C A l.
The functional organisation o f the hippocampus has traditionally been described 
in teiins o f the trisynaptic circuit (Andersen et al., 1966, Figure 1.5 B). This older 
view is still useful for introducing the hippocampus. The fibres o f the perforant 
pathway arise from entorhinal cortex form excitatory synapses onto the dendritic 
spines o f the granule cells. The gi'anule cells o f the dentate gyi'us send their mossy 
fibre axons to the CA3 region. The pyramidal neurones o f the CA3 region send 
their Schaffer collateral axons to the CA l region. To complete the circuit CA l 
pyi'amidal cells send their axons back to the entorhinal cortex via the subicular 
complex. These tliree synapses define the trisynaptic circuit, which is a purely 
feed forward network (Brown and Zador, 1990). The circuit described includes a 
simple sequence of excitatory comiections fiom one region to the next, fomiing a 
closed loop that enables unidirectional flow o f information. More over, each
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region, with the exception o f the dentate gyrus, projects not only to the next 
region in the sequence but also to one or two after it (Brown and Zador, 1990). 
Thus, multiple closed excitatory loops appear to make up the normal hippocampal 
circuitry.
1.4.5 Local interactions
In addition to synaptic comiections among regions o f the hippocampus formation, 
there are also relatively complex synaptic interactions within each region. These 
local circuits consist o f principal neurones and a diverse an*ay o f  GABAei'gic 
intemeurones (Freund and Buzsaki, 1996).
Recurrent axon collaterals o f CA3 pyi'amidal cells make extensive excitatory 
synapses on the dendrites o f neighbouring pyramidal cells (Li et al., 1994) so that 
when one pyramidal cell fires, its neighbours are powerfully excited (MacVicar 
and Dudec, 1982; Miles and Wong, 1983). This facilitates the rapid 
synchronisation o f action-potential firing in CA3 neurones that underlies the 
normal electroencephalogi'aphic pattern known as hippocampal shaip wave 
activity (Buzsaki, 1986) and periodic in vitro burst discharges (Traub, 1991). This 
synchrony is important for activity-dependent modification o f synaptic strength 
(Buzsaki, 1986), but the positive feedback from recurrent collaterals that underlies 
the synclu'onisation should produce continuous discharging o f all CA3 neurones, 
such as may occur during human temporal lobe seizures (Jefferys, 1993). But why 
does this not happen under normal conditions and what process terminates burst 
activity?
The primary mechanism terminating CA3 bursts are inliibitory conductances. As 
indicated earlier, the pyramidal neurones of the CA3 region also receive powerful 
synaptic inhibition. There is both feedback and feedfom ard synaptic inliibition o f 
the pyi'amidal neurones in the CA3 region (Brown and Zador, 1990).
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Moreover, calcium influx during the burst triggers a potassium current that results 
in an afterhyperpolarisation that can terminate bursts o f  action potentials initiated 
by a depolarising current injection (Wong, 1981). Thus the afterhyperpolarisation, 
in conjunction with inhibitory postsynaptic conductances, is a logical mechanism 
for burst termination (Traub, 1991). Some evidence, however, raise the possibility 
that inliibitory conductances are not the primary mechanism terminating CA3 
bursts. According to Staley et al (1998), population-burst duration is limited by 
depletion o f the releasable glutamate pool at these recurrent synapses and 
postsynaptic inhibitory conductances fLirther limit burst duration but are not 
necessary for burst termination. The interval between bursts in vitro depends on 
the rate o f replenishment o f releasable glutamate vesicles and the probability of 
release o f those vesicles at recurrent synapses. Therefore presynaptic factors 
controlling glutamate release at recurrent synapses regulate the probability and 
duration of synclrronous discharges of the CA3 network (Staley et al., 1998).
L4.6 Input and output pathways
The major inputs to the hippocampus and dentate gyrus arise from the entorhinal 
cortex, the contralateral hippocampus, and the septal region. There are also 
important but less numerous projections from several other regions including the 
brain stem, hypothalamus, thalamus and amygdala (Brown and Zador, 1990).
The entorhinal cortex, a transitional area between the cortex and hippocampus, 
provides a major sensory input to the hippocampus, dentate gyrus and subiculum 
via the fibres o f the alvear and perforant pathways. The fibres o f the perforant 
pathway arise from stellate and pyramidal cells in layers 2 and 3 o f the medial 
(non-olfactory) and lateral (olfactory) entorhinal cortex (Steward, 1976). They 
pass tlu'ough the subicular complex and form excitatory synapses onto the 
dendritic spines o f the granule cells. The entorhinal cortex also receives inputs 
from many other regions o f the brain including the association cortices, several 
thalamic nuclei, the claustrum, and the amygdala.
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The medial septum and diagonal band o f Broca provide one o f the major 
subcortical inputs to the hippocampus. Five cell types have been distinguished in 
these nuclei (Jakab and Leranth, 1995), however the two major types are 
cholinergic and GABAergic in nature. These neurones have large cell bodies and 
project via the fimbria-fornix to tenninate in all levels o f the hippocampus. This 
projection was first suggested in 1910 (Henick, 1910) and is now firmly 
established.
The medial septum provides a major cholinergic and GABAergic input to the 
hippocampus. The cholinergic afferents o f the septo-hippocampal input are thin 
beaded fibres (Heimiich and Frotscher, 1993) making up 2/3 o f all projections. 
These projections contact both intemeurones and principal cells (pyramidal and 
dentate granule cells) synapsing on dendritic shafts, spines and cell bodies 
(Heimrich and Frotscher, 1993). The GABAergic afferents are thick in diameter 
with large varicose swellings and make up only 1/3 o f all projections. These 
GABAergic afferents contact only intemeurones (Freund and Antal, 1988).
The cholinergic nature o f  the septo-hippocampal projection was first 
demonstrated in 1967 (Lewis and Shute, 1967) and almost a decade later septal 
stimulation was shown to cause a direct increase in acetylcholine released within 
the hippocampus (Dudar, 1977; Smith, 1974). The cholinergic component o f the 
septo-hippocampal input has received considerable attention due to its prominent 
role in cognitive functions, if  the input is destroyed hippocampal dependant 
teaming is severely impaired (Dutar et al., 1995; Hasselmo, 1999). The 
cholinergic input is involved in generation and patteming of theta activity (Cobb 
et al., 1999) tlirough the action o f acetylcholine at principal cells and 
intemeurones. The septal afferents are not the only source o f acetylcholine as 
local cholinergic neurones also exist (Frotscher et al., 1986; 2000).
The hippocampus also has several output pathways and targets. One major output 
proceeds via the fimbria, which is a sheet composed o f the axons o f pyramidal 
cells and cells in the subiculum. These axons then gather to form the fornix, which
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crosses the midline o f the brain. The other major outputs are to the subiculum and 
to the deep layers o f the entorhinal cortex. Thus the hippocampus projects to 
many o f the same regions that provide its input (Brown and Zador, 1990).
1.4.7 Neurotransmission in the hippocampus
1.4.7.1 Gamma-amino butyric acid (GABA)
G ABA is considered the main inliibitory transmitter in the hippocampus (Roberts 
et ah, 1976), which can be released by inliibitory intemeurones onto the soma, 
dendritic regions and axons o f pyramidal and granule neurones (Buhl et ah, 1994; 
Freund and Buzsaki, 1996). Although glycine is a prominent inhibitory 
neurotransmitter in the spinal cord and in some brain regions, it plays little role as 
a classical neurotransmitter in the hippocampus.
It was once believed that inliibitory synapses were primarily on the cell bodies o f 
pyramidal neurones (Andersen et ah, 1964). There is now much evidence that 
GABAergic synapses occur both on the cell bodies as well as tluoughout the 
neurone.
1.4.7.2 Glutamate
Glutamate is the most important excitatory neurotransmitter in the hippocampus 
(Roberts et ah, 1981). Various combinations o f AMPA, kainate and NMDA 
receptors are present at all o f the excitatory pathways o f hippocampus although 
there may be variations at individual synapses (Johnston and Amaral, 1998). For 
example there are fewer NM DA receptors at mossy fibre synapses (Monaghan et 
ah, 1983). Also it has been proposed that some Schaffer collateral synapses 
contain only NMDA receptors (Isaac et al., 1995; Liao et ah, 1995). The 
metabotropic glutamate receptors are also present at glutamatergic synapses, both 
at the pre- and postsynaptic side o f synapse. They coexist in different
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combinations with ionotropic receptors postsynaptically and modulate transmitter 
release presynaptically (Schoepp and Conn, 1993).
1.4.7.3 Acetylcholine
Acetylcholine (ACh) is widely distributed in the hippocampus, where it exerts a 
number o f neuromodulatory effects. The hippocampus exhibits a particularly high 
level o f nACliR expression on both principal cells and GABAergic intemeurones 
where they are located at presynaptic, postsynaptic and extra-synaptic sites 
(Fabian-Fine et al., 2001). As such, nAChRs are ideally placed to regulate 
neuronal excitability within hippocampal circuits. In this respect, nAChRs 
classically mediate fast acetylcholine-mediated neurotransmission in the 
hippocampus (Alkondon et al., 1998; Frazier et al., 1998a; 1998b; Jones and 
Yakel, 1997; McQuiston and Madison, 1999b). In addition, there is now mounting 
evidence for both excitatory and inliibitory modulatory effects o f nAChR 
activation. Thus, neurochemical evidence indicates that activation o f presynaptic 
nAChRs enhances the release o f neurotransmitters such as acetylcholine, GABA 
and glutamate (Gray et a l ,  1996; Vogt and Regeln, 2001; Wonnacott et a l ,  1989). 
Therefore, both excitatory and inhibitory synapses can be modulated by nAChR 
activation.
In the hippocampus, fast nACliR-mediated transmission has been identified only 
onto GABAergic intemeurones. iiAChR activation produces a variety o f 
responses in intemeurones. The majority o f intemeurones show a fast 
depolarisation mediated by a7subunit containing receptors (Frazier et a l , 1998a; 
1998b; McQuiston and Madison, 1999b). However, McQuiston and Madison 
(1999) also reported a subset o f intemeurones that showed a fast depolarisation in 
combination with a slower response and Alkondon (1997) reported seeing similar 
response in some intemeurones but also intemeurones which displayed only a 
slow response probably due to the activation o f a4|32 nAChR. Intemeurones 
showing no nicotinic response at all have also been observed (McQuiston and 
Madison, 1999b).
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Functional nACliRs are also present on pyi'amidal cells (Albuquerque et al., 1997; 
Alkondon et al., 1997; Ji et al., 2001) yet the production o f postsynaptic responses 
in these cells is the subject o f an ongoing dispute. Alkondon (1997) reported that 
pyramidal cells responded to application o f nicotinic agonist with a slow 
depolarisation, however studies by Frazier (1998b) and McQuiston and Madison 
(1999b) generally disagree with these findings reporting no response in the 
majority o f pyramidal cells. In another study, properly timed nicotinic activity at 
pyi'amidal neurones increased the induction o f long-term potentiation via 
presynaptic and postsynaptic pathways but nAChRs activation evoked currents in 
these cells were smaller than in intemeurones (Ji et al., 2001).
niACliRs have been described at both pre and post synaptic sites in the 
hippocampus (Williams and Johnston, 1993). Their presynaptic effects are to 
decrease glutamate and GABA release and thus could be considered inliibitory or 
excitatory. Their postsynaptic effects are to decrease potassium conductances, the 
M current, Im (Halliwell and Adams, 1982) and the calcium activated current, Iahp 
(Storm, 1990) , which in tum  produces a depolarisation o f the postsynaptic 
neurone, making it more likely to fire an action potential (Halliwell and Adams, 
1982). This action is decidedly excitatory because not only is the neurone 
depolarised by the action o f ACh on muscarinic receptors but the decrease in the 
potassium conductance increase the input resistance, making other concomitant 
excitatory inputs more likely to fire the neurone (Jolmston and Amaral, 1998). By 
Recording directly from intemeurones, using the whole cell patch clamp 
teclmique, McQuiston and Madison (1999) have recently shown that inAClfR 
activation produces a variety o f responses in intemeurones including 
depolarisation, hyperpolarisation, a biphasic response or no response but failed to 
find a relationship between interneurone subtype and the nature o f the 
pharmacologically induced cholinergic responses (McQuiston and Madison, 
1999a). Moreover, such changes are not reported to be associated by a change in 
input resistance in intemeurones. Similar findings have recently been reported in
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intemeurones in response to physiological stimulation o f cholinergic afferents 
(Ferrigan et al., 2003).
1.4.8 hippocampal slices
Since it was shown that slices o f brain tissue could be maintained in vitro, slices 
have been extensively used as in vitro models o f CNS activity (Yamamoto and 
Mcllwain, 1966). In vitro brain slices also have considerable value in 
pharmacological experiments whereby the physiological actions o f 
neurotransmitters and drugs can be easily investigated. Several aspects o f the slice 
preparation facilitate this type o f analysis. Many classical pharmacological 
techniques (e.g., dose-response curves, tests for competitive and non-competitive 
antagonisms) can be used to examine dnig responses because dnigs can be applied 
and tested in a relatively quantitative manner (Dunwiddie et al., 1983).
Transverse hippocampal slice has been so useful in evaluating synaptic and circuit 
properties because trisynaptic circuitry is organised approximately in a plain that 
is perpendicular to the long axis o f the hippocampus (Andersen, 1971). This is 
why organisation o f the hippocampus is sometimes teimed “Lamellar” . This 
parallel lamellar organisation favours the use o f the hippocampus as a slice 
preparation since each slice containing all the functional areas and can act as a 
single unit. However, the actual synaptic organisation is not exclusively lamellar. 
There are, in fact, significant longitudinal connections that are not preseiwed 
within thin transverse brain slices (Amaral, 1987).
According to Jefferys (1994), in hippocampal slices seizure-like activity can be 
induced with ease by a variety o f epileptogenic agents, and stable potentials can 
be recorded over several hours. Moreover, drugs can be used without the 
restriction o f the Blood Brain Barrier and systemic metabolism. However, for 
studies o f seizure-like activities, which involve larger areas o f the brain, absence 
o f the rest o f the brain can be a real problem and influence these studies (Jefferys, 
1994).
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1.4.9 The hippocampus and epilepsy
Despite practically every part o f the brain being able to generate an epileptic 
seizure, not all parts o f brain are equally susceptible to epileptic activity. In 
general it is the cortex which is most directly implicated, either the neocortex, or 
older regions such as the hippocampus, entorhinal cortex and piriform cortex. 
Moreover, the interaction o f the cerebral cortex and the thalamus, in conjunction 
with intrathalamic communication, can generate spike waves similar to those 
occuiTing during human absence seizure discharges. Therefore, the stmcture 
affected determines the kinds o f symptoms, the time course and to some extent the 
cellular substrate for the epileptic activity (Jefferys, 1993).
The hippocampus is a major site o f seizure generation (Schwartzki'oin, 1994) and 
it has the lowest seizure thi'eshold o f any brain region (Green 1964). Clinical foci 
here often present a major challenge to current drug therapies and can result in 
cognitive impairments. Indeed, epilepsies with a hippocampal foci constitute a 
significant part o f the caseload in surgery for epilepsy (Laidlaw et al., 1993).
In the hippocampus, the CA3 region normally initiates epileptic discharges 
resembling brief “interictal” electroencephalogram spikes (Jefferys, 1993; Traub, 
1991). CA3 susceptibility results from relatively powerful connections between its 
pyramidal cells (MacVicar and Dudec, 1982; Miles and Wong, 1983), with 
unitary excitatory postsynaptic potentials (EPSP) up to approximately Imv 
between 1% and 2% o f pairs o f neurones (Jefferys, 1994).
The cells o f the CA3 region can produce paroxysms, which transmit to the CAl 
region in a number o f models in dependent o f the dentate gyrus (Schwartzki'oin 
and Prince, 1978). For this reason, the CA3 region has been named the “epileptic 
pacemaker” for the hippocampus (Lothman and Collins, 1990). Ionic movement 
tlirough numerous voltage and ligand gated channels can determine the basal level 
o f cell excitability. Transmission between CA3 neurones can be also amplified by 
“intrinsic burst” driven by dendritic voltage-dependent calcium currents (Wong 
and Prince, 1978). Even under normal conditions CA3 cells can produce
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spontaneously bursting activity which resembles paroxysmal depolarisation shifts 
(PDS) (Wong and Prince, 1978). As indicated earlier, connections between CA3 
cells are numerous and excitatory, thus excitation in one cell can be 
communicated to the next and so forth. Normally synaptic inhibition contains the 
spread o f  excitation tlnough the CA3 network, but when this is blocked, or 
excitation or excitability is enhanced, activity in one or more neurones causes a 
chain reaction which recruits all the neurones within five to six synaptic relays, or 
a few 10s o f milliseconds (Jefferys, 1993; Traub, 1991). Recurrent discharges 
generated by CA3 cells spread to CA l where ictal events can be generated. 
Pyi'amidal CA3 cells may act as interictal spikes pacemakers, because o f very 
high calcium conductance and a profuse disposition o f recun-ent axonal 
collaterals, predisposing to PDS (Ure and Perassolo, 2000). Conversely, CAl 
region is able to maintain seizures by itself, without previous interictal spikes 
(Lothman and Collins, 1990).
Wlien ictal activity encompasses the dentate gyi'us, it will increase in C A l, 
subiculum and entorhinal cortex, which can initiate the discharges via the 
perforant pathways making epilepsy difficult to arrest (Heinemann et al., 1994). 
Moreover, other features o f the hippocampus, electronic synapses, feedback loops 
and ephaptic coupling are important in epilepsy and can reinforce the 
synchi'onisation o f activity (Reviewed by Jefferys, 1995). The anatomical 
arrangement o f neurones into regular sheets provides an ideal substrate for the 
action o f electric fields on membrane potentials. This complex organisation with 
so much potential for abenant excitation makes the hippocampus so prone to 
epileptic tendencies.
1.5 In vitro epileptiform models
1.5.1 General
In vitro models o f epileptiform activity have been used extensively over the last 
few decades to investigate the genesis o f epilepsy-like behaviours within
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hippocampal and neocortical circuits. These models generally involve slices of 
brain tissue, for example hippocampus (M om s et al., 1996; Voslcuyl and Albus, 
1985; Watts and Jefferys, 1993), neocortex (Mattia et al., 1993) and amygdala 
(Arvanov et al., 1995).These preparations can be manipulated by either changing 
the medium used for perfusion or by the direct application o f compounds to the 
slice. Epileptiform activity is generated by the raising the basal level o f  excitation 
or by altering the ion content o f the perfusing medium. Epileptifonn activity can 
take the form o f spontaneous bursts o f population spikes or as multiple waveforms 
in response to afferent stimulation. As mentioned earlier, epileptifonn activity in 
vitro consisting o f short periods o f defined activity is referred to as inter-ictal due 
to the resemblance to this activity in vivo. Similarly periods o f intense activity 
lasting seconds to minutes is denoted ictal-like activity. Although caution must be 
exercised when making direct comparisons between situations in vitro and in vivo, 
in vitro models have been beneficial in understanding the fundamental 
mechanisms which may underlie the generation o f human epilepsy (Jefferys, 
1993).
Indeed, in vivo models have been used in screening potential anticonvulsant 
activity o f many AEDs. Many coimnonly used AEDs have been shown to be 
efficacious in suppressing epileptiform activity in brain slices (Dost and 
Rundfeldt, 2000; Kapetanovic et al., 1995; Sagratella, 1998; Sclnieiderman and 
Schwartzkroin, 1982). Such slice models, whilst reductionism in nature, do 
therefore represent a good predictive indicator o f whether a particular compound 
or receptor type are likely to be o f significance in human epilepsy states.
Moreover, with specific regard to the septo-hippocampal cholinergic system, the 
morphological and physiological literatures suggest that the human and rodent 
innervation and cholinergic receptor expression are very similar (Reviewed by 
Gotti et al., 1997). However, the precise nicotinic receptor distribution in human 
is still not clear and further studies are needed to complete our understanding of 
receptor (and particularly receptor subtype) distribution. Knowledge o f receptor 
subtype distribution is important in order to allow the correct con*elations to be
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made between receptor subtypes and brain functions or pathologies, which would 
thus assist in the search for the subtype-specific therapeutic agents.
1.5.2 4-aminopyridine- induced epileptiform activity
As a specific blocker o f current (Hermaim and Gorman, 1981), 4- 
aminopyi’idine (4AP) has been widely used as a pharmacological agent in diverse 
studies o f channels (Klee et al., 1995; Storm, 1988; Ulbricht and Wagner, 
1976), mechanisms o f epileptogenesis (Chesnut and Swami, 1988; Galvan et al., 
1982; Rutecki et ah, 1987; Voskuyl and Albus, 1985) and synaptic plasticity 
(Andreasen and Lambert, 1999; Buckle and Haas, 1982; Lee et al., 1986). 4AP 
can induce epileptiform activity in vitro (Avoli et al., 1996; Chesnut and Swann, 
1988; Galvan et al,, 1982; Traub et al., 1995; Watts and Jefferys, 1993) and in 
vivo (Morales-Villagran et al., 1996; Szente and Baranyi, 1987; Szente and 
Pongracz, 1979) as well as producing clinical seizure in man (Spyker et al., 1980; 
Thesleff, 1980). Relevant biophysical actions o f 4AP include the following: (1) 
Blockade o f transient currents in postsynaptic soma-dendritic membrane, 
including the fast A current and the slower “delay” (D) current. The A current is a 
rapidly activating and deactivating cuiTent and involved in controlling excitability 
via a role in spike repolarisation (Voskuyl and Albus, 1985). Epileptogenic 
concentrations o f 4AP (<75 pM) probably do not block the A current (Storm, 
1988; Traub et al., 1995). The D current has a rapid activation but a slow 
inactivation, which introduces a long delay in firing induced by just tlrreshold 
depolarisations (Storm, 1988). The D current is more sensitive to 4AP with 
complete blockage occurring between 30-40 pM (Storm, 1988). (2) An increase in 
the excitability o f axons and presynaptic terminals (Buckle and Haas, 1982; 
Kocsis et al., 1983), probably also caused by current blockade which prolongs 
the action potential in the nerve tenninals, allowing a greater calcium influx and 
thus a larger transmitter release (Molgo et al., 1977). (3) A direct effect on
voltage dependent calcium channels could also be an effect o f  4AP (Lundh and 
Thesleff, 1977; Rogawski and Barker, 1983).
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Three types o f spontaneous, synchronous activity were recorded in the presence of 
4AP. The most prevalent is the generation o f frequently occurring bursts o f short 
duration which are reminiscent of inter-ictal activity seen in vivo (Avoli et al., 
1993; M attia et al., 1994; Morris et al., 1996; Voskuyl and Albus, 1985; Watts 
and Jefferys, 1993). Less frequent negative potentials which have been proposed 
to be GABAergic have been found in some instances (Voskuyl and Albus, 1985; 
M attia et al., 1994; Michelson and Wong, 1994; Morris et al., 1996; Perreault and 
Avoli, 1991; 1992; Avoli et a l ,  1993;). Prolonged seizure-like bursts, ictal 
activity, lasting up to tens o f seconds can also occur (Avoli et a l ,  1993; 1996; 
Gean, 1990; M attia et a l ,  1993; Watts and Jefferys, 1993).
The involvement o f glutamatergic transmission in 4AP-induced epileptifonn 
activity has been investigated using selective NMDA and non-NMDA receptor 
antagonists. There are some reports showing that interictal and ictal-like activity 
induced by 4AP are suppressed by non-NM D A  receptor antagonist 6-cyano-7- 
nitroquinoxaline-2,3-dione (CNQX) and 6,7-dinitroquinoxaline-2,3(lH,4H)-dione 
(DNQX) (Avoli et a l ,  1996; Avoli et a l ,  1993; Gean, 1990; Perreault and Avoli, 
1991). NMDA receptor antagonists generally have no or very little effect on 4AP- 
induced bursts (Avoli et a l ,  1993; Gean, 1990; Perreault and Avoli, 1992). 
However, exceptions have been reported. Avoli et al (1996) showed that ictal-like 
events in the entorhinal cortex were abolished by an NMDA receptor antagonist 
3-(±-2-carboxypiperazine-4-yl)-propyl-l-phosphonic acid (CPP) (Avoli et a l ,  
1996). This data was further supported by Gulyas-Kovacs et al (2002), who 
showed that another NMDA receptor antagonist D,L-2-amino-5-phosphonovaleric 
acid (APV) significantly decreased frequency of 4AP-induced epileptiform 
activity (Gulyas-Kovacs et a l ,  2002). Inter-species differences, the cortical area 
from which the slice originated and different experimental conditions may 
account for such differences. For example, 4AP-induced ictal-like bursts in rat 
neocortex were inhibited by non-NMDA receptor antagonist and not affected by a 
NMDA receptor antagonist, whereas the opposite finding was observed with 
slices o f guinea-pig origin (Mattia et a l ,  1993).
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The disappearance o f 4AP bursts in low or zero calcium media also suggests a 
dependence on synaptic activity for generation (Gean, 1990; Voslcuyl and Albus, 
1985).
One o f the unusual features o f 4AP-induced epileptiform activity is that both 
excitatory and inhibitory synaptic transmission is enhanced (Perreault and Avoli, 
1991; Rutecki et al., 1987; Tapia and Sitges, 1982). Unlike other convulsant drugs 
that act primarily by diminishing the efficiency o f GABA-mediated inhibition, the 
evidence available indicates that 4AP-induced epileptiform activity occur despite 
the presence o f normal or even enhanced synaptic inhibition (Chesnut and Swann, 
1988; Rutecki et ah, 1987).
1.5.3 Epileptiform activity induced by GAB A receptor
antagonists
In respect to the action o f these compounds epileptiform activity results primarily 
from reduced G ABA mediated inhibition. Reducing the amplitude o f GABAa- 
mediated IPSPs by 20% is sufficient for synchronous discharges in neocortex 
(Chagnac-Amitai and Connors, 1989). However, the hippocampus is more 
resistance, requiring a nearly complete block o f evoked inliibitory potentials for 
synchronous bursts (Schneideiman et ah, 1992). While much o f the early work 
studied the topical application o f these compounds to the neocortex, hippocampus 
and other structure in vivo, most o f current understanding o f the cellular 
mechanisms o f their actions derives from work on brain slices (Jefferys, 1994). 
Several in vitro models have produced epileptiform activity by using various 
G ABA receptor antagonists, for example picrotoxin (Knowles et ah, 1987; Kohr 
and Heinemann, 1990) and bicuculline (Colom and Saggau, 1994; Gulyas-Kovacs 
et ah, 2002; Herron et ah, 1985). The activity found with these disinhibitory 
models is reminiscent o f the iiiterictal spike o f the epileptic EEG (Jefferys, 1994).
The synchi'onisation o f  neuronal discharges in disinhibited hippocampal slices 
using GAB A receptor antagonists has been studied in some detail. These studies
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revealed that hippocampal neurones are required tlu'ough a network o f recuiTent 
excitatory synaptic connections between CA3 pyiamidal cells (Miles and Wong, 
1987; Traub and Wong, 1982). Recurrent GAB A mediated inhibition normally 
exerts a tight control over the spread o f activity via polysynaptic recurrent 
excitatory pathways between CA3 cells (Miles and Wong, 1987). Disinhibition of 
hippocampal slices by picrotoxin or bicuculline revealed a polysynaptic 
comiection between cells, which previously were not connected. Bicuculline 
decreases the amplitude o f inhibitory postsynaptic potentials and impairs 
inliibition, therefore facilitate propagation o f excitatory signals tluough 
multisynaptic pathways (Gutnick et a l ,  1982; Miles and Wong, 1987).
Development o f synchronised PDSs contribute to burst generation in the 
spontaneous epileptiform process (Prince, 1968). In bicuculline-containing 
solutions a regenerative Ca spike is suggested to initiate depolarisation and 
contribute to the PDS formation (de Curtis et al., 1999). The cellular mechanisms 
involved in the generation o f spontaneous epileptiform potentials in bicuculline 
model are investigated in the pirifom cortex o f the in vitro isolated guinea-pig 
brain (de Curtis et al., 1999). In this study, a large plateau potential similar to that 
obseiwed in neocoitical pyi'amidal neurones bathed in tetrodotoxin and 
tetraethylammonium (Friedman and Gutnick, 1989) is activated at high threshold 
during the spontaneous interictal spike when the sodium conductance is blocked 
in the presence o f a calcium chelator. Such a plateau potential was reversibly 
abolished by a selective blocker o f the calcium conductances and by membrane 
potential hyperpolarisation. The exact tlireshold o f activation o f this calcium 
potential could not be deteimined.
1.5.4 Low magnesium-induced epileptiform activity
Reduced levels o f magnesium have been associated with symptoms o f clinical 
epilepsy (Durlach, 1967). Slice preparations of various central nervous system 
tissues generate epileptiform activity when perfused with a medium devoid o f 
added magnesium: hippocampus (Mody et ah, 1987; Schneiderman and
47
Chapter 1
MacDonald, 1987; Wliittington et al., 1995), entorhinal cortex (Jones, 1989), 
neocortex (Horne et al., 1986) and amygdala (Gean and Shinniclc-Gallagher,
1988).
At normal physiological concentrations magnesium exerts a voltage-dependent 
block on NMDA receptors by binding to a site which is thought to be located 
within the ion channel (Ascher and Nowak, 1988; Mayer et al., 1984; Nowak et 
al., 1984). Relief o f this block can ensue during periods o f depolarisation, 
allowing the movement o f Na^, K"*' and Ca^^ through the receptor channel. The 
activation o f NMDA receptors following removal o f magnesium from the bathing 
medium is considered to he the principal mechanism involved in the generation of 
epileptiform activity in low magnesium model. Evidence comes from the total or 
partial reduction o f epileptiform activity in the presence o f selective NMDA 
receptor antagonists (Home et al., 1986; Mody et al., 1987; Sclmeiderman and 
MacDonald, 1987; Tancredi et al., 1990).
In general the epileptiform activity instigated by low magnesium medium is inter- 
ictal-like and characterised by burst o f milliseconds (Mody et al., 1987; Tancredi 
et al., 1990; Whittington et al., 1995). Ictal events with conesponding tonic and 
clonic periods o f activity has also been recorded in hippocampal slices using a 
low magnesium medium (Anderson et al., 1986).
GABAergic inhibition is still evident during low magnesium epileptiform activity 
due to the maintained ability to evoke inliibitoiy postsynaptic potentials (IPSPs) 
(Tancredi et al., 1990) and thus may act to limit the extent o f firing. In other 
studies inliibition has been found to be reduced in comparison to normal 
circumstances (el-Beheiry and Puil, 1990; Jefferys, 1994).
1.5.5 Elevated potassium-induced epileptiform activity
The extracellular concentration o f potassium rises during seizures induced in vivo 
in cats (Fisher et al., 1976; Moody et al., 1974) and in vitro hippocampal slices
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(Yaari et al., 1986). Basal extracellular potassium levels are approximately 3 mM. 
Raising the concentration o f potassium in the medium bathing slices to 5-10 mm 
results in the generation o f epileptiform activity in vitro (McBain, 1994; Traub 
and Dingledine, 1990; Traynelis and Dingledine, 1988).
Inter-ictal activity in the CA3 region o f hippocampus occur when slices are bathed 
in a high potassium medium (Kom et al., 1987; Rutecki et al., 1985; Traynelis and 
Dingledine, 1988). This activity propagates to the CA l where intense ictal like 
activity results (Traynelis and Dingledine, 1988). The transition from inter-ictal to 
ictal-like activity has been suggested to revolve around an increase in potassium 
concentration (Dichter et al., 1972).
Increased extracellular potassium reduces potassium efflux as a result o f a 
modified concentration gradient (Dietzel et ah, 1980) which increase neuronal 
excitability and increases incidence o f spontaneous EPSPs (Jefferys, 1993). 
Increased potassium levels, paralleled with a decreased potassium driving force, 
cause a decrease in the amplitude o f a potassium mediated after hyperpolarising 
potential (AHP) and a decrease in the amplitude of GABAergic IPSPs (Kom et 
ah, 1987; McBain, 1994). Inhibition is depressed in this model because the 
reversal potential for Cl" shifts towards the resting potential but it is not abolished 
(Jefferys, 1993).
1.5.6 Low calcium-induced epileptiform activity
Reducing extracellular calcium [Ca^^]o is a method o f inducing epileptifoiin 
activity in rat hippocampal brain slices that effectively blocks all chemical 
synaptic transmission (Haas and Jefferys, 1984; Jefferys and Haas, 1982; Taylor 
and Dudek, 1982). This model o f  synclrronisation was reported by several 
laboratories within a few weeks o f each other (Haas and Jefferys, 1984; Jefferys 
and Haas, 1982; Taylor and Dudek, 1982). Hippocampal slices bathed in solutions 
containing level o f [Ca '^^jo low enough (0-0.2 mM) to block synaptic transmission, 
after a delay o f tens o f minutes, started to generate synchronous discharges. These
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discharges differed from those seen with more commonly used convulsant 
treatments in originating most easily fr'om the CA l region. They also differed in 
their appearance which is more prolonged lasting up to tens o f seconds (Jefferys,
1993),
Two non-synaptic mechanisms were at work in the low [Ca^^Jo field bursts. Fast 
synchronisation which is mediated by electric field effects and slower 
synchronisation is mediated tlirough fluctuations in [K^] (Dudek et ah, 1986; Haas 
and Jefferys, 1984; Konnerth et al., 1984). The electric field effects are caused by 
the extracellular currents generated by the activity o f one gi'oup o f neurones 
depolarising the membranes o f their neighbours enough to change their 
excitability. This phenomenon has also been termed ephaptic interaction. As with 
the low magnesium model a reduction in the concentration o f divalent cations 
reduces membrane charge screening and produces high extracellular cuirent 
densities and thus facilitates membrane depolarisation (Frankenhaeuser and 
Hodgkin, 1957; McLaughlin et ah, 1971). The slower form o f non-synaptic 
synchronisation is due to fluctuations in extracellular ions, specially increased 
[K"^ ], result fi'om neuronal activity, and tend to depolarise neighbouring neurones 
and glia (Komierth et ah, 1984). A reduction in calcium dependent potassium 
currents which are responsible for after-hyperpolarisation also contribute to low 
calcium epileptogenesis (Jefferys and Haas, 1982).
The essential condition for this kind o f synclrronisation is that the neurones need 
to be close to threshold. Experimentally this is achieved by the low [Ca^^]o, low 
to normal [Mg '^^Jo and moderately high [K’^ 'jo (Jefferys, 1993). These conditions 
can arise during seizures (Heinemamr et ah, 1986), so that non synaptic 
synchronisation may well have a role in development o f seizure rather than the 
generation of seizure (Jefferys, 1993). One factor in susceptibility o f the CA l to 
this kind o f synchronisation is the tight packing o f the pyramidal cell bodies in 
stratum pyramidale', the restricted extracellular space reinforces both the electric 
and ionic mechanisms (Jefferys, 1993).
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1.5.7 Other models
Much o f the early experimental works used intact laboratory animals, either under 
anaesthesia or freely moving, for studies o f the epilepsy as a disorder o f whole 
brain. These preparations in vivo have largely replaced by preparation in vitro, 
such as the brain slice, for studies at the level o f the single cell or o f small 
population o f cells and local circuits. However, studies in vivo still have important 
roles for placing more reductionist studies into context. Even the most distinct 
focal epileptic discharge tends to propagate to other parts o f the brain, and indeed 
may have profound effects on the body as a whole tlrrough the motor, autonomic 
and endocrine systems. In vivo methods also are crucial for screening new 
anticonvulsants and studying their toxicity and phannacokinetics. They are also 
essential for studying seizure propagation and generation, the behavioural 
correlates o f seizures, the long term structural and functional consequences of 
repeated seizures (Jefferys, 1993).
Kindling is a special clu’onic model o f experimental epilepsies which differs from 
many o f the other chronic models in that it does not necessarily involve 
convulsant drugs (Jefferys, 1993). Its essential feature is the repeated presentation 
o f subconvulsive stimulus that involves activity-dependent changes in neuronal 
structure and flmction (Mody, 1993). The phenomenon o f kindling in epilepsy 
was first discovered by accident by researcher Graham Goddard in 1967. Goddard 
was studying the learning process in rats, and part o f his studies included 
electrical stimulation o f the rats' brains at a very low intensity, too low to cause 
any type o f convulsing. Wliat he found was that after a couple o f weeks o f this 
treatment, the rats did experience convulsions when the stimulation was applied 
(Goddard et al., 1969). Goddard and others later demonstrated that it was possible 
to induce kindling using a chemical (Bell et ah, 1992; Goddard and Douglas, 
1975) such as pentylenetetrazol, either injected through an implanted electrode, or 
given systemically. The definitive feature o f kindling is that the electrical and 
behavioural response to these stimuli progressively increases, so that a constant 
stimulus which initially can be minimal and clearly non-convulsive response
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reduces seizure tlu'esliold and eventually triggers generalised motor seizures 
(Jefferys, 1993),
Activation o f muscarinic cholinergic receptors produces oscillations in the 
hippocampal slice that resemble the theta rhythm, but also may produce abnormal 
synchronous activity that is more characteristic o f  epileptifoiin activity. 
Pilocarpine, a muscarinic agonist, can produce status epilepticus in vivo 
(Cavalheiroet a l , 1991, 1996; Turski et ah, 1983, 1984; Liu et al., 1994) as well 
as inducing epileptiform activity in vitro (Nagao et al., 1996; Rasmussen et al., 
1996; Rutecki and Yang, 1998). When applied to rat hippocampal slices, 
pilocarpine (10 pM) produced brief interictal-like activity, as well as more 
prolonged ictal-like activity, which was comparable to epileptiform activity 
induced by 4AP. However, the interictal activity observed in pilocarpine-treated 
slices displayed a lower rate o f occurrence and a longer duration than in 4AP- 
bathed slices (Nagao et ah, 1996). All types o f synelironous epileptifomi activity 
induced by pilocaipine disappear during application o f the non-NMDA receptor 
antagonist (Nagao et ah, 1996). However, NMDA receptor antagonists can only 
reduce epileptiform discharge duration (Nagao and Avoli, 1994). G ABA mediated 
inliibition is decreased in pilocarpine model (Houser and Escaplez, 1996). 
Moreover, a recent study has revealed that intrinsic bursting in C A l pyramidal 
cells is upregulated in the piloearpine model (Sanabria et ah, 2001).
Numerous other compounds, in addition to the ones already mentioned, have been 
used both in vivo and in vitro to generate epileptiform activity:
• Kainic acid (Stringer and Sowell, 1994; Westbrook and Lothman, 1983)
• Penicillin (Dichter and Spencer, 1969; Lathers et ah, 1993; Wong and Prince, 
1979)
• Pentylenetetrazol (Mirski et ah, 1994; Stringer, 1994; Stringer and Sowell,
1994)
• Tetanus toxin (Wlrittington and Jefferys, 1994)
52
Chapter 1
Trains o f electrical stimuli (Anderson et al., 1987; Staslieff et al., 1985)
Clearly there are multiple experimental approaches that could be used to 
investigate the role o f nACliRs in epilepsy states including human and whole 
animal studies (Damaj et a l ,  1999; Dixit et al., 1971; Miner et al., 1985) as well 
as in vitro imaging (calcium or voltage sensitive dyes) (Gray et al., 1996; 
McGehee et al., 1995; Vogt and Regelrr, 2001) and biochemical (transmitter 
release assays) (Gray et al., 1996; Marshall et al., 1997; Sershen et al., 1997; 
Vidal and Changeux, 1993) approaches. However, I have chosen to adopt 
(induced in vitro slice epileptiform activities monitored by electrophysiological 
means) was based upon the ease o f pharmacological and electrophysiological 
intervention and thus the ability to investigate underlying synaptic and cellular 
mechanisms for an electrophysiological perspective.
1.6 Aims
This project aims to establish the role that nicotinic acetylcholine receptors may 
play in experimental models of epilepsy and to assess whether pharmacological 
agents acting at these receptors might represent a novel avenue for developing 
future anticonvulsants. Specific questions to be addressed include:
1. Investigation into the effects o f iiAChR activation on various experimental 
models o f epilepsies.
2. Identification the subtypes o f nACliRs in modulating epileptiform 
activities.
3. Establish tlirough which circuits iiACliR-mediated effects might be 
occurring.
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MATERIAL AND METHODS
2.1 Slice Preparation
All experiments carried out during the course o f this project were approved by the 
Ethical Review Process Applications panel o f the University o f Glasgow and were 
performed in accordance with the UK Animals (Scientific procedures) Act 1986.
Male wistar rats (2-6 weeks) were bred and housed in gi'oup cages under 
controlled environmental conditions (temperature 19-23°C and 121rr light/dark 
cycles).
All efforts were made to minimise the number o f animals used and their suffering. 
2-3 weeks old wistar rats were cervically dislocated and decapitated in compliance 
with Home Office guidelines on the operation o f the Animals (Scientific 
Procedures) Act 1986. Older rats (4-6 weeks) were terminally anaesthetised with 
an intraperitoneal injection o f Pentobarbitone Sodium (lOOOmg/kg) and then 
decapitated, following unconsciousness and lack o f paw pitch pain reflexes.
An incision was made along the midline o f the head using a scalpel and the skin 
separated to reveal the skull. Using sharp dissecting scissors the skull was cut 
down the midline from back to front and the bone folded to each side to expose 
the brain. The brain, separated from the spinal cord, was carefully removed with a 
small spatula and placed in a beaker o f chilled (0-3°C), oxygenated (95% oxygen- 
5% carbon dioxide) artificial cerebrospinal fluid (ACSF). The standard perfusion 
medium (ACSF) comprised (mM): NaCl, 124; KCl, 3; NaHCOg, 26; NaH2P0q,
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1.25; CaCl2, 2; MgSOq, 1; D-glucose, 10. 5% CO2 was included to maintain a 
correct PH o f 7.4.
Horizontal orientation was chosen for slice preparation (Figure 2.1). The brain 
minus the cerebellum was subsequently hemisected and top surface o f brain was 
glued to the stage o f a vibrating blade microtome (Leica VTIOOO, Milton Keynes, 
U.K.). 400 pm thick transverse horizontal slices were cut using a vibrating 
microtome (Leica VTIOOO, Milton Keynes, U.K.). Tlu'oughout the slicing 
procedure the brain and slices were held in a chamber containing chilled (-2-4°C) 
ACSF. Using a large bore suction pipette, the slices were then transferred to a 
cold petri dish containing chilled ACSF where the hippocampal region o f each 
slice was dissected free from surrounding brain tissue. Hippocampal slices were 
maintained in an interface incubation chamber with an oxygen-emiched 
atmosphere at room temperature (controlled at 26 ± 2°C). Following an incubation 
period o f Ihour the slices were individually transferred to the recording chamber 
using a large bore suction pipette. Spare slices were stored in the interface 
incubation chamber where remained viable for up to 12 hours.
For path clamp recordings hippocampal slices were made from male and female 
Wistar rats (PI 6-28). Animals were terminally anaesthetised with an 
intraperitoneal injection o f Pentobarbitone Sodium (lOOOmg/kg). Following 
unconsciousness and lack o f paw pitch pain reflexes, the abdomen and rib cage 
were opened and a tianscardial perfusion was performed. A hypodermic needle 
(19G 1 Vz) was inserted and fixed into the left ventricle and an incision made in 
the right atrium, the heart was then perfused with 20-60ml o f chilled high sucrose 
ACSF (composition mM: NaCl, 87, KCl, 2.5, NaHCO], 25, NaH2P04, 1.25, 
M gS04, 7, CaCfr, 0.5, glucose, 11, sucrose, 75) in accordance with U.K. home 
office guidelines. Removal o f the brain and preparation o f 250pm slices followed 
an identical procedure to that stated above but in the presence o f a high sucrose 
ACSF solution. Slices were transfeiTed to a submerged holding chamber, heated 
to 37°C for 1 hour and the higli sucrose ACSF was gradually (10% every 15mins) 
changed to normal ACSF over a period of two hours. Slices were stored in the
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Figure 2.1. Process and orientation for slice preparation.
A. Diagram illustrating the direction of slicing. For preparation of slices in a horizontal 
orientation the cerebellum was firstly separated and the brain then hemisected along 
the midline (1). The top part of brain was separated (2) and the brain was then 
inverted and the top surface of brain glued to the stage of a vibrating blade microtome 
(3). Slices were subsequently cut from the bottom surface of the brain at a thickness 
of 400pM. Dotted lines indicate the incisions made and the exposed surface of the 
brain. All procedures were carried out at 2-4°C to reduce metabolic decay and to firm 
the brain for care of sectioning. B. Picture of a trimmed hippocampal slice showing 
several fields of the hippocampal formation and the intrinsic connections.
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submerged style holding chamber at room temperature (19-24°C) until needed. 
They were then individually transferred to a submerged recording chamber using 
a large bore suction pipette as needed.
2.2 Electrophysiology
2.2.1 Recording set-up
The recording chamber, microscope (Olympus, IMT-2, Japan) and manipulators 
(Narishige, MC35, Japan) were mounted on a pressure sensitive anti-vibration 
table (Intracel, UK, Figure 2.2). All other electrical equipment including signal 
processor (model 440, Brownlee Precision), analogue-to-digital converter 
(Digidata 1320 series, Axon instruments), humbug noise subtraction device 
(Quest Scientific) and PC were secured in a racks alongside the Axoclamp 2B 
current and voltage clamp amplifier (Figure 2.2). A schematic o f the experimental 
apparatus is illustrated in Figure 2.3.
An interface type chamber (Figure 2.4) was chosen for extracellular and 
intracellular recordings. This consisted o f a 35 mm diameter plastic chamber in 
which the slices were placed on a small 1 cm square pieces o f lens tissue at the 
interface o f a wanned ACSF and an oxygen-enriched, humidified atmosphere.
The ACSF was heated to approximately 32-34 ®C and bubbled with 95% 0%, 5% 
CO2 to provide a humid oxygen enriched atmosphere. Oxygenated ACSF was 
pumped, by means o f a peristaltic pump (Gilson, France), through the central
chamber providing a constant flow rate o f 1-2 ml.min"^.
Recordings electrodes for extracellular and intracellular experiments were pulled 
from standard-wall (1.2mm internal-/0.69mm external-diameter) borosilicate glass 
capillaries on a Brown and Flaming-type horizontal electrode puller model P-87
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Micromanipulators
Axoclamp 2B Amplifier
Recording chamber
iMicroscope
Pump
Heater
Stimulation
controller
Antivibration air table PC
Figure 2.2. Photograph showing the Recording apparatus.
Photographic image illustrating manipulators and microscope secured on 
antivibration table, with all other equipment secured in racks alongside. 
Recording chamber is mounted under microscope. Micromanipulators are used 
to position recording electrodes. PC drives experiments and captures data.
Glass Mlcroelectrode.
Axoclamp 2B 
AmplifierHUMIDIFIER [warm 95% Og , 5% COg]
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ACSF.Og, COg 
and Drugs OUT
ACSF.Og, CO; 
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Figure 2.3, Schematic of the experimental apparatus.
Flow chart illustrates the apparatus used for electrophysiological recordings. Heated 
oxygenated ACSF is pumped through the central chamber providing a constant flow 
rate. As indicated, the system can be operated in a closed loop so that small 
volumes of drug containing medium can be recirculated if necessary. Hippocampal 
slices are placed in recording chamber at an ACSF/ humidified oxygen (95% Og, 5% 
COg) interface and extracellular recordings then made from hippocampal slices 
using glass microelectrodes. Such field potentials are amplified by an Axoclamp 28 
amplifier and a Brownlee 440 signal processor. Extraneous 50Hz line frequency 
noise was subtracted from traces where necessary using a humbug device. Data is 
digitised (Digidata 1342) and captured as a continuous data stream on PC for further 
off-line analysis.
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Figure 2.4. Interface recording chamber.
Top view of interface recording chamber showing position of hippocampal slices, 
recording microelectrodes, silver wire (amplifier ground) and lens tissue. Oxygenated, 
heated ACSF is pumped through the chamber. Two hippocampal slices are transferred 
to recording chamber and extracellular recordings then obtained from stratum  
pyramidale of area CA3 using glass microelectrodes. Experiments can thus be run in 
tandem to increase throughout.
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(Sutter Instmments, USA). Electrode resistance and filling solutions varied 
according to the type o f experiment perfoimed. Recording electrodes for 
extracellular recordings had blunt tips and were filled with standard ACSF to a 
d.c. resistance o f around 1-5MQ. Electrodes for intracellular recordings were 
filled with 1.5M potassium methyl sulphate and had a d.c. resistance in the range 
of80-150M Q.
Filled recording electrodes were mounted into electrode holders where their filling 
solution came into contact with silver chloride coated silver wire. The electrode 
holder was then inserted into a unity gain head stage (current gain 0.1: Axon 
instruments) and comiected to the axoclamp 2B amplifier. In many experiments, 
two headstages were employed so that it was possible to run experiments on 2 
hippocampal slices in parallel (thus increasing the yield of data collection) or to 
enable simultaneous intra and extracellular recording from an individual slice. A 
silver chloride bath reference electrode submerged in the recording chamber was 
also connected to the headstage.
Bipolar stimulation electrodes were constmcted from two lengths o f 0.05mm 
diameter Nickel 80% /clnomium 20% wire (Advent Research Materials Ltd., 
England) twisted together and cut at the end to produce a focal stimulation. 
Stimuli were produced by constant cuiTent isolated stimulator boxes (Digitimer 
Ltd., England), which in turn were triggered by a Master 8 pulse generator 
(A.M.P.L, Israel).
All stimulating and recording electrodes were mounted on micromanipulators 
(Narishige MC35, Japan) to allow course and fine movement in all {x,y and z) 
directional planes.
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2.2.2 Recording Technique 
2.2.2.1 Extracellular field recordings
These experiments were perfonned in an interface recording chamber. Standard 
ACSF was used as the electrode filling solution to achieve a final d.c. resistance 
between l-SM H.
Spontaneous epileptiform activity recordings:
In order to measure synchronous neuronal discharges that characterise 
epileptiform activities, the majority o f recordings were earned out using the 
extracellular configuration (Figure 2.5). Following an equilibration period o f 1 
hour, two slices were transfeiTed to the recording chamber where the slices were 
allowed to a further equilibration period o f at least 15 minutes before recording 
commenced. Simultaneous extracellular recordings were then made from area 
CA3 of each hippocampal slice.
The recording electrodes were placed on the surface o f each hippocampal slice, 
close to stratum pyramidale within area CA3 (usually CA3c), A  microscope slide 
was subsequently placed over the recording chamber to maintain a high hiunidity. 
Synelironous activity within the slice was manifested extracellularly as field 
potentials (positive and negative deflections) capable o f being detected by 
electrodes in contact with the external space (Figure 2.5). Such field potentials 
were first amplified 10 times by an Axoclamp 2B amplifier operated in bridge 
mode, then a further 200 times by a Brownlee 440 signal processor. The DC 
recordings were then filtered (5 to lOOOHz band pass) and extraneous 50Hz line 
fi*equency noise was subtracted using a Humbug device (Quest Scientific, 
Canada). The processed signal was fed tlirough a Digidata 1320A analogue-to- 
digital converter operating at 0.5-2 IcHz, and thence to a PC for capture on hard­
disk using pClampS.O software (Axon hist.. Union City, CA, USA).
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Individual epileptiform bursting event
Figure 2.5. Examples of extracellular field potentials recordings.
PC screen image showing simultaneous recording from two channels, each 
representing activity in different hippocampal slice. Note that both traces show 
intermittent bursting responses which are recorded in chart recorder mode for 
subsequent off-line analysis.
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Tliree different convulsant models were used in this study: 4-aminopyridine 
(4AP), bicuculline and low magnesium ACSF. Spontaneous synchronous 
epileptifonn activity was induced via the addition o f 4AP (10-50 pM) or 
bicuculline (20 pM) to the perfusion medium, and the burst frequency then 
allowed to stabilise (~ 60 minutes). In the bicuculline experiments, the level o f 
KCl in the standard medium was raised from 3 to 5mM in accordance with 
previously described methods (Ives and Jefferys, 1990). In the low Mg^^ 
experiments, M gS04 was simply omitted from the perfusing ACSF medium 
(Gulyas-Kovacs et al., 2002),
Evoked responses recordings:
Extracellular recordings were carried out in both the CA3 and C A l region o f the 
hippocampus. The 1-5MO recording electrodes were placed on the surface o f the 
slice in the stratum radiatum  o f the CA3 and CA l regions. Stimuli were delivered 
o f 20 second inteiwals via the bipolar stimulation electrode positioned within the 
hilus or Schaffer collaterals pathways and resulting field EPSPs were recorded. 
The stimulus comprised o f a square wave pulses of 20ps duration and 0-30mA 
constant current amplitude. The stimulus intensity was adjusted to evoke a 
response o f half o f maximum response value for each experiment (range 1.2-2.5 
mA).
Z.2.2.2 Intracellular current clamp recordings
In a minority o f slices intracellular recordings were performed simultaneously 
with extracellular recordings. For intracellular recording, electrodes were filled 
with 1.5M potassium methylsulphate (filtered using 0.2pm syringe filter) to 
achieve a final d.c. resistance between 50 -  180MQ. Electrodes were pulled to 
provide a fire tip to pennit entry into pyramidal nem'ones with minimal injury 
discharge.
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Intracellular recordings were made from cells in stratum pyramidale close to the 
extracellular recording electrode. Putative pyramidal cells within area CA3 of the 
hippocampus were identified and differentiated from fast spiking interneurones 
based upon their characteristic properties including a pronounced spike frequency 
adaptation and relative lack o f very fast afterhypeipolarisations (Buhl et al.,1994).
Impalement o f pyramidal neurones was achieved by advancing the recording 
electrode tlri'ough the stratum pyramidale using a Narishige (MC35, Japan) water 
hydraulic drive in two axes. Negative current pulses (0.1 nA) were applied through 
the recording electrode so that any increase in voltage deflection gave an 
indication that the electrode tip was approaching a cell membrane. Subsequent 
application o f an oscillatory cuiTent “buzz” was then used to facilitate penetration 
o f the electrode tip. Following successful impalement spontaneous epileptiform 
activity at the single cell level was monitored under current clamp bridge mode. 
Signals for intracellular recordings were typically amplified x 100 and DC 
recordings low pass filtered (Brownlee 440, 8-pole bessel) at 2KHz and sampled 
at 5-10 KHz for subsequent off-line analysis.
2.2.2.3. Patch clamp whole-cell recordings
Patch clamp experiments were performed with the assistance o f  Leamie Ferrigan. 
Slices were transfeiTed fi*om the holding chamber to a submerged recording 
chamber mounted on the stage o f an Olympus BX50WI upright microscope. 
Electrodes were back filled with a intra-pipette solution, composition (mM): 
KmeS04, 122.5, KCl, 17.5, NaCl, 9, M gCb, 1, EGTA, 0.2, GTP, 0.3, ATP, 3 and
0.5% Neurobiotin or CsCl, 135, M gCb, 2, HEPES, 10 and 0.5% Neurobiotin. 
(Filtered using 0.2pm syringe filter) to achieve a final DC resistance between 6- 
lOMO. Wliole-cell voltage clamp recordings were obtained from CAl
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interneurones under visual control using infrared differential interference contrast 
(DIC) optics and the blow and seal patch-clamp teclmique.
Healthy target cells were chosen on a shiny, smooth appearance o f the cell 
smface. Slight positive pressure was applied to the pipette interior while 
advancing through the slice towards the chosen target cell so that the pipette 
solution streamed outwards maintaining a clean electrode tip and cleaning the 
surface o f  the target cell. The electrode tip was slowly manoeuvred to the cell 
surface while recording cun'ent steps applied tluough the electrode. Once the 
electrode tip touches the cell membrane the positive pressure was immediately 
released to form a low resistance seal, characterised by a reduced cun’ent trace. At 
this point slight negative pressure was applied to increase the seal resistance until 
a high resistance gigaohm seal was achieved. Subsequent hyperpolarisation o f the 
electrode to -70m V  and application o f short suction pulses ruptured the 
membrane patch to achieve the whole cell patch-clamp formation. Voltage clamp 
configuration was chosen for the duration of the experiment and spontaneous 
inliibitory postsynaptic currents (IPSC) were recorded from C A l intemeurones 
within stratum radiatum  and stratum oriens.
2.3 Data Display and Storage
All digitised data captured directly onto DAT tape (DTR-1404; Biologic 
Scientific Instalments, Claix, France) and/or onto a PC hard disk using pClamp8.0 
software (Axon Instruments, CA., U.S.A.) for further analysis.
2.4 Data Analysis
All analysis was carried out off-line using pClampS (Axon Instruments), Origin 6 
(Microcal, MA. U.S.A.) and Mini Analysis version 5.6.28 (Synaposoft Inc. GA,
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USA) software packages. Instantaneous frequency was calculated at a given time 
point as the inverse of the preceding inter-event inteiwal. The data were then 
represented in the scatter plots in which time point o f a given experiment was 
plotted against the inverse of the preceding inter-event inteiwal (‘frequency’). In 
order to not bias any change, which occurred within clusters individual events 
were considered independently. As the basal frequency o f bursting imder control 
conditions varied considerably from slice to slice (Figure 2.5), all data within a 
given experiment were normalised to the mean activity recorded in the presence 
o f each convulsant alone (i.e., mean burst frequency induced by 4AP, BIC or low 
magnesium) to enable comparison and pooling o f data between individual 
experiments (control; 100%). For example when calculating mean values for the 
frequency o f bursting, the average number o f spikes over a 10 minutes period 
before (-10 to 0 mins o f pre-drug control period), dining (10 to 20 mins post-drug 
application) and following wash out o f drugs (20-30 mins following 
commencement o f washout) was measured and nomialised to mean control 
values. Thus all data were expressed as a percentage change from the pre-drug 
control value and presented as means ± standard error o f the mean (S.E.M.). 
Statistical significance determined using Wilcoxon matched pairs test, paired 
Students /-tests, analysis o f variants (ANOVAs) and subsequent post hoc tests 
(Student-Newman-keuls and tukeys) were performed using Graph Pad InStat 
version 3.05 for windows (GraphPad Software, San Diego California, USA). 
Probability values o f less than 0.05 being taken as indicating statistical 
significance, n values refer to the number o f times a particular experiment was 
repeated.
2.5 Drugs and Chemicals
4-aminopyiidine (4AP), choline, dimethylphenyl-piperanzinium (DMPP), N- 
methylcarbamylcholine (MCC), (±) epibatidine, cytosine, atropine, dihydro-(3- 
erythroidine (DH(3E), a-bungarotoxin (a-Bgt), methyllycaconitine (MLA) and
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mecamylamine, all purchased from Sigma-Aldrich Company Ltd (Poole, 
England); Bicuculline, baclofen and 6-nitro-7sulphamoylbenzo[/]quinoxaline~
2.3-dione (NBQX) purchased from Research Biochemicals International (Natick, 
MA, USA.); and Nicotine pmchased from BDH chemicals Ltd (Poole, England.). 
Lobeline and (S)-a-methyL4-carboxyphenyglycme (MCPG) were purchased from 
Tocris Cookson (Bristol, U.K.).
D-(E^-2-Amino-4-methyl-5-phosphono-3-pentanoic acid (CGP 40116), [l-(6)-
3.4-dichlorophenyl)ethyl]amino-2-(6)-hydroxypropyLp-benzyl-phosphoic acid 
(CGP 55 845A) were gifts from Dr Kumlesh Dev, Novartis Phannaceuticals, 
Basel, Switzerland.
All drugs were dissolved in deionised water and stored as frozen 1ml aliquots of 
stock solutions 100 to 1000 times the final concentration. Drug application (final 
dilution) was via perfusion medium for a period not less than 15 minutes.
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REGULATION OF 4-AM INOPYRIDINE- 
INDUCED EPILEPTIFORM  ACTIVITY BY  
nAChR ACTIVATION
3,1 Introduction
The 4-Aminopyridine (4AP) model of epileptiform activity was initially chosen for 
this study since it gives rise to rather stereotyped and reliable responses that are stable 
over prolonged periods. We also become interested in 4AP as our main experimental 
model of focal epilepsy for since its action as a convulsant is well described. First, 
4AP can induce epileptiform activity in vivo (Morales-Villagran et al., 1996; Szente 
and Baranyi, 1987; Szente and Pongracz, 1979) and in vitro (Avoli et al., 1996; 
Chesnut and Swann, 1988; Galvan et al., 1982; Traub et al., 1995; Watts and Jefferys, 
1993) when injected or applied in low concenti'ations. 4AP is also reported to produce 
clinical seizures in man (Spyker et al., 1980; Thesleff, 1980). Second, unlike other 
convulsant drugs that act primarily by diminishing the efficiency of GABA-mediated 
inhibition (Avoli et al., 1988), the evidence available indicates that 4AP-induced 
epileptiform discharges occur despite the presence of normal and even enhanced 
synaptic inhibition (Chesnut and Swami, 1988; Rutecki et al., 1987). 4AP may 
therefore provide a suitable model to investigate the pathophysiological mechanisms 
involved in the generation of epileptiform activity in conditions where synaptic 
inliibition is preserved. Third, 4AP is known primarily as a blocker of currents, the 
fast A cruTent and the slower D cunent (for review see Rudy 1988), although other 
evidence suggests it might affect Ca^ "*" currents as well (Rogawski and Barker, 1983; 
Segal and Barker, 1986). In the somato-dendrite region, these effects of 4AP on
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intrinsic conductance depolarise the cell so membrane potential is become closer to 
action potential threshold and reduce the latency o f action potential generation (Rudy, 
1988), whereas at presynaptic teiininals, the result is a facilitation o f neurotransmitter 
release (Thesleff, 1980) that can enhance both excitatory and inhibitory synaptic 
transmission (Kita et a l, 1985; PeiTeault and Avoli, 1991; Rutecki et al., 1987; 
Thesleff, 1980)).
Three types of burst characteristics have been documented to result from the use of 
4AP, The most prevalent is the generation of frequently occuning bursts of short 
duration, namely interictal activity (Watts and Jefferys, 1993; Mattia et al., 1994; 
Avoli et al., 1996; Morris et al., 1996). Less frequent negative potentials, which have 
been proposed to be GABAergic have been found in some instances (Michelson and 
Wong, 1991; Perreault and Avoli, 1991,1992; Mattia et ah, 1994). Prolonged seizure­
like binsts, ictal activity, can also occur (Gean et al., 1990; Mattia et al., 1993: Watts 
and Jefferys, 1993; Avoli et al., 1996; Morris et al., 1996).
The specific aims of this initial result chapter were to:
1. Identify whether riAChR ligands modulate 4AP-induced epileptiform bursting.
2. Identify the subtypes of rrAChRs involved in modulating epileptifonn activity.
3. Identify the site of generation of epileptiform activity produced by 4AP.
3.2 Characteristics of 4AP-induced epileptiform activity
Extracellular recordings were obtained from the cell body layer o f area CA3 in 
hippocampal slices prepared from 2-6 week old Wistar rats (n=280). Recordings 
under control (ding free) conditions revealed the absence o f any detectable 
spontaneous extracellular field events in all slices tested (n=280). Subsequent 
application of the potassium channel blocker and convulsant 4-aminopyridine (10-50
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pM) resulted in the gi'adual appearance of intermittent large amplitude (0.5~4mV 
peak-to-peak; mean=1.78 ± 0.2mV) rhythmical field potentials (Figme 3.1 A and 
Figure 3.2 A) that eventually settled into a regular frequency of occunence that 
persisted for long periods in the majority of slices tested (n=250 of 280). Tliis 
intermittent bursts activity was reminiscent of inter-ictal activity seen in vivo and was 
similar to those reported previously (Voskuyl and Albus, 1985).
Individual interictal-like (hereafter referred to as interictal) events comprised of (1) an 
initial negative potential followed by (2) a slow positive potential and then (3) a slow 
negative potential and lasted in the range of 200-400ms (mean burst dm’ation=257.2 ± 
15.2ms; Figure 3.1 Bi). On top of this characteristic triphasic waveform however was 
a higher frequency oscillatory component (Figure 3.1 Bii) with voltage fluctuation in 
the range of 82 to 175Hz (mean 129 + 9Hz). Simultaneous intracellular recording 
from CA3 pyramidal cells close to the extracellular recording electrode revealed the 
intracellular con elate of individual spontaneous field events to comprise of a burst of 
action potentials on top of a slower depolarising waveform (Figure 3.1 A-B, n=6). 
Closer scrutiny of such traces showed an association between the timing of action 
potentials within individual bursts and the higher frequency oscillatory activity nested 
within each individual field event (see stippled lines in Figure 3.1 Bii). As the 4AP 
washed into the bath, the instantaneous burst frequency increased to eventually 
become very stable and unifoim over long periods (Figure 3.2 A). At a concentration 
of 20pM 4AP, individual epileptiform bursts occurred every 2.6 ± 0.1s (n=26, range 
= 1.5-3.3s), a mean instantaneous frequency of 0.4 ± 0.02Hz.
Upon washout of 4AP the spontaneous field potentials steadily decreased in 
frequency although complete abolition of spontaneous events was never achieved 
even after prolonged (up to 200 minutes) washout (n=5, Figme 3.2 B).
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Figure 3.1. 4-aminopyridine-induced epileptiform bursting activity in area CA3 of 
the rat hippocampal slice.
A. Intracellular (1C) recording from a putative CAS pyramidal cell and 
simultaneous extracellular (EC) field potential recording upon bath application of 
the convulsant compound 4AP (20pM) as indicated by the solid bar. Note that 
under control conditions the CAS pyramidal cell and extracellular field response 
displays little or no spontaneous activity.Following 4AP application both traces 
become dominated by an intermittent and coherent bursting response. Bi. 
Expanded traces from the same slice showing individual bursting responses both 
at the level of the single cell and the population response. For the extracellular 
trace, arrows indicate the characteristic (1) fast negative potential followed by a 
(2) slow positive potential and (3) slow negative potential. Bii Further expansion of 
an individual burst event reveals coherent high frequency oscillatory activity within 
each burst as indicated by the stippled lines. Scales vertical 1C = 25mV, 1C = 
1mV; horizontal A, 1min, Bi, 1s, Bii, 20ms.
A
NX 0 .8
I  0
I
3.Û(O3O0)cOJ
2 0 p M  4 A P
30 60 90 120 150
B
1 0 u M  4 A P
1.2
Wash out 4AP
0 20 40 60 80 100 120 140 160 180 200
Time (mins)
Figure 3.2. 4AP-induced epileptiform discharges remain stable over prolonged 
periods.
A. Scatter plot showing the burst frequency for the duration of a typical experiment. 
Note burst frequency increases as 4AP washes into the bath before settling into a 
very regular and stereotyped pattern which persists for hours. B. Another experiment 
in which subsequent washout of 4AP results in a significant reduction in burst 
frequency but complete abolition is never achieved even after sustained washout.
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Interictal activity described above was observed in the oveiwlrelming majority of 
recordings from hippocampal slices. Less frequent prolonged ictal-like (hereafter 
referred to as ictal) discharges lasting up to tens of seconds were also observed in 
small minority of experiments (n=5 of 250, Figure 3.3). In the age gi'oup analysed, 
the occurrence of ictal discharges was inversely related to the age o f animal. For 
instance, all ictal activity was recorded using animals as young as 2-3 weeks old, 
which was consistent with previously reported studies (Avoli et al., 1993; Fueta and 
Avoli 1992). In line with this finding, experiments perfonued imder similar 
experimental conditions in hippocampal slices from older rats (4-5 weeks old) have 
indicated that 4AP is only capable o f inducing interictal discharges (Avoli et al., 
1993; Fueta and Avoli 1992).
3.3 Effect of nAChRs agonists on 4AP-induced 
epileptiform activity
Application of the nAChR agonists nicotine (30pM), 1,1 -dimethyl-4-phenyl- 
piperazinium iodide (DMPP, 30pM) and choline (0.3-lmM) to naïve slices in the 
absence of 4AP did not produce any detectable extracellular field activity in any 
slices tested (n=6; data not shown). As nACliR activation did not induce any 
spontaneous network activity, we then went on to assess whether nAChR activation 
modulates pre-expressed synclu'onised bursting activity.
Once stable 4AP-induced epileptifomi activity was established a range of nAChR 
agonists were co-applied in order to examine the effect that nAChR activation had 
upon this form of synclrronised bursting. As the basal frequency o f 4AP-induced 
bursting under conhol conditions varied considerably from slice to slice, all data 
within a given experiment were normalised to the mean activity recorded in the 
presence of 4AP alone to enable comparison and pooling of data between individual 
experiments (control; 100%).
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3.3.1 Effect on burst frequency
In a first set of experiments co-application of the selective nAChR agonist DMPP 
(0.3 to 300 pM) produced a sustained and concenhation-dependent increase in the 
frequency of 4AP- induced epileptifoim bursting activity (Figures 3.4 A; P<0.05). 
This robust response was observed in 31 of 37 slices tested and was reversible upon 
agonist washout (Figure 3.4 A). The concentration response relationship for DMPP 
induced enhancement of burst frequency was unusual in that it was bell shaped 
(Stauderman et al., 1998) with a mean maximal frequency potentiation of 37 ± 5% at 
30 pM and an EC50 calculated fi'om the rising phase of this concentration response 
relationship of 3.5 pM (Figure 3.6 A). At concentrations beyond 30 pM  DMPP still 
potentiated burst frequency but to a level that was significantly reduced to that 
induced by 30 pM DMPP.
In a separate series of experiments application of the weak nAChR agonist choline 
(0.3-1.0 mM) also produced no effect in naïve slices (n=6) but induced a modest 
increase in the frequency of 4 AP-induced epileptiform bursting (Figures 3.4 B and 
3.6 A; E C 5 0  150 pM). The magnitude of this effect was more variable than that seen 
with DMPP and was observed in 23/33 slices tested. Nevertheless the effect of 
choline was similar to that induced by DMPP as it was reversible upon washout of 
agonist and produced a maximal frequency enliancement of 27 ± 5%.
In further experiments, application of the selective and potent iiAChR agonist 
lobeline produced a modest yet significant (P<0.05) increase (24 ± 11%) in burst 
frequency at 10-30pM in 8 out of 10 slices tested (Figme 3.5 A). However, further 
increasing the concentration of lobeline produced a reduction in bm st frequency 
below levels observed in 4AP alone which presmriably reflects the non-selective
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Figure 3.4. Effect of nAChR agonists on 4AP-induced epileptiform bursting in are CA3 
of the hippocampus.
A. Scatter plot showing instantaneous burst frequency in response to continuous 
application of 10pM 4AP for the duration of a representative experiment. Co­
application of the selective nAChR agonist DMPP (SOpM) as indicated by the 
horizontal bar results in an increase in burst frequency. Inserted voltage traces show 
rhythmical bursting in the extracellular field potentials before, during and after DMPP 
application at times indicated by arrows. B. Similar scatter plot in which the selective 
nAChR agonist choline results in a similar dose-dependent and reversible increase in 
burst frequency. Scales A, 2mV, 10s; B ImV, 2s.
A
NX
S-C0)3D"0)
CO30  (ü CjS
1c
B
NX
&C0)3cr0)
(/)30  0 Ci5
1c
1
10 |JM* ; t ‘ i I
JWa^h out lobpline
2mVL
■ ■"^?2CLS'». '  5s / 0.5s
20 pM 4AP
lobeline 
10 uM
[k~
20
20 pM 4AP
40 60 80 100 120
«ftp
0.S
l lü îU :* .
n ; 300 pM
* 'jWash out lobeline
0 20 40 60 80 100 120 140 160
Time (mins)
Figure 3.5. Effect o f lobeline on 4AP-induced epileptiform bursting in are CA3 o f the 
hippocampus.
A. Scatter plot showing frequency of 4AP-induced epileptiform discharges in another 
hippocampal slice. Sections of voltage trace corresponding to timepoints as indicated 
by arrows are shown at bottom of graph. Co-application of 30 pM lobeline ( horizontal 
bar) results in a significant increase in burst frequency. Note that the increase in burst 
frequency in response to lobeline application is accompanied by the appearance of 
burst doublets (indicated by *). Curved arrows indicate expanded sections of trace 
illustrating individual field potential events. Subsequent washout of lobeline resulted in 
the abolition of doublet events and a reduction in burst frequency to baseline levels. B. 
Similar scatter plot showing an increase in 4AP-induced burst frequency following 
application of lobeline (10 and 30 pM, horizontal bars). Further increase in lobeline 
concentration (>10 '^  M) results in a reduction in burst frequency to levels below control 
values reflecting a non-selective blockade of calcium channels (Santha, 2000). Note 
that the decrease in burst frequency in response to high concentration of lobeline is 
reversed upon washout of lobeline. Scale A, 2 mV, 5 s; 2 mV, 0.5 s for expanded inset
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calcium channel blocldng activity of this compound (Santha et ah, 2000) (Figure 3.5 
B and 3.6 A).
In contrast to a constant increase in burst fi'equency induced by DMPP, choline and 
lobeline, application of the agonist nicotine (10-100 pM) produced only a transient 
increase in burst frequency in 7/10 slices tested (Figui'e 3.6 B) and a sustained 
increase in the other tlnee slices examined.
Two other nAChRs agonists (±) epibatidine (O.Ol-lOpM, n=10) and cytisine (0.1- 
30pM, 11=10) were examined but found to produce no consistent or significant change 
in 4AP-induced bui'st frequency at the range of concentrations tested (Figure 3.7).
Figure 3.8 shows summary of nAChR agonists-induced maximal bui'st frequency 
potentiation. A comparison of the effects of various nAChR agonists on 4AP-induced 
burst frequency exposed that whilst DMPP, choline, lobeline and nicotine could 
potentiate 4AP-induced bursting activity significantly, two other selective nAChR 
agonists, epibatidine and cytisine were either poor or ineffective at increasing 
epileptiform burst frequency.
In addition to fast signalling, acetylcholine is laiown to mediate a slower modulatory 
function tlnough both nicotinic and metabotiopic (muscarinic) subtypes of 
acetylcholine receptor (Benardo and Prince, 1982; Cole and Nicoll, 1983; Fraser and 
Macvicar, 1996; Wonnacott, 1997). hi order to rule out any contribution of 
muscarinic type acetylcholine receptors in the effects described above, further 
experiments were carried out in the presence of mACliR antagonist atropine at a 
concentration (lOpM) that is known to completely suppress synaptically and 
pharmacologically evoked mACliR mediated responses in the hippocampal neurones 
(Cobb et ah, 1999; Morton and Davies, 1997). Under these conditions DMPP 
produced a potentiation of epileptiform burst frequency that was comparable to that
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Figure 3.6. Concentration-response relationship for nAChR agonist-induced 
potentiation of epileptiform bursting.
A. Line plot showing the normalised frequency of 4AP-induced bursting events in the 
presence of DMPP (filled squares), choline (triangies) and lobeline (inverted triangles). 
Note that all three agonists produce a dose-dependent increase in burst frequency 
followed by a decrease in burst frequency at higher agonist concentrations (see text). B. 
Scatterplot showing the normalised increase in bursting activity in response to nicotine 
application as indicated by the solid bar (average of 7 slices). Note the transient nature 
of the frequency potentiation.
A
0.6 HNX'—" n 5 -
Üc0) 0 4  -3cr(D4= 0.3 -
(/)3O 0.2 -0)c
c 0.1 -(0(/)c 0
B
NX
s-C0)3O"
ê(/)30 0) cB
1c
1 0  pM 4 -A P  
"4-------------
*r
1.4 !->- 
1,2 ■
1
0.8 ^
0,6 ■
0.4 ■
0.2 j
0 !
0
epibatidine 30 nM 
3 nM 100 nM
Li.îi
20 40 60
Tjme(mlns)
80 100
1 0  pM 4 -A P
cytisine I iKÂ  ^n I
30 60
Time(mins)
90 120
Figure 3.7. Effect o f epibatidine and cytisine on 4AP-induced epileptiform bursting in 
area CA3 of the hippocampus.
Scatter plot showing instantaneous burst frequency in response to continuous 
application of lOpM 4AP throughout two representative experiments. Co-application 
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in the absence of atropine (n=3; Figure 3.9) suggesting a lack o f mAChR involvement 
in this effect.
In further experiments, application of N-methylcarbamylcholine (MCC), a n-methyl 
derivative of carbachol that confers enlianced selectivity for nACliRs over muscarinic 
receptors produced a significant enhancement of 4AP-induced burst frequency when 
applied at a concentration of 10-30pM (n=3 o f 3). However, subsequent experiments 
(see section 3.5) showed this effect to be principally due to its actions at muscarinic 
acetylcholine receptors (mAChRs).
DMPP generated the most dramatic alterations in the parameters of the epileptifoim 
discharges, compared to those induced by the other nAChR agonists. For this reason 
we focused our attention to the effect of DMPP with respect to further and more 
detailed analysis of the various characteristics of 4AP-induced epileptiform activity 
(see below).
3.3.2 Effect on burst duration
In addition to its action on buist frequency, DMPP produced a significant reduction in 
the duration of individual burst events but without causing any overt change in the 
overall waveform (Figure 3.10 A; n=31). The duration o f events decreased as 
frequency increased and both effects were reversible upon agonist washout (Figure 
3.10 B). Detailed analysis revealed a strong correlation between this reduction in 
burst diu'ation and the increase in burst frequency. Figure 3.10 C shows results from a 
representative experiment in which the bui’st frequency could be plotted against the 
burst duration and the data fitted by linear regression (r2=0.653, P<0.0001).
As in the case of DMPP, choline co-application resulted in an increased burst 
frequency that was accompanied by a reduction in the duration of individual burst 
events (data not shown).
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Figure 3.9. Effect of atropine on DMPP-induced burst frequency potentiation. 
Scatter plot shows the action of 10 pM atropine preincubation indicated by 
horizontal bar on DMPP-induced burst potentiation. Note that the selective 
mAChR antagonist does not prevent DMPP-induced potentiation of 
epileptiform burst frequency suggesting that the response to DMPP is due to 
its action at nAChRs.
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Figure 3.10. nAChR activation potentiates burst frequency and reduces duration of 
individual burst events.
A. Extracellular voltage traces showing individual burst events in response to application 
of 4AP alone (i, 20|.iM), co-application of DMPP (ii, 30pM) and following washout of 
DMPP (iii). Note the fast oscillatory component during each burst event. S. Scatter plot 
showing the action of DMPP on the incidence and duration of individual burst events. 
Note that the duration of events decreases as frequency increases and that both effects 
are reversible upon agonist washout. C Same data set in which burst frequency is plotted 
against duration reveals a relationship in which data could be fitted by linear regression 
(r2=0.653, P<0.0001). D. In a minority of slices (see text), burst frequency increases and 
displays secondary bursts or afterdischarges. Scatterplot indicates 4AP-induced 
epileptiform burst frequency for the duration of an experiment. Sections of voltage trace 
corresponding to timepoints as indicated by arrows are shown at bottom of graph. Note 
that the increase in burst frequency in response to DMPP application (30pM, horizontal 
bar) is accompanied by the appearance of burst doublets (indicated by *). Curved arrow 
indicates expanded section of trace illustrating an individual doublet event. Subsequent 
co-application of the nAChR antagonist a-bungarotoxin (lOOnM, horizontal bar) results in 
the abolition of doublet events and a reduction in burst frequency to baseline levels. 
Scales A, 1mV, 50ms; D 2mV, 5s; 2mV, 0.5s for expanded inset.
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3.3.3 Effect on burst waveform
So far we have shown the action of a range of iiACliR agonists including DMPP, 
choline and lobeline all of which produce a concentration dependent increase in brust 
frequency and decrease in bm*st duration without causing any overt change in the 
wavefoixn of individual bursts. In the majority of slices tested, co-application of 
DMPP produced a unifomi increase in bui'st frequency (Figures 3.4 A, 3.10 B). 
However, in a minority of slices (n=6 o f 31) besides a general increase in burst 
frequency, application of DMPP resulted in the appearance of secondary or tertiary 
bursts resulting in doublets and triplets (Figure 3.10 D, indicated by * in sections of 
voltage trace at bottom of graph). This effect was reversible upon washout or upon 
application of the nAChR antagonist (Figure 3.10 D). Similarly, in 2 out of 8 slices 
tested, lobeline application resulted in doublet and triplets bursts which were 
reversible upon washout of lobeline (see Figure 3.5 A). However, the emergence of 
event clusters was not observed following application of choline and nicotine (data 
not shown).
3.3.4 Effect on burst amplitude
The amplitude of epileptifomi bursting is theory provides information regarding the 
number of neurones firing together with the precise degree of synchrony. However, 
our recordings revealed considerable variation between as well as within individual 
experiment. This variation was likely due to factors such as mechanical instability 
and for this reason further analysis was restricted to burst frequency and pattern rather 
than overall amplitude.
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3.4 Effect of nAChRs antagonists on 4AP-induced 
epileptiform activity
In the presence of 4AP alone (i.e., no nAChR agonist present), subsequent application 
of mecamylamdne (200|_iM, n=10) produced no significant change in burst frequency 
(data not shown) whilst dihydro-(3-erytlu'oidine (DH(3E, 20pM, Figure 3.11) and a - 
bungarotoxin (a-Bgt, lOOnM, data not shown) produced a modest decrease in burst 
frequency in 1 of 4 slices tested for each antagonist suggesting that there was little or 
no basal activation of nAChRs under control conditions in the majority of slices 
tested.
3.5 Effect of nAChRs antagonists on nAChR-induced 
burst frequency potentiation
The findings described above using a variety of nAChR agonists suggest that nACliR 
activation is a key diiver for frequency potentiation of 4AP-induced epileptifomi 
activity. To confirm this hypothesis a series of subsequent experiments were 
performed to establish whether a range o f selective iiACliR antagonists could reverse 
the burst frequency potentiation brought about by DMPP and choline. A series of 
experiments were therefore carried out using a range of selective iiACliR antagonists 
including DH(3E, a-Bgt, methyllycaconitine (MLA) as well as the iiACliR non­
competitive channel blocker mecamylamine. Low concenti'ations of DH(3E (IpM ), 
which are ineffective in antagonising a7 nACliR-mediated currents (Mann and 
Greenfield, 2003), were found to have no significant effect on the DMPP-induced 
potentiation of epileptiform bursting. However, the effect of DMPP was completely 
blocked by the 10-30 fold higher concentrations of DH(3E (10-30 pM; n=6 of 8; 
Figure 3.12 A). At a concentration of 20 pM, such co-application of DH(3E caused a
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Figure 3.11. Basai activation o f nAChRs under control conditions.
Application of 10-30 |iM DHpE produced a modest decrease in 4AP-induced burst 
frequency in only one slice (A) but in the majority of slices tested produced no 
significant change in burst frequency (B) suggesting no or minimal basal activation 
of nAChRs under control conditions.
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Figure 3.12. Effect o f selective nAChR antagonists on DM PP-induced potentiation of 
epileptiform bursting in area CA3 o f the hippocampus.
A. Scatter plot showing instantaneous burst frequency in response to continuous 
application of 20 pM 4AP (horizontal bar) for the duration of a representative 
experiment. Co-application of the nAChR agonist DMPP (30pM) as indicated by the 
horizontal bar results in an increase in burst frequency. This is reversed upon 
subsequent co-appilcation of the selective nAChR antagonist Dihydro-p-erythroidine 
(10-30pM). 8. Similar scatter plot in which the potentiating effect of DMPP is 
reversed upon co-application of non-competitive antagonist and nAChR channel 
blocker mecamylamine (200pM).
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significant reduction in bui'st frequency by 55 ± 14.6% (P<0.01). In further 
experiments, DMPP-induced (30 pM) biust frequency potentiation was significantly 
reduced upon co-application of mecamylamine (50-200 pM; n=3 of 4; Figme 3.12 
B), a-Bgt (lOOnM; n=4; Figure 3.13) and MLA (100 nM, n=5) with the tluee 
antagonists producing a reduction in bm*st frequency by 47 ± 14.8%, 86 ± 14% and 
47 + 15.7 respectively (all P<0.05).
Likewise, very similar reversals o f choline-induced (1 mM) burst potentiation were 
achieved using mecamylamine (200 pM, n=5) and a-Bgt (100 nM, n=4); these 
antagonists reducing the potentiation of burst frequency by 67 ± 19% and 65,3 ± 22% 
respectively (both P<0.05). Co-application of MLA (5pM; n=5) also caused a 
significant reduction in burst frequency by 57.07+9.3%. Figure 3.14 shows frequency 
plots from a representative experiment showing that co-application o f MLA and 
mecamylamine results in a reduction of burst frequency to near pre-choline levels.
The pooled results for all antagonist studies are summarised in histogiam format as 
shown in figure 3.15 A-D for DMPP-induced bm’st frequency potentiation and figure 
3.15 E-G for choline-induced burst frequency potentiation.
To expend on these experiments and mle out any contribution of muscarinic 
acetylcholine receptor activation contributes to the burst frequency potentiation, we 
examined the effect of afropine, a mAChRs antagonist, on DMPP-induced burst 
frequency potentiation. In the first set o f experiments slices preincubated with lOpM 
atropine, were still able to exhibit burst frequency potentiation upon DMPP 
application (n=3; Figure 3.10). In other experiments, afropine (lOpM) was co-applied 
following DMPP-induced potentiation but did not reverse or otherwise alter DMPP- 
induced potentiation (n=3; Figme 3.16 A). Together, these experiments suggest that 
mAChRs were not involved in the obseived burst frequency facilitation.
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Figure 3.13. Effect of a-bungarotoxin on DMPP-induced potentiation o f epileptiform 
bursting in area CA3 of the hippocampus.
The scatterplot indicates 4AP induced epileptiform burst frequency for the duration of an 
experiment. Co-application of the selective nAChR agonist DMPP for the period 
indicated by the horizontal bar results in an increase in burst frequency. Sections of 
voltage trace corresponding to the timepoints indicated by the arrows are shown at the 
bottom of the graph. Note that the increase in burst frequency in response to DMPP 
application (30 pM, horizontal bar) is accompanied by the appearance of burst doublets 
(indicated by *) in a minority of slices (see text). Curved arrow points to an expanded 
section of trace illustrating an individual doublet event. Subsequent co-application of the 
nAChR antagonist a-bungarotoxin (100 nM, horizontal bar) resulted in the abolition of 
doublet events and a reduction in burst frequency to baseline levels. Scale C, 2 mV, 5 s; 
2 mV, 0.5 s for expanded inset.
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Figure 3.14. Effect of MLA and mecamylamine on choline-induced potentiation of 
epileptiform bursting in area CA3 of the hippocampus.
Scatter plot showing instantaneous burst frequency in response to continuous 
application of 50 pM 4AP (horizontal bar) for the duration of a representative 
experiment. Co-application of the selective nAChR agonist choline for the period 
indicated by the horizontal bar results in an increase in burst frequency. Subsequent 
co-application of the nAChR antagonist MLA (5 pM, horizontal bar) resulted in a 
reduction in burst frequency. Further reduction in burst frequency was achieved 
following application of 50 pM mecamylamine.
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Figure 3.15. Sum mary o f nAChR antagonist action on D M P P  and choline-induced burst 
frequency potentiation.
A-D. Histograms showing burst frequency as percentage of baseline (i.e. 20 pM 4AP alone) 
in response to DMPP (30pM) and subsequent co-application of the selective nAChR 
antagonists dihydro-(3-erythroidine (A; 20pM), mecamylamine (S; 200pM), a-bungarotoxin (C; 
1G0nM) and methyllycaconitine (D; lOOnM). Note that all antagonists produce a significant 
reduction in DMPP-induced burst potentiation. E-G. Similar histograms quantifying the effects 
of the selective nAChR antagonists a-bungarotoxin (E; lOOnM), mecamylamine (F; 200pM), 
and methyllycaconitine (G; 5pM) on choline-induced (ImM) burst potentiation. Note that all 
three antagonists produce a significant reduction in choline-induced burst potentiation. 
Horizontal bars indicate P values between respective columns as determined using ANOVA.
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The only exception of this finding was in the case of MCC. As mentioned in page 68, 
application of 10-30 pM MCC produced a significant increase on 4AP-induced burst 
frequency. However, when lOpM atropine was co-applied following MCC-induced 
potentiation, a resultant reduction in burst frequency to baseline level was observed 
(n=3, Figure 3.16 B). Preincubation with lOpM atropine (n=3; data not shown) also 
prevented the MCC-induced burst frequency potentiation. Together, these data 
suggest activation of niACliRs to underlie the observed bui'st frequency potentiation.
3.6 Assess the site of generation of 4AP-induced 
epileptiform activity in the hippocampus
In our studies we predominantly focused our investigations and recordings within 
area CA3 of the hippocampus which is known to be the primary generator of 
epileptiform responses in the hippocampal slices (Lotlnnan et al, 1981). Previous 
studies have shown that all areas of the hippocampus partake in the syncln*onous 
discharged evoked by 4AP (Colom and Saggau, 1994; Perreault and Avoli, 1992). 
However, a question we wished to addiess was to assess whether iiAChRs can 
modulate the spread o f activity from one area to another. Simultaneous extracellular 
field recordings were therefore carried out from the cell body layer of area CA3 and 
at the same time, area CAl of the liippocampal slice. Concurrent extracellular 
recording revealed that spontaneous epileptiform activity induced by 4AP was 
synchronous both within the CA3 and CAl regions (Figure 3.17 A, n=4). Subsequent 
bath application of 30 juM DMPP thus resulted in an identical increase in 4AP- 
induced burst frequency in both CA3 and CAl regions (Figiue 3.17 A ,li-2i). As CA3 
and CAl subfields are mono-synaptically connected via the Schaffer-collateral 
pathway the question arises: Can synclrronous epileptiform discharges in CAl area be 
maintained in the absence of this connection? After transection o f the Schaffer- 
collateral afferents (Figure 3.17 B), extracellular field potential activity was abolished 
in the CAl subfield but preserved in the CA3 in the majority of slices tested (n=12 of
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Figure 3.16. Effect o f selective m AChR antagonist atropine on D M P P  and M C C - 
induced potentiation o f epileptiform bursting in area CA3 o f the hippocampus.
A. Scatter plot showing instantaneous burst frequency in response to continuous 
application of 10 pM 4AP (horizontal bar) for the duration of a representative 
experiment. Co-application of 30 pM DMPP as indicated by the horizontal bar 
results in an increase in burst frequency. Subsequent application of 10 pM 
atropine does not affect DMPP-induced burst frequency potentiation suggesting 
that this effect is due to activation of nAChRs. 6. Similar scatter plot in which the 
potentiating effect of MCC, a n-methyl derivative of carbachol is reversed upon 
co-application of 10 pM atropine suggesting that mAChRs were involved in 
MCC-induced burst frequency potentiation.
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Figure 3.17. Activation of nAChRs can modulate 4AP-induced epileptiform activity in 
both CA3 and CA1 regions.
A. Simultaneous extracellular recording from the CA1 (site 1) and CAS (site 2) subfields 
of a hippocampus slice perfused with 20 pM 4AP showing coherent epileptiform activity 
at both recording sites. Scatter plots showing the effect of application of 30 pM DMPP on 
4AP induced bursting activity in CA1 (1i) and CA3 (2i). Note the frequency of 4AP- 
induced epileptiform activity and also DMPP-induced potentiation are exactly same at 
both recording sites. B. Transection of the Schaffer-collaterals connections results in a 
non synchronous and independent epileptiform activity in CA1 (1) and CA3 (2) subfields 
(in a minority of slices, n= 3 of 15) suggesting that both areas have the capacity to 
generate epileptiform activity (see text). Application of 30 pM DMPP results in a 
significant increase in burst frequency in both CAl (1i) and CA3 (2i) yet their activity 
remains independent.
Chapter 3
15, data not shown). However, in 3 out of 15 slices, a non synclnonous and less 
frequent epileptiform activity was also recorded on CAl (Figure 3.17 B, a mean 
instantaneous frequency of 0.6 ± 0.2Hz in CAl compared to 0.86 + 0.3Hz in CA3, 
n=3). This result suggests that epileptifomi activity generated in CA3 and propagated 
to area CAl is the predominant from of network activity. On the other hand, 
extracellular activity recorded in CAl region in the absence of a functional Schaffer- 
collateral input suggests that the CAl field can generate epileptifomi activity in 
dependent of the CA3 and under these circumstances, bursting activity recorded in 
CAl and CA3 are independent. Subsequent application of 30 pM DMPP also resulted 
in an asynchronous increase in 4AP-induced burst frequency on CA3 and CAl 
regions (Figure 3.17 B,li-2i; n=3) suggesting that nAChR-induced modulation of 
epileptiform activity is not unique action with area CA3.
3.7 Discussion
3.7.1 4AP“induced epileptiform activity
The majority of the results described in this chapter were carried out in rat 
hippocampal slices using the extiacellular recording configuration to monitor network 
activity. Extracellular recording from the in vitro hippocampal slice preparation is an 
ideal method with which to study epileptiform discharges (Jefferys, 1993) in that it 
allows synchronous activity of populations of neurones to be detected. A limited 
number of intracellular recordings were also carried out to confirm that the patterns of 
activity studied at the extracellular (network) level reflected the activity of neurones 
at the single cell level. Although such cellular recording studies can reveal important 
mechanistic information regarding the excitability and biophysical properties of 
individual neurones, they do not truly reflect the pathophysiological aspects of the 
disease, with regard to excessively co-ordinated firing of groups of nerve cells. This, 
together with the robust responses and ability to maintain stable recording over long
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periods was the justification for utilising the extracellular recording configur ation for 
the majority of experiments described. Similarly, the 4AP model of epileptifomi 
activity was initially chosen for its rather stereotyped nature and ability to give 
reliable responses that are stable over prolonged periods. The characteristics of 4AP- 
induced spontaneous bursting activity have been described both in hippocampus 
(Avoli et al., 1993; Buckle and Haas, 1982; Ives and Jefferys, 1990; Perreault and 
Avoli, 1989; Perreault and Avoli, 1991; Perreault and Avoli, 1992; Rutecki et al., 
1987; Segal, 1987; Traub et al., 1995; Voskuyl and Albus, 1985) as well as other 
cortical areas (Baikal et al., 1995; Hoffman and Prince, 1995; Mattia et al., 1993). 
Three types of burst characteristics have been documented to result from the use o f 
4AP (see section 3.1). In our experiments, negative potentials were never detected 
and long lasting ictal-activity was only recorded in small minority o f slices (2%). The 
typical activity was a series o f interictal epileptiform discharges, which was seen in 
%98 of all slices tested.
Experimental conditions, such as the cortical area from which the slice originated, 
species and age of animal used for slice preparations, ionic concentrations, 
temperature and the exact recording site within the slice all considerably affect the 
characteristics o f spontaneous activity. For example, the neocoitex of guinea-pig has 
a higher propensity to generate 4AP-induced spontaneous epileptiform activity than 
that of rat (Mattia et ah, 1993). Moreover, slices from the somatosensory cortex of 
adult rats proved to be less prone to epileptic seizures than hippocampal or entorhinal 
cortex slices or cortical slices prepared from young animals (Coiu'tney and Prince, 
1977; Wong and Yamada, 2001). Therefore, we have tried to caiTy out all of 
experiments in the same experimental set-up, using same type o f preparation and 
under similar experimental conditions.
The spontaneous extracellular field events described here comprised of a brief initial 
period o f negativity followed by a slower positive and then negative potential which 
is in agreement with original descriptions (Vosloiyl and Albus, 1985). However,
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within individual biu'st events there existed higher frequency oscillatory components 
in the range of 82 to 175Hz that resembled hippocampal sharp waves described in 
vivo (Buzsaki, 1986) and which have also been described in vitro under conditions of 
elevated extracellular potassium concentrations (Staley et a l , 1998). Extracellular 
field recordings are ideally suited to the study of epileptiform activity and other 
network responses that are characterised by synclnonous activity within neuronal 
ensembles (Jefferys, 1993). That the fast extracellular potentials were associated with 
neuronal discharges at the level o f single cells as shown in figui'e 3.1 A confirms that 
the 4AP-induced field events recorded did indeed represent the coherent activity of 
populations of neurones within the hippocampus. Furthermore, these data also 
highlight the precision o f firing within individual burst events whereby coherent 
action potential discharge appears to be regulated on a millisecond time scale 
(Mainen and Sejnowski, 1995). The precise mechanisms underlying 4AP-induced 
bursting is not fully characterised but appears to involve multiple synaptic and non- 
synaptic elements that together contribute to the overall activity (Traub et al., 2001; 
Traub et al., 1995). An important element of this is likely to be the role of direct 
electrical coupling tluough gap junctions. Indeed, recent studies have shown 4AP- 
induced epileptiform activity to be sensitive to both gap junction blockers as well as 
comiexin 36 gene knockout (Maier et al., 2002; Ross et al., 2000; Traub et al., 2001). 
Wliilst activation of iiAChRs resulted in an increase in burst Eequency, it is apparent 
that the mechanisms responsible for the precise firing of action potentials and fast 
activity within individual bursting events are not compromised upon nACliR 
activation.
The observation that transection of the Schaffer-collateral connections results in 
epileptiform activity being restricted to the CA3 region in the majority of slices tested 
confirms the role o f the CA3 region as being the primary generator o f 4AP-induced 
epileptiform bursting (Jefferys, 1993) and thus points to CA3 pyramidal cell recuiTent 
connections as having a critical roll in generation of this activity as has been 
suggested previously (Clnistian and Dudek, 1988; Mac Vicar and Dudek, 1980). On
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the other hand, the ability o f a minority of isolated CAl ‘mini slices’ to generate 
4AP-induced epileptiform bursting reveals the inhinsically ability o f CA l circuits in 
generating epileptiform activity. It is likely that this ability is normally masked by the 
dominant action of the CA3 circuits which are normally propagated via the Schaffer- 
collateral pathway.
3.7.2 Regulation of burst frequency by nAChR activation
The main finding of this study so far is the demonstration that activation o f nAChRs 
using a range o f selective nAChR agonists results in a modest enhancement of 4AP- 
induced binsting activity in the hippocampus. The pro-epileptogenic action of 
iiACliR agonists was rather subtle however. Indeed, when applied to naïve 
hippocampal slices on their own, the nAChR ligands tested did not produce any 
detectable spontaneous extracellular field activity suggesting that they do not produce 
epileptiform activity per se but rather have a modulatory action over pre-expressed 
synclnonised buisting activity.
Irrespective of their differing pharmacological profiles at recombinant nAChRs, most 
agonists tested produced a concenhation dependent increase in burst frequency in the 
presence of 4AP. Analysis of their potencies for facilitating epileptiform activity 
revealed that they were consistent with their potencies in functional studies that 
directly assess nAChR activity (Alkondon et al., 2000; 1997; Chavez-Noriega et al., 
2000; Guo and Chiappinelli, 2002; Stauderman et al., 1998). The maximum 
enliancement induced by lobeline, choline, DMPP and nicotine was relatively agonist 
independent amounting to a 25-35% potentiation in each case. Baning nicotine which 
sometimes produced a transient increase in burst frequency, each agonist induced a 
potentiation that persisted for the period of agonist application, hrterestingly, most 
agonists when applied at high concentrations produced lower levels o f potentiation, 
or even inliibition, thereby generating bell shaped concentration response
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relationships; a finding that mirrors the profile of activity of these nAChR agonists in 
expression systems (Chavez-Noriega et ah, 2000; Staudennan et al., 1998). The 
explanation for this shared yet unusual profile of activity is unclear. Aside from the 
relative affinity of different agonists for the various nACliR subtypes (Gotti et al., 
1997) which will contribute to the differences in potency and duration of effect of 
each agonist tested it is likely that (a) the degi'ee or state of receptor desensitisation 
(Fenster et al., 1999), (b) degree o f channel block (Marshall et al., 1991; Staudennan 
et al., 1998) and (c) non specific activity (e.g. in the case of lobeline block of voltage 
gated calcium channels (Santha et al., 2000) contribute to shaping the concentiation 
response curve. This latter effect may explain the finding that lobeline produced a 
reduction in buist frequency to levels below control conditions. Another possibility is 
that there exists a significant degree of tonic activation of nACliRs in some slices 
causing a basal nAChR-mediated elevation in epileptiform buisting. This is perhaps 
not surprising given that 4AP is likely to enliance release of neurotransmitters horn 
all terminals within the hippocampus (Rutecki et al., 1987) including cholinergic 
terminals. The subcortical cholinergic innervation to the hippocampus is very dense 
and it is possible that there is a constant release of ACh from the degenerating 
cholinergic terminal field. Moreover, there is also reported to be a sparse population 
of cholinergic intemeurones within the liippocampus (Frotscher et al., 1986; 
Frotscher et al., 2000) which may contribute to tonic nAChR activation (Cobb et al., 
1999). nAChRs are known to exhibit significant receptor desensitisation in the 
presence of high agonist levels. One explanation therefore is that high concentrations 
of nAChR agonists may cause oveiwhelming desensitisation of the hippocampal 
nACliR population and thus reduce the tonic activation of the receptor population 
within the slice. We think this is unlikely however, as application of iiACliR 
antagonists in the absence of nAChR agonist failed to produce any detectable change 
in burst frequency in the majority of slices tested. That said, the lack of effect of 
nACliR antagonists alone on epileptiform activity in isolated hippocampal slices 
suggests little or no tonic activation of nAChRs controlling epileptiform activity. 
However, it should be noted that in such an isolated in vitro system the major
79
Chapter 3
cholinergic afferents are severed. Pertinent to this point, additional nACliR-mediated 
mechanisms to those present in hippocampal slices must operate in vivo to explain 
why nAChR agonists induce epilepsy in their own right in whole animal experiments 
(Damaj et al., 1999; Miner et al., 1985).
Irrespective of which mechanism(s) is/are operating the finding that choline 
potentiates epileptiform activity raises the possibility that this chemical entity may 
provide a physiologically relevant contribution to the patterning of epileptic activity 
in vivo since this natural breakdown product of acetylcholine achieves plasma 
concentrations close to the levels that we have used to potentiate epileptiform activity 
in vitro (Klein et al., 1992).
A striking feature of the nAChR-induced enliancement of bui'st frequency described 
here was that the effect was prolonged, generally lasting for the duration of agonist 
application. An exception to this finding was the effects produced by nicotine that 
commonly resulted in only a transient increase in burst frequency. The reason for 
such differences is unclear but may reflect differences in the degi'ee or state of 
desensitisation or relative affinity for different iiACliR subtypes (Gotti et al., 1997). 
Whilst nAChRs are classically considered to be for fast signalling and rapidly 
desensitise, recent reports in the autonomic nervous system suggest that nAChR 
agonists including nicotine can produce calcium spiking in presynaptic neiwe 
temiinals (Brains et al., 2001) which are sustained over prolonged periods of agonist 
application similar to those used in this study. This supports the proposal nACliRs 
have a dual role in both mediating fast synaptic excitation in certain hippocampal 
circuits (Frazier et al., 1998b; Hefft et al., 1999) whilst mediating a slower 
nem'omodulatory action (McGehee and Role, 1996; Role and Berg, 1996; Wonnacott, 
1997), in particular the modulation of neurotransmitter release (Albuquerque et al., 
1997; Gray et al., 1996; Ji and Dani, 2000) and synaptic plasticity (Ji et ah, 2001). 
Furthermore, it is possible that nAChR activation produces a transient activation of
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the receptor, which in tmii ti'iggers a more prolonged action perhaps involving 
calcium-mediated signalling pathways.
A consistent finding in these experiments was the shortening of burst dmation as the 
frequency o f bursts increased. Such a relationship between bui'st duration and 
frequency has been studied in detail by Staley and colleagues (Bains et al., 1999; 
Staley et al., 1998) who concluded that both parameters relate to the presynaptic 
release of glutamate from recurrent circuits. The action of nicotinic acetylcholine 
receptors with regard to the modulation of glutamatergic recurrent collaterals is 
addi'essed specifically in chapter 5,
3.7.3 Pharmacology of nAChR-induced effect
The cholinergic afferents of the septohippocampal pathway is effective in generating 
limbic seizures (Fraser and Macvicar, 1996) and, thus, injection of cholinergic agents 
is used as a model for temporal lobe epilepsy (Lothman et al., 1991). Indeed, 
hippocampal sclerosis after infusion of cholinergic agonists accurately mimics 
numerous pathological indices of hiunan status epilepticus (Wasterlain et al., 1993). 
In the hippocampal slice preparation, these same analogs generate prolonged 
depolarisations (Bianchi and Wong, 1994) and result in a cholinergic-dependent slow 
afterdepolarisation and long-lasting plateau potential which has properties 
reminiscent of ictal depolarisations obseiwed during cholinergic-induced seizures 
(Fraser and Macvicar, 1996). These actions have been attributed to the activation of 
muscarinic receptors as they are blocked by the selective muscarinic receptor 
antagonist atropine (Bianchi and Wong, 1994; Fraser and Macvicar, 1996). 
Activation of muscarinic receptors during blockade of GABA(A)-mediated inliibition 
also induces synclrronous epileptiform activity in immature rat hippocampus 
(Psarropoulou and Dallaire, 1998) and neocortex (Sutor and Hablitz, 1989).
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In addition to the role of muscarinic acetylcholine receptor in modulating 
epileptiform activity, many reports indicate that nicotinic acetylcholine receptors also 
regulate neuronal excitability within the CNS (Jones et al., 1999) and may be relevant 
to several forms of idiopathic epilepsy (Steinlein, 2001). It has recently been found 
that certain forms of epilepsy may arise from mutations in the genes responsible for 
encoding of nicotinic acetylcholine receptor subimits (Steinlein et ah, 1997; Steinlein 
et al., 1995). Many reports have also shown that high doses o f nicotine induces 
seizures in animals, an effect shown to be blocked by a variety of iiACliR antagonists 
(Damaj et al., 1999). Therefore, it seems that both nicotinic and muscarinic subtypes 
of acetylcholine receptors are likely to modulate epileptiform activity. However, the 
relative contribution of nAChR versus mAChR action in regulating epileptiform 
activity remains unclear. In our experiments we used very selective nAChR ligands to 
minimise any probable contribution of mAChRs. Moreover in order to confirm that 
the observed burst frequency potentiation is tlirough activation of nAChRs and not 
mAChRs, a series of experiments carried out in the presence o f atropine. Such 
application of atropine did not affeet the ability of DMPP to potentiate epileptiform 
burst frequency suggesting that mAChRs were not involved in the obsei^ved burst 
frequency facilitation. Conversely, the effect of DMPP was significantly blocked by 
co-application of iiACliR selective antagonists confirming the involvement of 
riACliRs in DMPP-induced burst frequency facilitation. Only in these experiments 
where the burst frequency potentiation was induced by MCC, was the obserwed burst 
frequency potentiation reversed following co-application of atropine. This result 
indicates that the response to MCC at the concentration tested (10-30 pM) was 
principally due to its actions at mACliRs. In conclusion these results support a dual 
influence of muscarinic and nicotinic acetylcholine receptors on epileptiform activity.
Wliilst the overall pictme that activation of nAChRs can potentiate 4AP-induced 
epileptiform activity in the hippocampus is evident, the precise pharmacology of such 
effects were rather complex and difficult to interpret fully. The agonists DMPP, 
lobeline, choline and nicotine are recognised to be selective nAChRs ligands. Our
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results agree with functional studies which show DMPP to have potent agonist 
actions with EC50 values in the inicromolar range (Chavez-Noriega et al., 2000; 
Stauderman et al., 1998). Choline is a weaker agonist yet is nevertheless reported to 
be an agonist at a l  subunit containing nAChRs (Albuquerque et al., 1997; Alkondon 
et al., 2000). Moreover, a recent report suggest that choline may also activate a novel 
form of nAChR that is distinct from the classical a l  subunit containing nAChR (Guo 
and Chiappinelli, 2002). Again the potency o f choline in potentiating 4AP-induced 
epileptiform responses agrees with published data looking directly at nAChRs 
(Alkondon et al., 1997; 2000; Guo and Chiappinelli, 2002). Indeed, the finding that 
choline produced a pro-epileptogenic actions may be significant since, as the natural 
breakdown product of acetylcholine synthesis, choline may achieve high plasma 
concentrations approaching those levels used in this study (Klein et al., 1992). 
Further studies are required however, to establish whether as an endogenous activator 
of certain nAChRs, choline may serve pathological roles in vivo.
The concept that the effects of the agonists used in this study are due to activation of 
nACliRs is supported by the obseiwations that agonist induced frequency potentiation 
is inhibited by selective iiACliR antagonists, hi general terms, all antagonists tested 
including the non-selective and non-competitive antagonist mecamylamine (Chavez- 
Noriega et al., 1997) as well as the a4p2 subimit preferring antagonist DHpE 
(Alkondon and Albuquerque, 1993; Chavez-Noriega et al., 1997) and the a l  subunit 
preferring nAChR antagonists a-Bgt and MLA (Alkondon et al., 1992) produced a 
reversal of the burst frequency potentiation induced by DMPP or choline. DMPP, 
wliich is known to have affinity for a number of subtypes o f nAChR, is 
predominantly mediating its effects through non-a7 subunit-containing receptors 
whilst the choline response is primarily mediated through a l  subimit containing 
receptors and displays specificity for this receptor subimit (Albuquerque et al., 1997; 
Alkondon et al., 2000). The fact that the effects of both agonist were inliibited by the 
a l  iiAChR-specific antagonist a-Bgt (100 nM), but not by Dh(3E (1 pM) at
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concentrations known to be selective for non-a7 nACliRs perhaps points to these 
possibility that a7  subunit containing receptors are contributing to the frequency 
potentiation induced by both DMPP and choline and that the differences may simply 
reflect the competitive interaction between the ligands. However, in this study it was 
not possible to define with any certainty the precise subtypes of nACliRs involved in 
frequency potentiation. Firstly, the pharmacopea of very selective subtype specific 
nAChRs is as yet rather limited. Few agonists have sufficient nAChR subtype 
selectivity for the exclusive activation of a particular subtype. Thus, with such a 
divers range of subimits, which can give rise to a large niunber o f receptor subtypes, 
determining which nicotinic receptor type is mediating this effect is difficult. 
Secondly, high concentrations of pharmacological agents were used in this study to 
overcome tissue penetration problems associated with brain slices maintained in the 
interface configuration. Most of the dings lose selectivity or can show some 
nonspecific effects at high concentrations: DH(3E is selective for a4|32 receptors at 
10'^ to lO'*^  M. At concentrations as high as 10'^ M, it begins to lose selectivity and 
will block a fraction (30-50%) of a7~mediated response at equilibrium (Alkondon 
and Albuquerque, 1993; Chavez-Noriega et ah, 1997). a-Bgt appears to be specific 
for a l  receptors in the hippocampus, while MLA is selective for a l  receptors at low 
nM concentrations, but will begin to block a4(32 receptors at higher concentrations 
(Alkondon et al., 1992; Alkondon and Albuquerque, 1993). Finally, there was 
considerable inlierent variability in the precise features o f epileptiform activity 
between slices even using the same epileptiform model (Jefferys, 1994). 
Nevertheless, taken together, the antagonist data suggest that a l  subunit containing 
receptors are at least in part involved in the regulation of epileptiform busting. 
Clearly fiuther detailed pharmacological studies using submerged slices and more 
selective agents are required to deteimine the important question relating to the 
relative contribution of different subtypes of nAChR in regulating epileptifoim 
activities. It is interesting to note, however, that recent studies point to specific 
nAChR subimits being important in certain forms of epilepsy (Elmslie et al., 1997).
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Thus, autosomal-dominant nocturnal frontal lobe epilepsy (ADNFLE), wliich is a 
form of idiopathic epilepsy, has linkages to genetic mutations encoding a loss of 
function of the a4 nACliR subunit (Steinlein et a l , 1997; Steinlein, 2000; Steinlein et 
a l, 1995) which causes a reduction in seizure threshold (Gotti et a l, 1997) and other 
epilepsies to mutations in the genes encoding the a l  and P3 nAChR subunits (Durner 
et a l ,  1999; Elmslie et a l, 1997; Neubauer et a l ,  1998; Phillips et a l , 1998); these 
data supporting our own concept that multiple iiACliR subunits are involved in the 
patterning of epileptiform activity.
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REGULATION OF BICUCULLINE AND 
LOW MAGNESIUM-INDUCED EPILEPTIFORM
ACTIVITY BY nAChR ACTIVATION
Chapter 4
C H A PTER  4 
R EG U LA TIO N  OF BICU C U LLIN E AND LO W  
M A G N ESIU M -IN DU C ED  EPILEPTIFO R M  
A C TIV ITY  BY  nA C hR  A C TIV A TIO N
4.1 Introduction
Epileptifomi activity has been reported to be induced following incubation by 
various GAB A receptor antagonists including picrotoxin (Knowles et a l ,  1987; 
Kohr and Heinemami, 1990) and bicuculline (Colom and Saggau, 1994; Gulyas- 
Kovacs et al., 2002; HeiTon et al., 1985). With respect to the phaimacological 
action of these compounds epileptifomi activity results primarily from reduced 
GABAa receptor mediated inliibition. In addition to receptor antagonists, various 
brain slice preparations generate epileptiform activity when perfused with a 
medium devoid o f added magnesium (Gulyas-Kovacs et al., 2002; Horne et al., 
1986; Jones, 1989; Mody et a l ,  1987; Wliittington et a l ,  1995). The mechanism 
by which this occurs relates to the ability o f the decreased [Mg '^^Jo to remove the 
voltage-dependent Mg "^  ^ block from the NMDA-activated channels, thus the 
excitatory glutamatergic transmission is enormously enhanced (Mody et a l ,  1987; 
Traub et a l ,  1994).
To assess whether the nACliR induced facilitation of epileptiform bursting was 
unique to 4AP-induced activity or whether iiAChR activation had a more general 
modulatory influence over other forms o f epileptiform activity, we examined the 
effect o f the iiAChR agonist DMPP on two additional pharmacological 
paradigms, bicuculline (reduced inhibition) and low magnesium (enlianced 
excitation) models.
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4.2 Bicuculline (BlC)-induced epileptiform model
4.2.1 Characteristics of BIC-induced epileptiform activity
Extracellular recordings were made from the CA3 pyramidal cell layer o f rat 
hippocampal slices, which were disinliibited by bath application o f the GABAa 
receptor antagonist bicuculline (30 pM). This resulted in a constant, gradual 
appearance o f spontaneous field potentials 125 + 40 minutes after bath application 
o f bicuculline (30 pM, n= 4). BIC-induced epileptiform discharges occurred every 
5 to 20 s with a mean frequency o f 0.13 ± 0.04Hz and a mean dmation o f 392 ± 
39ms. An elevated level o f ions in the ACSF to 5mM was used in subsequent 
bicuculline experiments in order to decrease the latency o f appearance of 
bicuculline-induced epileptiform discharge. Increasing [K"^ ]o from 3 to 5mM 
resulted in an earlier appearance o f epileptiform discharges (mean latency=20.8 + 
5.5 minutes after application o f 20 pM  bicuculline) and brought the bursts slightly 
closer to the duration and frequency observed in the 4AP induced bursting model 
(mean burst duration=366.6 ± 64ms, mean burst frequency=0.146 ± 0.02Hz, 
n=30)(Ives and Jefferys, 1990).
The overall shape o f an individual epileptifoim discharge induced by bicuculline 
was different from those observed in the presence o f 4AP. They usually observed 
in three types: (1) single, short inter-ictal bursts (Figure 4.1, asterisks in Ai); (2) 
double bursts (Figure 4.1, double asterisks in Ai) and (3) long polyspike bursts 
(Figure 4.1, triple asterisks in Bi). The short inter-ictal like bursts (mean burst 
duration=258 ± 8ms) comprised o f an initial short negative potential (<10ms) 
followed by a biphasic potential, similar to those recorded in 4AP model (Figure
4.1 A, asterisks). A similar high frequency component was also evident 
throughout the event (Figure 4.1 Aii, arrows). Double bursts consisted o f two 
single bursts each o f which had a triphasic waveform (mean burst duration=360 ± 
10ms; Figure 4.1 A, double asterisks). The long polyspike bursts consisted o f a 
primary burst, resembling an inter-ictal burst, followed by a train o f repetitive 
short bursts lasting up to 600 ms (mean burst duration=482.7 ± 32ms; Figure 4.1
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Figure 4.1. Bicuculline-induced epileptiform bursting activity in area CA3 of the rat 
hippocampal slice.
Ai. Extracellular field potential recording from the CA3 stratum pyramidale indicate 
two types of BIC-induced bursting activity: single short bursts (asterisks) and 
double longer bursts (double asterisks). A/7. Expanded traces showing individual 
single (right) and double (left) bursting responses at the level of the population 
response. Bi. Third type of BIC-induced epileptiform bursting indicated by triple 
asterisks. Bii. Expanded trace showing individual long polyspike bursts consisting 
of a primary burst, followed by a train of short individual discharges. Scales 
vertical Ai,Bi: ImV; horizontal Ai.Bi: 10s; Aii,Bii: 200ms.
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B, triple asterisks). However, it is noticeable that the Irigh frequency component is 
mainly restricted to the initial event in the train. Single and double bursts were 
obseiwed in most slices and polyspike bursts were present in 7 out o f 30 slices.
Scatter plot in figure 4.2 shows a representative experiment in which the slices 
were incubated in a raised [K ‘*']o to 5mM medium prior to disinlribition by 
application o f 20 pM bicuculline. This resulted in a regular synclironised 
extracellular discharge, which persisted for the duration o f experiment (>2hours).
4.2.2 Effect of nAChR agonist on BIC-induced epileptiform 
activity
Once stable BIC-induced epileptiform discharge was established, the nACliR 
selective agonist DMPP was co-applied in order to examine the effect o f nicotinic 
receptor activation upon this fonn o f  synclnonised bursting. In 14 o f 14 slices 
tested, subsequent co-application o f DMPP (10-30 pM) produced a significant 
increase in burst frequency (Figure 4.3; mean maximal frequency 
potentiation-248 ± 76% of pre-DMPP baseline frequency) that was reversible 
upon washout o f DMPP (n=6. Figure 4.3). In further experiments, co-application 
o f the nACliR antagonists mecamylamine (50-200 pM, n -3 ; Figure 4.4 A) and 
DHpE (20-40 pM; n=4 o f 5; Figure 4.4 B) were also found to reverse the DMPP- 
induced burst frequency potentiation.
As in 4AP model, application o f DMPP resulted in a significant reduction in the 
duration o f individual BIC-induced burst events from 366.6 ± 64ms (mean o f pre- 
DMPP baseline duration) to 280 ± 25ms after DMPP application.
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Figure 4.2. Bicuculline-induced epileptiform discharges remain stable over 
prolonged recording periods.
Scatter plot showing a representative experiment in which disinhibition of the slice 
following application of the GABA^ receptor antagonist bicuculline (20 pM) at time 
point 0 produced a regular synchronised extracellular discharge. Note that 
bicuculline-induced burst frequency remained stable over the extended period of 
experiment.
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Figure 4.3. nAChR activation potentiates BIC-induced epileptiform activity in vitro. 
Scatter plot showing instantaneous burst frequency in response to continuous 
application of 20pM bicuculline for the duration of a representative experiment. Co­
application of the selective nAChR agonist DMPP (30pM) as indicated by the 
horizontal bar results in an increase in burst frequency. This was partially reversible 
upon subsequent washout of DMPP.
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Figure 4.4. Effect o f selective nAChR antagonists on DM PP-induced potentiation of 
BIC-induced epileptiform bursting in area CA3 of the hippocampus.
A. Scatter plot showing instantaneous burst frequency in response to continuous 
application of 20 pM bicuculline (horizontal bar) for the duration of a representative 
experiment. Co-application of the selective nAChR agonist DMPP (10-30 pM) as 
indicated by the horizontal bar results in an increase in burst frequency. This is 
reversed upon subsequent co-appilcation of non-competitive antagonist and nAChR 
channel blocker mecamylamine (200pM). B. Similar scatter plot in which the 
potentiating effect of 10 pM DMPP is reversed upon co-application of the selective 
nAChR antagonist Dihydro-(3-erythroidine (30pM). Insets represent spontaneous 
field potentials before, during and after nAChR activation. Scales vertical:I mv, 
horizontal: 10 s
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4.3 Low magnesium-induced epileptiform model
4.3.1 Characteristics of low magnesium-induced epileptiform 
activity
Extracellular recordings were made from the CA3 pyiamidal cell layer o f rat 
hippocampal slices incubated in ACSF in which ions had been omitted
(n=21). Spontaneous field potentials typically appeared 5-30 minutes following 
switch over to low magnesium ACSF, with an average latency of 19.8 ± 4  min, 
similar to that reported previously (Hsu et ah, 2000).
Three different types o f spontaneous synchronous activity were recorded in the 
CA3 stratum pyramidale o f slices exposure to low magnesium ACSF. Brief, 
single inter-ictal-like discharges (mean diiration=204.6 ± 18.9ms; mean, frequency 
= 0.2 ± 0.03FIz; Figure 4.5 A, asterisks) and double bursts (mean duration=383 ± 
6ms; mean, frequency = 0.16 ± 0.03Hz; Figure 5 A, double asterisks) were present 
in all slices tested (n-21). In addition, more prolonged ictal-like discharges (mean 
duration=3640 ± 900ms; mean frequency=0,04 ± 0.01 Hz) were seen in 4 out o f 21 
slices (Figure 4.5 B).
4.3.2 Effect of nAChR agonist on low magnesium-induced 
epileptiform activity
To assess the effect o f nACliR activation on ongoing low magnesium-induced 
epileptiform discharges, the selective iiACliR agonist DMPP was bath applied to 
slices displayed stable epileptiform burst activity. Subsequent co-application of 
DMPP (30 pM; n=10 o f 10 slices) resulted in a significant {P<0.03) increase in 
event frequency (mean maximal frequency potentiation=l 10 ± 37% o f pre-DMPP 
baseline frequency). DMPP also increased the frequency o f pre-existing ictal-like 
discharges (n=4 o f 4 slices). Increase in burst frequency was associated with 
decrease in the duration o f both inter-ictal-like and ictal-like discharges. For
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Figure 4.5. Low magnesium-induced epileptiform bursting activity in area CA3 of 
the rat hippocampal slice.
Ai. Representative examples of brief spontaneous synchronous events recorded 
in the CA3 stratum pyramidal of slices incubated in low magnesium ACSF: Brief, 
single discharges (asterisks) and double bursts (double asterisks) . Aii. Expanded 
traces showing individual single (right) and double (left) bursting responses at the 
level of the population response. Bi. In a minority of slices, low magnesium 
medium resulted in the appearance of more prolonged ictal-like epileptiform 
discharges. Bii. Expanded trace showing individual long polyspike bursts 
consisting of a train of short individual discharges lasting up to several seconds. 
Scales vertical Ai,Bi: 1mV; horizontal Ai,Bi: 10s; Aii:200 ms; Bii: 1s.
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example, there was a reduction in the duration o f ictal-like bursts hom  3640 ± 900 
ms (mean o f pre-DMPP baseline duration) to 1100 + 126.5ms after DMPP 
application. Furthermore, in 4 o f 10 such slices tested, DMPP resulted in the 
appearance o f many more secondary bursts or afterdischarges which had been 
infrequent or absent prior to nACliR agonist application (Figure 4.6 A).
DMPP-induced effects were reversible upon washout o f the agonist (Figure 4.6 A; 
11=3) or upon co-application o f the nACliR antagonists dihydro-p-erytliroidine 
(20-40 pM; n=3 o f 5; Figiue 4.6 B) and MLA (5 pM; n=2 o f 2; data not shown).
4.4 Comparison of spontaneous epileptiform activity in 
three in vitro epilepsy models
Spontaneous, recurring, inter-ictal-like epileptifoim bursting developed in all 
thiee convulsant solutions. However, the exact characteristics o f epileptiform 
activity were different. Comparing the three models, differences were detected in 
the time o f appearance o f the first spontaneous epileptiform discharge and in the 
fi'equency o f epileptiform discharges after a 30-45-min stabilisation period. The 
duration o f the individual spontaneous epileptiform bursting events was also 
different. The longest duration o f discharges was obseiwed in low magnesium, 
whilst the highest frequency o f spontaneous events was detected in 4AP (Table 
4.1). Slices exposed to 20 pM  4AP generated spontaneous epileptiform bursts, 
which lasted about 200-400ms and recurred regularly at a rate which varied 
between slices but which were in the range o f 18-40 events per minute. Slices 
exposed to 20 pM  BIG and low magnesium medium generated longer, less 
frequent bursts, lasting about 400ms and recurring iiTcgularly at about 10 events 
per minute. The shape o f spontaneous epileptiform discharges was rather 
complex. The overall waveform o f an epileptifoim discharge developed in 4AP 
was different fi'om those observed in the other two convulsants, hi 4AP model, a 
single triphasic waveform was observed in the majority o f  slices tested, whilst in 
BIG and low magnesium models double or poly spike bursts were common.
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Figure 4.6. Effect of selective nAChR-antagonists on DM PP-induced potentiation 
of low magnesium-induced epileptiform bursting in area CA3 o f the hippocampus. 
A. Scatter plot showing frequency of epileptiform events in another hippocampal 
slice in which NMDA-mediated excitation was enhanced by removal of Mg'"”" ions 
from the perfusing medium. Sections of voltage trace corresponding to the 
timepoints indicated by the arrows are shown at the bottom of the graph. Note that 
the increase in burst frequency in response to DMPP application (30pM, 
horizontal bar) was accompanied by the appearance of burst clusters or 
afterdischarges (indicated by *). Curved arrows point to expanded sections of 
trace illustrating individual field potential events. Subsequent washout of DMPP 
resulted in a reduction in burst frequency to baseline levels. Shaded horizontal 
bars indicate the period over which an individual agent was applied to the bath. B. 
Similar scatter plot in which the potentiating effect of 30 pM DMPP is reversed 
upon co-application of the selective nAOhR antagonist Dihydro-(3-erythroidine 
(30pM). Scales A, 2mV, 10s, 0.5s for expanded inset.
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Indeed ictal-like activity recorded more generally in low magnesium model and 
observed in 4 out o f 21 slices tested.
Table 4.1 Characteristic parameters o f  seizure discharges developing in solutions containing 
different convulsants.
Latency (min) Frequency (Hz) Duration (ms)
4AP(n=26) 17 ±2.6#  _ a 0.4 ±0.02.................
257 ±15.2
BIC (n=30) 20.8 ± 5.5 0.146 ±0.02 366.6 ± 64
Low magnesium 
'  (n=2iy 19.8 ± 4 0.165 ± 0.024 711.62 ±295
A comparison o f the effects o f DMPP upon the three models o f epileptiform 
bursting revealed that whilst nAChR activation potentiated burst frequency in 
every model, there were quite marked differences in the magnitude o f potentiation 
induced in each model. Application o f DMPP (10-30 pM) resulted in a burst 
frequency potentiation in 4AP, BIC and low magnesium-induced activity with a 
mean maximal frequency potentiation o f 37 ± 5%, 248 ± 76% and 110 ± 37% for 
three treatments, respectively (P<0.01). Clearly, application o f DMPP produced a 
significant increase in all three models. However, comparing across models, 
qualitative and quantitative differences emerged: potentiation was most 
pronounced in the bicuculline model with lesser potentiation in the low 
magnesium model and lowest potentiation in the 4AP model. These data are 
summarised in histogram format in figure 4.7. The same data normalised to 
control (pre-DMPP) frequency show a significant increase in all cases (Figure 4.7 
B, P<0.01) but with a greater frequency facilitation in bicuculline and low 
magnesium paradigms.
91
ANX
S'c<D3O '0)
3CÛ
B
0.6
0.5
0.4
0.3
0.2
0.1
0
4AP bicuculline low 
magnesium
500
400S'c  (D 3
2  300y—
I  200
Eo c
1 0 0
0
P=0.0001
P=0.0001 
n=14 ^
P=0.007
4AP bicuculline low 
magnesium
Figure 4.7. Sum mary o f DM PP-induced burst frequency potentiation in all three 
models o f epileptiform activity.
A. Histogram summarising 10-30 pM DMPP-induced burst frequency potentiation 
in 4AP, bicuculline and low magnesium models. B. Same data normalised to 
control (pre-DMPP) frequency show a significant increase in all cases (Wilcoxon- 
matched pair test, P<0.01). Note the relative burst frequency enhancement is 
greatest for bicuculline and under low magnesium conditions.
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4.5 Discussion
Characteristics o f the spontaneous epileptifonn activity developed in different 
convulsants depend on the underlying mechanisms o f neuronal synchronisation. 
4AP, as a blocker o f different chamiels (Storm, 1987; Storm, 1988), results in 
the direct depolarisation o f pyramidal cells whilst also directly facilitating 
synaptic glutamate release (Perreault and Avoli, 1991; Traub et al., 1995). BIC, as 
a GABAa receptor antagonist, decreases the amplitude o f irrhibitory postsynaptic 
potentials, therefore facilitates propagation o f excitatory sigrrals tlrrough 
multisynaptic pathways (Gutnick et al., 1982; Miles and Wong, 1987). 
Bicuculline will also suppress the basal inhibition due to tonic release o f GAB A 
that is reported to occur in the hippocampal formation (Soltesz and Mody, 1994). 
hr low magnesium, voltage-dependent blockade o f #-methyl-D-aspartate 
(NMDA) receptors is reduced, thus allowing excitatory glutanratergic 
transmissiorr to be enormously entranced (Mody et al., 1987; Traub et al., 1994).
Different types o f in vitro slice models have been introduced to analyse the 
development, maintenance and pharmacology o f  epileptiform activity evoked by 
the application o f these different convulsants (Gulyas-Kovacs et al., 2002; 
Gutnick et al., 1982; Home et al., 1986; Jefferys, 1994; Jones, 1989; Mody et al., 
1987; Traub et al., 1994). The characteristics o f resultant epileptiform activity 
have varied between studies. This is likely due to differences in the brain region 
from which the slice originated, in the method o f drug application, or in the 
conditions of the recording epileptiform activity. For this reason, we carried out a 
series o f experiments to compare the characteristics o f spontaneous epileptiform 
activity induced by tluee different convulsant solutions and the effect o f nAChR 
activation on these tluee convulsant models in the same type o f  preparation and 
under similar experimental conditions. However, characteristic features and 
pharmacological sensitivity o f  the discharges differed among the thr'ee models 
despite the fact that recordings were always carried out in the same place: in the 
cell body layer o f area CA3 in hippocampal slices prepared from juvenile Wistar 
rats. The shortest latency o f the first spontaneous epileptiform discharge and the
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highest frequency were detected with 4AP. The longest duration o f epileptiform 
discharges and bursts with duration approximating seizures were obseiwed with 
low magnesium (Jefferys, 1994; Swartzwelder et al., 1987). In deed these results 
agi'ee well with a recent comparative report, studying the characteristic o f seizures 
developed in somatosensory cortical slices in these tluee models (Gulyas-Kovacs 
et al., 2002).
Inter-ictal discharges are characterised by two major abnormal properties: each 
involved neurone exhibits a transient large amplitude depolarisation (the 
"depolarisation shift") associated with repetitive spike generation, and this 
excitation arises with virtual syncluony in the majority o f cells in a local 
population (Prince, 1968; Prince and Connors, 1986). The duration and amplitude 
o f the paroxysmal depolarisation shift (PDS) depend on the actual membrane 
characteristics and on network properties. These characteristics may vary in 
different convulsant solutions. In BIC the syncluonisation is mainly due to the 
altered network properties, namely inhibition is reduced in the local circuits. In 4- 
AP, and especially in low magnesium, changes in the membrane characteristics of 
neurones play a crucial role in the increased excitability. Thus, the characteristics 
o f epileptifonn discharges induced by each o f these convulsants vary because of 
the different basic processes underlying epileptiform activity in each of them. 
Synchronised PDS activity o f all neurones fonning an active network determines 
the shape, duration and amplitude o f the epileptifonn discharges, which are 
detected extracellularly as field potentials (Gulyas-Kovacs et al., 2002).
The activation o f NMDA receptors is accounted in some studies (Siniscalchi et 
al., 1997; Valenzuela and Benardo, 1995) to be the most important factor in the 
development o f epileptic activity. Moreover, these receptors play a crucial role in 
the initiation and maintenance o f  epileptiform activity (Jefferys, 1994), especially 
in low magnesium (Gulyas-Kovacs et a l ,  2002). In low magnesium the 
excitability o f these receptors increases extremely, which contributes to the 
development o f long PDSs generating bursts or series o f spikes. Both in BIC- and 
in 4AP-containing solutions, PDSs develop, which contribute to burst generation.
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In BIC, however, a regenerative calcium-mediated spike was suggested to initiate 
the depolarisation (de Curtis et al., 1999). It is also reported that, in disinliibited 
hippocampal slices non-NMDA type receptors have the primary role in the 
initiation o f epileptiform activity (Traub et al., 1993) and NM DA type receptors 
are important in the maintenance o f epileptiform activity beyond the first 100-200 
ms (Jefferys, 1994). While in 4AP enonnous excitatory synaptic potentials 
tlnough both types o f ionotropic excitatory amino acid receptors were recorded as 
contributors to the PDS formation (PeiTeaiilt and Avoli, 1991). This difference 
may be an important factor in the alteration o f the shape o f inter-ictal discharges 
(Gulyas-Kovacs et al., 2002).
The waveform o f the discharges also depends on the relative location o f the 
recording site and the burst initiation site. In different convulsants, seizure 
initiation may occur in different places, hi many cases, including bicuculline and 
4AP, the CA3 subfield is the site o f initiation o f epileptiform discharges (Jefferys, 
1993). Wliere as, the prolonged ictal-like discharges in low magnesium and liigh 
[K^]o start in C A l, not CA3, thus leading to the proposal that C A l contains a 
separate neuronal aggi'egate necessary for seizures (Jefferys, 1993; Jefferys, 1994; 
Jensen and Yaari, 1988).
In previous chapter I have shown that nACliRs regulate epileptiform bursting 
induced by 4AP in rat hippocampal slices. The objective o f the experiments 
described in this chapter was to assess whether nAChR activation has a general 
excitatory influence over patterned neuronal activity within cortical circuits, we 
examined the effect o f the iiACliR agonist DMPP on two additional epileptifonn 
models: BIC and low magnesium models. Our results showed that nAChR 
activation again potentiates epileptifonn activity in both two models. Application 
o f DMPP resulted in an entranced burst frequency, which was reversed upon 
washout or co-application o f the selective nAChR antagonists. Moreover, DMPP 
made polyspike bursts or afterdischarges appear when absent in control in all 
three models or increased the frequency o f pre-existing ictal-like discharges in 
low magnesium model. In all cases increase in burst frequency was associated
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with decrease in burst dmation and in the case o f low magnesium decrease in 
duration o f ictal-like bursting. The finding that nACliR activation also potentiates 
epileptifonn bursting resulting from inliibition o f GABAa receptors by application 
o f BIC and reduction o f Mg^"  ^ ions from the perfusion medium and concomitant 
elevation in NMDA receptor-mediated excitation (Traub et a l ,  1994) suggests 
that nAChRs affect a cellular mechanism that is common to all tlnee epilepsy 
models investigated. In this respect, a potentially important locus o f action is 
likely to be the recurrent glutamatergic synapses in area CA3 since these recurrent 
comiections are believed to be critical in the generation and regulation o f bursting 
activity within the CA3 network (Bains et a l ,  1999; Staley et a l ,  1998; Traub,
1991). Supporting this idea are recent studies that have demonstrated 
acetylcholine to modulate these synapses directly (Vogt and Regelm, 2001). Thus, 
it is plausible that frequency potentiation described here reflects the activation of 
presynaptic nACliRs that facilitate glutamate release which, in turn, forces the 
network into a higher frequency bursting mode. Consistent with this hypothesis as 
the frequency o f bursting increased so the duration o f bursts decreased; a 
relationship that has been studied in detail by Staley and colleagues during other 
experimental manipulations that increase burst frequency (Bains et a l ,  1999; 
Staley et a l ,  1998) and who concluded that both parameters relate to the 
presynaptic release of glutamate fr'om recurrent circuits. An important obsei*vation 
in this study was that iiACliR activation appeared to produce a greater 
enliancement o f epileptiform burst frequency in the bicuculline and low 
magnesium experiments than in the 4AP studies (Figure 4.7). 4AF is known to 
enhance the release o f all transmitters in the hippocampus including glutamate 
(Rutecki et a l ,  1987). Should iiACliRs be acting tlrrough presynaptic facilitation 
o f glutamatergic recurrent collateral comiections then it is likely that in the 4AP 
model these synapses would already be potentiated partially by 4AP itself since 
this agent gi'eatly promotes glutamate release (Rutecki et a l ,  1987). Such an 
explanation would account for the relative greater effectiveness o f nACliR 
agonists in the bicuculline and low magnesium models. A  second potential site for 
the involvement o f iiACliRs is in modulating GABAergic circuits. Indeed 
GABAergic hippocampal intemeurones are laiown to express nAChRs (Freedman
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et al., 1993; Freund and Buzsaki, 1996) and pharmacological studies have shown 
that either pharmacological or synaptic stimulation o f these receptors produce an 
postsynaptic depolarisation or inward cmi'ent (Frazier et al., 1998b; Jones and 
Yakel, 1997). Clearly however, further studies are required to establish the precise 
mechanisms by which nACliR activation promotes epileptiform bursting and 
other pathological network states (see next chapters).
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5.1 Introduction
The numerous subunits that make up nAChRs result in a great diversity o f 
functional receptors, equipping them with different pharmacological and 
biophysical properties, depending on iiACliR subtypes and their location. Located 
at both pre- post and extra-synaptic sites, nAChRs are ideally placed to regulate 
neuronal excitability in the CNS (Jones et ah, 1999). In the hippocampus, 
nACliRs, including the calcium permeable a7-type, are present on surface of both 
GABAergic inhibitory interneurones (Alkondon et ah, 1997; Frazier et ah, 1998a; 
Frazier et ah, 1998b; Freedman et ah, 1993; Freund and Buzsaki, 1996; Jones and 
Yakel, 1997; McQuiston and Madison, 1999b) and the excitatory glutamatergic 
pyiamidal cells (Albuquerque et ah, 1997; Alkondon et ah, 1997; Ji et ah, 2001), 
modulating both inhibitory and excitatory circuits. Thus, it is likely that the pro- 
epileptogenic action o f nACliR activation described in previous chapters is 
mediated tlmough glutamatergic circuits, GABAergic circuits or both.
In 1997 Alkondon reported that pyi'amidal cells responded to application of 
nicotinic agonist with a slow depolarisation. However, McQuiston and Madison 
(1999) reported that only 2 out o f 15 pyramidal cells responded to ACh 
application with a slow depolarisation and inward currents and that such 
responses were very small and only just at the level o f detection. A postsynaptic 
nicotinic response from pyramidal cells has been the subject o f an ongoing dispute 
with most previous studies reporting that pharmacological activation o f nAChRs
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do not produce any foiTn o f membrane potential response in these cells (Frazier et 
ah, 1998b; Jones and Yakel, 1997). Although pyramidal cells do express nicotinic 
receptors their role is thought to be presynaptic, important in the modulation of 
neurotransmitter release (Albuquerque et ah, 1997; Gray et ah, 1996; Ji and Dani, 
2000). It is hypothesised that activation o f presynaptic nicotinic receptors 
enhances transmission directly by elevating presynaptic calcium levels (Gray et 
ah, 1996). However, som e other studies were unable to evoke an increase in 
presynaptic calcium levels with local application o f nicotinic receptor agonists 
suggesting an indirect synaptic modulation could arise from nicotinic excitation 
(Vogt and Regehr, 2001).
Many reports have shown that high doses o f  nicotine acting at the neuronal 
nAChRs can induce seizures in animals (Damaj et ah, 1999; M iner and Collins, 
1989; Miner et ah, 1985). This effect has been studied in detail by Damaj and 
colleagues (1999) who concluded that nicotine by acting at the presynaptic 
nAChRs, enhance the release o f glutamate, which in turn stimulates NMDA 
receptors leading to nitric oxide fomiation and possibly seizure production. 
However, such studies were all carried out in vivo in which there is limited scope 
for direct investigation o f detailed synaptic and cellular mechanisms.
The work presented in this chapter was undertaken in hippocampal slice 
preparations to establish the mechanism by which nAChRs mediate their pro- 
epileptogenic actions and to investigate the probable contribution o f glutamate 
circuits in nAClfR-induced burst frequency potentiation. The specific aims o f this 
chapter were:
1. To investigate the action o f nAChRs on basal glutamatergic transmission
2. To investigate the effect o f nACliR activation on epileptiform bursting activity 
in the presence o f glutamate receptor antagonists.
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5.2 Investigation of the action of nAChRs on basal 
glutamatergic transmission
5.2.1 Effect of nAChR activation on evoked glutamatergic 
synaptic transmission on area CA3
111 this set o f experiments, field excitatory postsynaptic potentials (fEPSPs) were 
recorded in the CA3 region o f the hippocampal slices, placing recording electrode 
in the stratum radiatum  o f the CA3 region and stimulatory electrode within the 
hilus. Typically, fEPSPs evoked by local electrical stimulation consisted o f a 
compound glutamatergic EPSP mediating by the activation o f AMPA/Kainate and 
NMDA receptors. Figure 5.1 A shows a representative example o f a fEPSP 
recorded from the CA3 region on which specific glutamatergic antagonists were 
tested. Bath application o f the AMPA/Kainate receptor antagonist, NBQX (2 pM) 
decreased the amplitude o f the EPSP (Figure 5.1 A2) and the further addition of 
the NMDA receptor antagonist CGP40116 (50 pM) completely abolished the 
EPSP (Figure 5.1 A3), demonstrating the mixed NMDA and AMPA/Kainate- 
mediated nature o f the evoked synaptic response.
Initial experiments were to investigate the stability o f evoked fEPSPs in area 
CA3. hr order to ensure that the amplitude of the evoked EPSPs on area CA3 
remains stable over the period o f experiments, control fEPSPs were recorded in 
the absence o f DMPP. As illustrated in figure 5,1C, electrical stimulation o f 
afferent fibres within the hilar region resulted in the occurrence o f a stable EPSP 
in area CA3, which was sustained and stable for the extended duration o f the 
experiments (up to 60 minutes, n=4, Figure 5.1 C control).
To investigate the effect o f DMPP on evoked glutamatergic synaptic transmission 
in area CA3, 30 pM DMPP was applied following a stable EPSP baseline. The 
slices were stimulated once every 20 seconds for a period o f 20-30 minutes 
before, during and after superfusion with DMPP. Bath application o f DMPP (30 
pM) resulted in a sustained and reversible enliancement o f glutamate afferent
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evoked fEPSP amplitude by 15.7 ± 5.1% (mean ± SEM; P=0.007, One-way 
ANOVA) in the CA3 region o f the hippocampus (Figure 5.1 B-D, n=8 o f 12). 
These data suggest that glutamatergic transmission is enlianced by nACliR 
activation in the CA3 region of the hippocampus.
The Effect o f iiACliR activation on the amplitude o f fEPSPs recorded in area CA3 
was assessed at varying stimulus intensities. The result o f DMPP action on such 
stimulus-responses is given in figure 5.1 E. Paired t tests were performed on raw 
data at each point, revealing that fEPSP amplitudes were significantly increased 
from baseline following DMPP application across entire range o f  stimulus 
intensities {P<0.05),
5.2,2 Effect of nAChR activation on evoked glutamatergic 
synaptic transmission on area CAl
Addition experiments were carried out in area C A l. Field EPSPs were recorded in 
the CA l region o f the hippocampus by placing recording electrodes within the 
stratum radiatum  towards the middle o f the CA l region and subsequently 
stimulating the Schaffer collaterals with stimulation electrode placed within the 
stratum radiatum  close to the CA3/CA1 border. 30 pM DMPP was applied to the 
bath once a stable EPSP baseline amplitude was achieved. In contrast to findings 
in area CA3, no significant change (-5.25 ± 8.3%, mean ± SEM; P=0.4, One-way 
ANOVA) was observed on field EPSCs recorded in the CA l region (Figure 5.1 
C-D, n=4) upon application o f DMPP suggesting that application o f the nicotinic 
agonist does not alter glutamate transmission at this synaptic comiection.
5.3 Effect of glutamate receptor antagonists on 4AP and 
bicuculline-induced bursting activity
Results obtained from several models o f epileptifonn activity, both in vivo and in 
vitro, have emphasised the important role played by NM DA receptors in the
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generation o f epileptifonn discharges. To test the involvement o f NMDA 
receptors in the 4AP and bicuculline models, we analysed the effects o f a 
competitive NMDA receptor antagonist, D-(E)-2-amino-4-methyl-5-phosphono- 
3-pentenoic acid (CGP40116, 50 pM), on spontaneous epileptifonn activity 
induced by either 4AP or by bicuculline. The involvement o f other fast excitatory 
amino acid receptors was also assessed by use o f 2,3-dioxo-6-nitro-l,2,3,4- 
tetrahydrobenzo(f)quinoxaline-7-sulfonamide (NBQX, 2 pM) which is an 
antagonist o f AMPA/kainate (non-NMDA) receptors. In the first set of 
experiments, 50 pM CGP40116 and 2 pM NBQX were co-applied to slices 
displaying stable epileptiform burst activity to assess the general contribution of 
glutamate receptors on ongoing 4AP and BIC-induced epileptiform discharges. 
This combined application o f NMDA and AMPA/Kainate receptors antagonists 
resulted in a gi'adual reduction and eventually complete abolition o f 4AP-induced 
interictal activity 14.6 ± 6 minutes after bath application o f antagonists in all 
slices tested (nM ). However, this effect was not reversed after (up to 40 minutes) 
washout (n=2, Figure 5.2 A). A combined application o f CGP40116 and NBQX 
also completely blocked BIC-induced epileptiform activity (n=2, data not shown).
To examine whether NMDA and AMPA/Kainate receptors exerted deferential 
effects on 4AP and BIC-induced epileptiform activity, we tested the individual 
effect o f either CGP40116 or NBQX on 4AP and BIC-induced epileptiform 
activities.
For 4AP induced activity, epileptifonn discharges persisted following the 
application o f NMDA receptor antagonist, CGP40116 (50 pM), but their 
frequency significantly decreased from 0.52 ± 0.11 to 0.24 ± 0.03Hz (n=4, 
P=0.02, paired Student’s t-tests performed on raw data, Figure 5.2 B).
In a second set o f experiments, the involvement o f AMPA/Kainate receptors alone 
on 4AP-induced epileptiform activity was also assessed using the selective 
AMPA/Kainate receptors antagonist, NBQX. Wlien 2 pM NBQX was added to
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the bathing medium, 4AP-induced epileptiform discharges gi'adually reduced in 
Irequency and ultimately abolished completely (n=6, Figure 5.2 C).
In a mamier similar to that for 4AP-induced response, co-application o f 50 pM 
CGP40116 also produced a significant decrease in the frequency o f BIC-induced 
epileptiform activity from 0.14 ± 0.01 to 0.06 ± O.OlHz (n=4 o f 6, P=^0.01, paired- 
/-tests performed on raw data, Figure 5.3 A) but a complete abolishment o f 
epileptiform activity was also obseiwed in 2 out o f 6 experiments. On the contrary, 
application o f NBQX (2 pM) produced a complete blockage o f BIC-induced 
epileptiform bursting in all slices tested (n=4. Figure 5.3 B), an effect that was 
similar to those observed in 4AP model.
The effects o f these antagonists on burst frequency are summarised gi'aphically in 
figure 5.2 D for 4AP and figure 5.3 C for BIC-induced epileptiform activity.
5.4 Experiments to investigate the contribution of 
ionotropic glutamate receptors in uAChR-induced 
burst frequency potentiation
5.4.1 Effect of nAChR activation on 4AP and BIC-induced 
bursting activity in the presence of NMDA receptor 
antagonist
The previous experiments addressed the action o f nAChRs on basal glutamatergic 
transmission. We next turned our attention to the action o f iiACliR activation on 
ongoing epileptiform bursts activity within dynamically active glutamatergic 
circuits. In order to investigate any possible contribution o f NMDA receptors in 
DMPP-induced burst frequency potentiation, a series o f experiments were carried 
out using the NMDA receptor antagonist CGP40116. Once stable 4AP or BIC- 
induced epileptiform activity were established, 50 pM CGP40116 was co-applied 
in order to inliibit any NMDA receptor mediated component to the bursting 
activity as above. As stated, such application o f CGP40116 significantly
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decreased the frequency o f 4AP and BIC-induced bursting activity. After the 
stabilisation o f  the reduced frequency spontaneous epileptiform activity in the 
presence o f CGP40116, 30 pM  DMPP was subsequently co-applied to investigate 
the effect o f nACliR activation on ongoing 4AP and BIC-induced epileptifonn 
activity. In such experiments, it was found that the presence o f CGP40116 did not 
compromise the ability o f DMPP to potentiate epileptiform burst h 'equency in the 
both 4AP (n=4. Figure 5.4 A) and BIC models (n=4, Figure 5.4 B). Indeed, under 
such conditions, application o f 30 pM  DMPP produced a reversible increase o f 
burst frequency by 54.5 ± 18.98% and 277 ± 34.7% for 4AP and BIC-induced 
epileptiform responses, respectively (Figure 5.4 C).
5.4.2 Effect of nAChR activation on 4AP and BIC-induced 
bursting activity in the presence of AMPA/Kainate receptor 
antagonist
In contrast to a partial block o f epileptiform activity induced by 50 pM 
CGP40116, application o f the AMPA/Kainate receptor antagonist NBQX (2 pM) 
completely abolished epileptifonn activity induced by 4AP and BIC in all slices 
tested (n=9). We next investigated whether the pro-epileptogenic actions of 
nAChR activation could reverse the NBQX mediated suppression o f 4AP and 
BIC-induced epileptifonn activity.
In the first set o f  experiments in which 2 pM  NBQX abolished 4AP-induced 
epileptiform responses, subsequent co-application o f 30 pM  DMPP failed to result 
in the reappearance o f interictal discharges or produce any other fonn o f 
detectable extracellular field activity, in any slices tested (n=6, Figure 5.5 A). 
Similarly, 30 pM  DMPP was unable to reverse 2 pM  NBQX abolition o f BIC- 
induced bursts activity (n=3, Figure 5.5 B).
To investigate further the contribution o f AMPA/Kainate receptors during DMPP- 
induced burst frequency facilitation, we performed experiments using a lower 
concentration o f NBQX (0.2 pM). This concentration o f NBQX produces a partial
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Figure 5.4. Effect o f nAChR activation on epileptiform activity in the presence of 
NMDA receptor antagonist.
Scatter plot showing the effect of DMPP on 4AP (A) and BIC (B) -induced burst 
frequency in the presence of NMDA receptor antagonist, CGP40116. As can be seen, 
application of CGP 40116 did not affect the ability of DMPP to potentiate epileptiform 
burst frequency in the both 4AP and BIC models. C. Summary of the effects of 
application of DMPP on 4AP (n=4) and BIC (n=4)-induced burst frequency, when 
NMDA receptors are blocked. Horizontal bars indicate P  values between respective 
columns as determined using ANOVA performed on raw data.
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Chapter 5
block o f AMPA/Kainate receptor mediated synaptic responses (Randle et al.,
1992). Application o f 0.2 pM NBQX resulted in a marked reduction in the 
frequency o f 4AP-induced epileptiform activity (by 72.5 ±2 .5% , n=4, Figure 5.5 
C-D) but not a complete abolition o f epileptiform activity. Under such conditions, 
slices preincubated with 0.2 pM  NBQX, displayed a pronounced burst Requency 
potentiation upon DMPP (30 pM) application (96.42 ± 10.5%, n=4, Figure 5.5 C- 
D). These results suggest an involvement of AMPA/Kainate receptors in DMPP- 
induced burst h 'equency potentiation.
5.5 Experiments to investigate the contribution of 
metabotropic glutamate receptors (mGIuRs) in 
nAChR-induced burst frequency potentiation
Metabotropic glutamate receptors (niGluRs) have been shown to be critically 
involved in modulating ictal activity during seizures in animal models o f epilepsy 
(Dalby and Thomsen, 1996; Tizzano et ah, 1995). Group I mGluRs sustain or 
promote seizures (Camon et al., 1998; Chapman et al., 2000; Chapman et al,, 
1999), whereas group II, and group III mGluRs are reported to suppress seizures 
via presynaptic inhibition o f glutamate release (Attwell et ah, 1998). Moreover, 
investigation o f the concentration-dependence revealed that sustained low 
concentration o f niGluRs agonist elicited only facilitatory actions, whereas higher 
concentrations were suppressive (Burke and Hablitz, 1995). These obseiwations 
suggest the activation of different mGluR subtypes, which may be localised 
differentially at pre-and postsynaptic sites. Moreover, different neuronal 
populations, possible expressing different inGluR subtypes or coupling 
mechanisms, may play integral roles in the induction and generation o f 
epileptiform activities (Burke and Hablitz, 1995). These finding also indicate that 
a specific mGluR subtype(s) may modulate both excitatory and inliibitory 
synaptic transmission via a presynaptic reduction o f transmitter release (Burke 
and Hablitz, 1994).
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5.5.1 Effect of nAChR activation on BIC-induced bursting 
activity in the presence of mGIuR antagonist
Based on data supporting a critical role o f gi’oup I niGluRs in promoting seizures 
(Camon et al., 1998; Chapman et al., 2000; Chapman et al., 1999) and 
epileptiform activities in vitro (Cobb et ah, 2000; Merlin et ah, 1995; Burke and 
Hablitz, 1995), a series o f experiments were carried out in the presence o f mGluR 
antagonist to investigate the probable contribution o f mGluRs in DMPP-induced 
burst frequency potentiation.
Once stable BIC-induced bursting activity was established, a non-selective 
group I/II niGluR antagonist (S)-a-methyl-4-carboxyphenyglycine (MCPG, 500 
qM) was applied in order to block any contribution o f mGluR mediated 
responses. Subsequent co-application o f 500 qM MCPG did not produce any 
significant change in BIC-induced epileptifonn burst frequency, suggesting that 
activation o f such receptor was not a critical factor in the generation o f BIC- 
induced bursting activity (n=4, P>0.05, Figure 5.6). Moreover, pretreatment of 
slices with MCPG did not affect DMPP-induced burst frequency potentiation 
when DMPP (30 qM) was subsequently applied (n=4, Figure 5.6). This result 
suggests that mGluRs are not a critical factor in the modulation of BIC-induced 
epileptifonn activity by the activation of nAChRs.
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Figure 5.6. Effect o f nAChR activation on epileptiform activity in the presence  
of metabotropic glutamate receptor antagonist.
A. Scatter plot showing the effect of DMPP on BIC-induced burst frequency in 
the presence of the broad spectrum mGLuR antagonist, MCPG. Co-application 
of 500 |iM MCPG did not produce any significant change in BIC-induced 
epileptiform activity. Subsequent co-application of DMPP produced a significant 
increase in BIC-induced burst frequency. B. Summary of the effects of 
application of DMPP on BIC-induced burst frequency in the presence of MCPG 
(n=4). Horizontal bars indicate P  values between respective columns as 
determined using ANOVA.
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5.6 Discussion
5.6.1 Effect of DMPP on basal glutamate transmission
The aim o f this phase of study was to attempt to assess the precise synaptic 
mechanisms and identify possible excitatory circuit by which activation of 
nAChRs produce their pro-epileptogenic effects. In experiments devised to 
investigate the action o f nAClrRs on basal glutamatergic transmission, application 
o f selective nACliRs agonist DMPP resulted in a sustained and reversible 
enliancement o f glutamate afferent evoked field EPSP amplitude in the CA3 
region o f the hippocampus. Previous published results and aspects o f the present 
data indicate that nAChRs may enhance glutamate release from presynaptic 
terminals. In 1995 McGehee et a l  showed that nicotine enlianced glutamate 
transmission in the habenula nucleus o f chick (McGehee et al., 1995). This 
finding is further supported by the observation reported by Gray et a l  (1996) and 
Radcliffe and Dani (1998), who showed that nicotine increased the fi’cqueiicy o f 
mini EPSPs in the CA3 region o f the hippocampus and hippocampal cell cultures, 
respectively (Gray et ah, 1996; Radcliffe and Dani, 1998). Activation o f iiACliRs 
may increase the probability o f glutamate release either tlirough direct Ca^^ entry 
tluough the channel itself or indirectly tlirough recruitment o f  voltage-dependent 
calcium chamiels (VDCC) by the local depolarisation. According to Staley et al. 
(1998), increased probability o f release results in a decrease in inter burst inteiwal. 
This increased burst frequency is associated with a reduction in burst length 
(Staley et ah, 1998). If  DMPP acts to open presynaptic iiACliR channels, which 
are permeable to Ca^^ (Seguela et a l ,  1993), resultant changes in calcium 
dynamics within the presynaptic terminal may thus result in presynaptic 
modulation o f action potential-dependent release. Experiments using the paired- 
pulse paradigm, which provide indirect evidence o f likely presynaptic actions, 
may be useful to address this point. An increase in the paired-pulse facilitation by 
DMPP would support a hypothesis that its faeilitatory action occurs through 
activation of pre synaptic nACliRs.
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A complementary calcium imaging approach has also been adopted to investigate 
presynaptic action of iiACliRs on calcium transients in glutamatergic terminals. 
However, such studies are contentious with some groups claiming activation of 
iiACliRs enliances glutamatergic transmission directly by elevating terminal 
calcium levels (Gray et ah, 1996). However, other authors have shown no such 
actions and suggest nAChRs to effect excitability tlrrough other cells types and 
transmitters notably G ABA (Vogt and Regehr, 2001). As our evoked EPSP 
experiments were not carried out in the presence o f GAB A receptor antagonists, it 
is not possible to conclude whether nAChRs modulation is via a direct action on 
glutamatergic transmission or via a more indirect mechanism, possibly through 
regulation of GABAergic circuits. However, such an action o f iiACliRs appears to 
be independent o f fast GABAergic transmission, as detailed in chapter 4 o f this 
thesis, at least with respect to the pro-epileptogenic action. An important finding 
in this respect was that nAChR activation also resulted in a facilitation of 
epileptiform burst discharge in the bicuculline model (see chapter 4) in which 
GABAa receptors are blocked by high concentrations of the antagonist. However, 
an action on GABAergic circuits utilising GABAb receptors can not be excluded 
since these have recently been shown to exhibit pro-epileptogenic actions (Motalli 
et al., 1999) (see Chapter 6).
In our experiments increasing the stimulus intensity also increased the amplitude 
o f the evoked EPSP. This presumably reflects the fact that an increase in 
stimulation intensity would ultimately recruit more fibres and subsequently 
increases the amount o f synaptically released glutamate. Data showing modest but 
significant increase in the amplitude o f evoked EPSPs in the presence o f DMPP 
compared with the control is consistent with a general enhancement o f glutamate 
release across a population o f glutamatergic terminals although it is not possible 
to exclude the possibility o f other less direct effect tluougli other systems. Such a 
finding has been described by Mann and Greenfield (2003) who showed that the 
inhibition o f NMD A receptors revealed a long-lasting excitatory effect o f nicotine 
on hippocampal activity which appeared to be mediated via GABAergic 
intemeurones (Mann and Greenfield, 2003).
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In results indicated in this chapter no significant enliancement o f EPSP amplitude 
was seen following DMPP application in the CA l region. Application o f DMPP 
enlranced glutamate afferent evoked field EPSP amplitude in the CA3 region of 
the hippocampus but no such effect within area C A l. This observation is 
consistent with studies reporting that activation o f iiACliR enhances glutamate 
release from CA3 pyiamidal cells (Gray et ah, 1996) but not from C A l neurones 
(Alkondon et ah, 1997; Frazier et ah, 1998b; Jones and Yakel, 1997; McQuiston 
and Madison, 1999b). Work performed by Alkondon et al (1997) showed that 
CNQX, a competitive glutamate receptor antagonist that inhibits fast 
glutamatergic transmission mediated by AMPA/Kainate receptors, failed in 
blocking nACliR-elicited PSCs in CA l pyramidal cells, which indicated that 
nAChR activation is not linked to the release o f glutamate in C A l neurones. This 
finding is further supported by Jones et al (1997) and Frazier et al (1998) who 
showed pyramidal cells in the area CA l to be completely unresponsive to 
nicotinic receptor activation. McQuiston and Madison (1999) also reported that 
only 2 out 15 pyramidal cells in area CA l responded to ACh application and that 
such responses were barely detectable and significantly smaller than equivalent 
nACliR mediated responses recorded in hippocampal interneurones.
The conclusion drawn from these data suggests that nAChR activation regulates 
(potentiates) glutamatergic transmission at a subset o f synapses. The apparent 
selective modulation o f glutamatergic transmission by nAChRs mirrors the 
finding that inAChRs are reported to differentially suppress different excitatory 
pathways within the hippocampus (Hasselmo and Schnell, 1994). Such an action 
o f nACliRs would be consistent with previous modelling studies which predicted 
that the susceptibility o f  the hippocampus to generate epileptifonn activity is 
proportional to the strength of glutamatergic comiectivity in recurrent collateral 
synapses in CA3 region (Bains et ah, 1999; Staley et ah, 1998) . The tenninating 
o f CA3 bursts depends on depletion o f the releasable glutamate pool at these 
recurrent synapses, therefore presynaptic factors controlling glutamate release at 
recurrent synapses regulate the probability and duration o f synchronous 
discharges o f the CA3 network (Staley et ah, 1998). According to Vogt and
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Regelii' (2001) acetylcholine directly modulate these synapses (Vogt and Regelrr, 
2001), Thus, it is possible that frequency potentiation mediated by nAChRs 
reflects the activation o f presynaptic nAChRs that facilitate glutamate release 
which, in turn, forces the network into a higher frequency hursting models.
5.6.2 Involvement of glutamate receptors in epileptiform activity
Many factors have heen identified as being critical for the generation of 
epileptiform activity and one of them is activation o f excitatory amino acid 
receptors: NMDA and AMPA/Kainate receptors. The relevance o f each o f these 
receptors in focal epileptogenesis, however, remains very controversial because 
their relative contribution varies gi*eatly depending on the model being studied. 
For instance, although NMDA receptors have been shown to be involved in the 
production of epileptiform activity in some experimental models o f epilepsy 
(Meldrum, 1987; Thomson and West, 1986) such as low magnesium model 
(Home et ah, 1986; Mody et ah, 1987; Sclmeiderman and MacDonald, 1987; 
Tancredi et ah, 1990), NMDA antagonists have little or no effect on the 
epileptiform discharges seen with other models such as bicuculline and picrotoxin 
models (Neuman et ah, 1988; Thomson and West, 1986) suggesting that NMDA 
receptors are not necessary for generation o f epileptifonn activity. Similarly, the 
importance o f AMPA/Kainate in epileptogenesis remains unclear. On the one 
hand, there are some reports indicating that non-NM DA receptors are involved in 
the generation o f the bursts induced by the convulsants 4AP (Avoli et ah, 1993; 
Perreault and Avoli, 1991) and bicuculline (Gulyas-Kovacs et ah, 2002; Traub et 
ah, 1993). On the other hand, it has been shown that AMPA/Kainate receptors 
have a minor role in the generation o f epileptiform dischaiges in low magnesium 
model (Gulyas-Kovacs et ah, 2002). Finally some studies have provided direct 
evidence that abnormal excitatory synaptic transmission in the epileptogenic 
neocortex is primarily mediated by both NMDA and AMPA/Kainate receptors 
(Lee and Flablitz, 1991; Siniscalchi et ah, 1997; Valenzuela and Benardo, 1995). 
According to these studies there are two distinct phases in the development of 
epileptic activity, namely induction and maintenance, mediated by either NMDA
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or non-NMDA receptors depending on the model being investigated. For 
example, during exposure to magnesium-free solution, NM DA receptor 
antagonists prevent the development o f the induced epileptiform activity, while 
the non-NMDA receptor antagonist abolished the epileptiform discharge that 
persisted after slices were returned to control solution containing magnesium. 
This data suggests that in this model the enliancement o f NMDA receptor 
activation is responsible for the initiation o f spontaneous discharges and that non- 
NMDA receptors perform a more minor role in the initiation, but contribute to the 
maintenance o f epileptiform discharges (Gulyas-Kovacs et ah, 2002; Valenzuela 
and Benardo, 1995). It has also been shown that, in 4AP model, both types of 
ionotropic excitatory amino acid receptors are overactivated and contribute to 
seizure initiation and propagation (Gulyas-Kovacs et ah, 2002; Siniscalchi et ah, 
1997). This finding was further supported by studies investigating the role of 
excitatory amino acid receptors in generation o f picrotoxin-induced epileptiform 
activity in rat neocortex (Lee and Hablitz, 1991) and in recurrent collaterals of 
guinea pig hippocampal slice (Miles et ah, 1984) that showed a reversible 
blockade o f spontaneous synclu'onised bursts by the application o f several 
excitatory amino acid antagonists.
The involvement o f glutamate receptors in the epileptiform activity was studied in 
this chapter by the experiments utilising NMDA and AMPA/Kainate receptor 
antagonists. As detailed above, the majority o f previous electrophysiological 
studies have found that both NMDA and AMPA/Kainate receptors are strongly 
activated during epileptiform activity (Lee and Hablitz, 1991; Siniscalchi et ah, 
1997; Valenzuela and Benardo, 1995). According to these studies, we found that 
4AP and BIC-induced interictal-like epileptifoim activity are completely blocked 
by NBQX and their frequency significantly reduced by CGP40116. Our findings 
are different from the data obtained by Avoli and colleagues, who have showed 
that both interictal- and ictal-like epileptiform discharges induced by 4AP are not 
affected by NMDA receptor antagonists and who have concluded that 4AP- 
induced epileptiform activity are mediated tlu'ough the activation of 
AMPA/Kainate receptors (Avoli et ah, 1993; PeiTeault and Avoli, 1991).
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However, our results are in agi'eement with those o f Gulyas-Kovacs and 
colleagues (2002), who have shown that NMDA receptor antagonist significantly 
decrease frequency o f  4AP and BIC-induced epileptiform bursting with a similar 
degi'ee o f frequency depression. These authors have also reported that 
AMPA/Kainate receptor antagonist completely abolished BIC-induced 
spontaneous activity and significantly decreased the frequency o f epileptiform 
activity in 4AP model. This finding is again in agieement with our results with the 
only difference being that a complete abolition o f 4AP-induced epileptiform 
activity was observed in our experiments following application o f an 
AMPA/Kainate receptor antagonist. In fact, these authors concluded that there are 
significant alterations in contribution o f NM DA and AMPA/Kainate glutamate 
receptors to the development and maintenance of epileptiform activity in the 
different convulsants. However, our results suggest that the relative contributions 
o f NMDA and AMPA/kainate receptors are similar for the 4AP and BIC-induced 
epileptiform activities described here despite the epileptogenic stimulants acting 
through distinctly different mechanisms.
Thus, the main conclusion from the work described in this section o f the thesis is 
that, at least in these two models, the epileptic activity requires the activation of 
both NMDA and AMPA/Kainate glutamate receptors. However, relative 
contribution o f the respective subtypes o f glutamate receptor in mediating aspects 
of epileptogenesis is difficult to assess unequivocally.
In vivo data fr'om animal models o f  epilepsy have shown modulatory roles o f 
inGluRs on ictal activity during seizures (Dalby and Thomsen, 1996; Tizzano et 
al., 1995). Studies on in vitro hrain slices have also suggested that activation of 
group I inGluRs plays a critical role in the maintenance o f the prolonged 
synchronised discharges (Holmes et al., 1996; Lee et al., 2002; Merlin and Wong, 
1997) and in the transition o f interictal bursting into ictal activity (Merlin and 
Wong, 1997). It has been shown in these studies that inGluR antagonists have 
suppressive effects o f prolonged epileptiform activity, suggesting activation o f 
inGluRs during prolonged epileptiform discharges. However, in our experiments
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application of MCPG, a non-selective group I/II mGluR antagonist, failed to 
produce any significant change in BIC-induced epileptiform bursting activity, 
which was consistent with previously reported studies (Merlin and Wong, 1997; 
Lee et al, 2002). As only short interictal-like activity was recorded in our 
experiments, it is likely that this negative finding is attributable to lack of 
prolonged or ictal like activity in our recordings. This result suggests that group I 
mGluRs probably does not play a significant role during short interictal activity.
5.6.3 Contribution of glutamate receptors in DMPP-induced 
burst frequency potentiation
The aims o f this set o f experiments were to investigate the effect o f DMPP on 
epileptiform activity when glutamate receptors were blocked to uncover possible 
contribution o f glutamate receptors in the pro-epileptogenic action o f nAChP.s.
In this set o f experiments application o f NMDA receptor blocker CGP40116 
(resulting in a depression o f  burst frequency) did not affect the ability o f 
subsequent DMPP application to potentiate epileptifonn burst frequency. On the 
other hand, application o f the AMPA/Kainate receptor antagonist NBQX (2 pM) 
completely abolished epileptifonn activity suggesting that these receptors are 
crucial for supporting such activity. Moreover, subsequent co-application o f 
DMPP failed to make any change in extracellular field activity after block with a 
high concentration o f NBQX. However, slices preincubated with a lower 
concentration o f NBQX (0.2 pM), which results in a partial blockade o f non- 
NMDA receptor-mediated synaptic transmission, were still able to exhibit burst 
frequency potentiation upon DMPP application. These results suggest that NMDA 
receptors are not necessary in the DMPP-induced burst frequency potentiation and 
when these receptors are blocked DMPP can potentiate epileptiform activity 
tlrrough activation o f AMPA/Kainate receptors. Furthermore, in agreement with 
earlier chapters, activation o f nAChRs may facilitate ongoing epileptiform activity 
but does not result in the generation o f spontaneous activity in otheiivise quiescent 
circuits.
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In further studies, application o f mGluRs antagonist MCPG again did not affect 
the ability o f DMPP to potentiate epileptiform burst frequency suggesting that the 
response to DMPP was not due the recruitment o f niGluRs.
The main conclusion o f these results is:
iiAChR-mediated burst frequency potentiation is obseiwed during condition of 
NMDA receptor block suggesting that under this condition the proepileptogenic 
action o f nAChRs is therefore mediated via enhanced activation o f AMPA/kainate 
receptors. Thus it seems that NMDA receptors aie not essential for the 
proepileptogenic action of nAChRs. However, it is possible that under normal 
condition part o f nAChRs proepileptogenic action is due to an additional 
component in which NMDA receptor mediated transmission facilitated. Together 
these data suggest a presynaptic action o f nAChRs and increase glutamate release.
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CHAPTER 6 
INVESTIGATION OF THE CONTRIBUTION OF 
GABA CIRCUITS IN nAChR-INDUCED BURST 
FREQUENCY POTENTIATION
6.1 Introduction
Much o f the action o f acetylcholine within the hippocampus is thought to be 
mediated tlu'ough action on the GABAergic system (Gulyas et al., 1999). The 
main cholinergic input to the hippocampus is tlirough septohippocampal pathway, 
which originates from the medial septal nucleus and the nucleus o f the diagonal 
band o f Broca (Reviewed by Dutar et al., 1995) and contacts both intemeurones 
and principal cells o f hippocampus (Heimrich and Frotscher, 1993; Leranth and 
Frotscher, 1989). ACh may increase or decrease the activity o f  intemeurones via 
muscarinic receptors and excite intemeurones tlirough nicotinic receptors located 
in the soma-dendritic membrane. ACh may also modulate GABA release through 
presynaptic muscarinic and nicotinic receptors located on axon tenninals. 
Muscarinic acetylcholine receptor (niACliR) activation increases the frequency o f 
spontaneous IPSCs converging on to pyramidal cells, which is likely the result o f 
a direct postsynaptic excitation o f certain intemeurones (Behiends and ten 
Bruggencate, 1993; Pitler and Alger, 1992). On the other hand, mAChR activation 
decreases the frequency o f miniature IPSCs, which is a result o f a presynaptic 
reduction o f GABA release (Behrends and ten Bruggencate, 1993; Pitler and 
Alger, 1992).
The anatomical results, taken together with the electrophysiological data have 
shown that functional nicotinic receptors are also present on hippocampal 
intemeurones (Alkondon et al., 1998; Frazier et a l ,  1998a; Frazier et a l ,  1998b; 
Jones and Yakel, 1997; McQuiston and Madison, 1999b). It has been reported that
114
Chapter 6
either fast local application o f ACh or electrical stimulation o f cholinergic 
afferents depolarises intemeurones in the C A l sub field and the dentate gyrus and 
induces rapid firing (Frazier et ah, 1998a; Frazier et al., 1998b; Jones and Yakel, 
1997). Voltage-clamp recordings demonstrated that ACh produces a fast, rapidly 
desensitising inward current that is blocked by a-bungarotoxin, indicating that the 
fast excitation is mediated by a Ca^ "^  penneable variant o f the iiACliR containing 
the a l  subunit (Frazier et a l ,  1998a; Frazier et a l , 1998b; Jones and Yakel, 1997). 
hr contrast, pharmacological application o f nicotinic agonists have been reported 
not to change the firing or the membrane potential o f the majority o f hippocampal 
principal cells (Alkondon et al., 1997; Frazier et al., 1998b; McQuiston and 
Madison, 1999b).
Located at both pre, post and extra-synaptic sites o f intemeurones, nAChRs are 
ideally placed to modulate inliibitory circuits in the hippocampus. ACh increases 
the activity o f intemeurones via nicotinic receptors located in the soma-dendritic 
membrane of intemeurones and increases GABA release tlnough presynaptic 
nicotinic receptors located on axon terminals (Alkondon et al., 1997). Thus, it is 
likely that the pro-epileptogenic action o f  nAChR activation described in previous 
chapters is mediated in part through GABAergic circuits. However, such an 
action o f nACliRs appears to be independent o f  fast GABAergic transmission 
since the pro-epileptogenic actions o f nACloR activation is resistant to the 
blockade o f GABAa receptors, as detailed in chapter 4 o f this thesis. Thus, 
iiAChR modulation o f  GABAergic events is unlikely to be important in the pro­
epileptogenic action o f nicotinic receptor activation, although it is possible that an 
interaction between iiACliRs and GABAb receptor activation may play a role.
GABAb receptor-mediated mechanisms are involved in the generation o f focal 
seizures and in epileptogenesis (McLean et al., 1996; Scanziani et al., 1994; 
Veliskova et a l , 1996). Baclofen is a GABAb receptor agonist which has been 
shown to activate both pre- and post-synaptic GABAb receptors (Bowery et a l ,  
1980a; Newberry and Nicoll, 1985) and to inliibit many foiins o f synaptic
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transmission (Ault and Nadler, 1982) including glutamatergic (Lanthorn and 
Cotman, 1981; Thompson and Gahwiler, 1992), GABAergic (Lambert and 
Wilson, 1993; Thompson and Gahwiler, 1992) and cholinergic transmission 
(Morton et ah, 2001). However, baclofen may possess a surprising proconvulsant 
effect as documented in clinical practice (Kofler et ah, 1994; Rush and Gibberd, 
1990) and in certain models o f epileptiform discharge (Motalli et ah, 1999; Mott 
et ah, 1989; Watts and Jefferys, 1993). It has also been proposed that the 
proconvulsant effect o f baclofen is caused by a presynaptic, GAB As-mediated 
inliibition o f GABA release from inhibitory intemeurones leading to disinhihition 
(Mott et ah, 1989; Watts and Jefferys, 1993). Such an action has also been 
documented with the epileptifonn discharges induced by bath application o f 4AP 
to hippocampal slices (Motalli et ah, 1999; Watts and Jefferys, 1993), leading to 
hypothesise that GABAb receptor antagonists could exert anticonvulsant actions 
in this in vitro model o f epileptifonn discharge. Previous studies have indeed 
shown that the GABAb receptor antagonist CGP35348 has anticonvulsant actions 
in rodent models o f absence seizures (Bowery and Erma, 2000; Liu et ah, 1992). 
However, an opposite finding has been reported by Motalli et a l  2002, who found 
that the effect o f CGP35348 on 4AP-mduced epileptifonn activity to not be 
anticonvulsant and to some extent is similar to what was reported in this model 
during GABAb receptor activation (Motalli et ah, 2002). Given the conflicting 
results outlined above, the aim o f the experiments described in this chapter was to 
readdress the possible contribution o f GABAb receptors during epileptifonn 
activity and to investigate the involvement o f  GABAb receptors in nACliR- 
induced burst frequency potentiation. A  second aim was to further investigate the 
effect o f the nAChR agonist, DMPP on GABA release from hippocampal 
neurones with a view to uncover possible mechanisms responsible for the pro­
epileptogenic action o f DMPP.
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6.2 Investigation of the role of GABAb receptors in 
nACIiR-induced burst frequency potentiation
6.2.1 Effect of nAChR activation on 4AP-induced epileptiform 
activity in the presence of GABAb receptor antagonist
In order to investigate the possible involvement o f GABAb receptors in nACliRs- 
induced effect, a series of experiments were canied out using the selective 
GABAb receptor antagonist CGP55845A. Once stable 10 pM 4AP-induced 
bursting was established, 1 pM CGP55845A was co-applied in order to block 
phannacologically any involvement o f GABAb receptor mediated responses 
during epileptiform bursting. Such application o f CGP55845A did not 
significantly change the fi'equency o f 4AP-iiiduced bursting activity (mean 
frequency = 97.8 ± 4% o f control 4AP fi'equency; P>0.05; n = l l ;  Figure 6.1 A-B). 
After the stabilisation o f the 4AP-induced spontaneous epileptifonn activity in the 
presence o f CGP55845A, 30 pM  DMPP was co-applied to the convulsant 
containing solution to test the effect o f nAChR activation on ongoing 4AP- 
induced epileptiform activity when GABAb receptors are blocked. Wliereas slices 
in the absence of CGP55845A would exhibit robust burst frequency potentiation 
(see chapter 3), slices pre-incubated with CGP55845A (1 pM) failed to exhibit 
burst fi'equency potentiation upon DMPP application in 11 o f  11 slices tested. 
Scatter plot in figure 6.1 A shows a representative experiment in which the slices 
are pre-incub ated with GABAb receptor antagonist CGP55845A prior to 
application o f  DMPP. Such application of CGP55845A was found to prevent the 
ability o f subsequent DMPP application to potentiate burst frequency o f 4AP- 
induced epileptiform activity. In the presence o f CGP55845A, application o f 
DMPP resulted in no significant enhancement o f burst frequency compared to 
pre-DMPP levels (91.7 ± 7% o f pre-DMPP control; P> 0.05; n ^ d l; Figure 6.1 A- 
B). Overall, these data suggest that GABAb receptors may play a role in nACloRs- 
induced frequency potentiation o f 4AP-induced bursting.
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Figure 6.1. Effect of nAChR activation on 4AP-induced epileptiform activity in the 
presence of selective GABAq receptor antagonist.
A . S c a t t e r  p lo t  s h o w i n g  t h e  e f f e c t  o f  D M P P  o n  4 A P - i n d u c e d  b u r s t  f r e q u e n c y  in  t h e  
p r e s e n c e  o f  G A B A g  r e c e p t o r  a n t a g o n i s t ,  C G P 5 5 8 4 5 A .  C o - a p p l i c a t i o n  o f  1 ^iM 
C G P 5 5 8 4 5 A  d id  n o t  p r o d u c e  a n y  s i g n i f i c a n t  c h a n g e  in  4 A P - i n d u c e d  e p i l e p t i f o r m  
b u r s t  f r e q u e n c y .  S u b s e q u e n t  c o - a p p l i c a t i o n  o f  3 0  p M  D M P P  a g a i n  p r o d u c e d  n o  
s i g n i f i c a n t  c h a n g e  in  4 A P - i n d u c e d  b u r s t  f r e q u e n c y  in  t h e  p r e s e n c e  o f  C G P 5 5 8 4 5 A  
{P=0.45, O n e - W a y  A N O V A ) .  B .  S u m m a r y  o f  t h e  e f f e c t s  o f  a p p l i c a t i o n  o f  D M P P  o n  
4 A P - i n d u c e d  b u r s t  f r e q u e n c y  in  t h e  p r e s e n c e  o f  C G P 5 5 8 4 5 A  ( n = 1 1 ) .  T h i s  G A B A g  
r e c e p t o r  a n t a g o n i s t  p r e v e n t s  t h e  a b i l i t y  o f  D M P P  t o  p o t e n t i a t e  4 A P - i n d u c e d  
e p i l e p t i f o r m  b u r s t  f r e q u e n c y .  H o r iz o n t a l  b a r s  i n d i c a t e  P v a l u e s  b e t w e e n  r e s p e c t i v e  
c o l u m n s  a s  d e t e r m i n e d  u s i n g  A N O V A .
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6.2.2 Effect of nAChR activation on BIC-induced epileptiform 
activity in the presence of GABAb receptor antagonist
To assess the effect o f GABAb receptor antagonism on ongoing BIC-induced 
epileptiform discharges and their modulation by nACliRs-induced effect, the 
selective GABAb receptor antagonist CGP55845A was bath applied to slices 
displayed stable bicuculline-induced epileptiform burst activity. Subsequent co­
application o f CGP55845A ( l o r  3 pM in 6 and 3 experiments, respectively) to 
hippocampal slices generating interictal discharges under control conditions (BIC- 
containing medium) produced no significant change in burst frequency (mean 
maximal frequency = 106.8 ± 5% of control BIG frequency, P>0.05, Figure 6.2 
A-B). The effects induced by these two concentrations o f CGP55845A were not 
different and therefore the data were pooled together for further analysis.
Once stable epileptiform activity was established, 30 pM DMPP was co-applied 
in order to investigate the effect o f iiACliRs activation on ongoing BIC-induced 
epileptiform discharges in the presence o f CGP55845A. As detailed in chapter 4 
o f this thesis, BIC-induced epileptiform activity showed a profound frequency 
potentiation by subsequent co-application o f the selective nAChR agonist DMPP 
(248 ± 76% of baseline; n=14). In contrast, slices pre-incubated with the GABAb 
receptor antagonist CGP55845A (1-3 pM) exhibited negligible burst frequency 
potentiation upon DMPP application (27.6 ± 17.76% o f baseline; B>0.05; n=9; 
Figure 6.2 A-C). Although under this condition, there was no change in the 
frequency o f BIC-induced epileptiform bursting during DMPP application in the 
majority of slices tested (n=6 out o f 9 experiments. Figure 6.2 A), a small increase 
was observed in the other 3 experiments (Figure 6.2 B). However, these changes 
did not achieve statistical significance (One-way ANOVA, P=0.18, Figure 6.2 C).
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Figure 6.2. Effect of nAChR activation on BIC-induced epileptiform activity in the 
presence of GABAq receptor antagonist.
A . S c a t t e r  p lo t  s h o w i n g  t h e  e f f e c t  o f  D M P P  o n  B I C - i n d u c e d  b u r s t  f r e q u e n c y  in  t h e  
p r e s e n c e  o f  G A B A g  r e c e p t o r  a n t a g o n i s t ,  C G P 5 5 8 4 5 A .  C o - a p p l i c a t i o n  o f  1 |iM  
C G P 5 5 8 4 5 A  d id  n o t  p r o d u c e  a n y  s i g n i f i c a n t  c h a n g e  in B I C - i n d u c e d  e p i l e p t i f o r m  b u r s t  
f r e q u e n c y .  In t h e  m a j o r i t y  o f  t h e  s l i c e s ,  s u b s e q u e n t  c o - a p p l i c a t i o n  o f  D M P P  a g a i n  d id  
n o t  p r o d u c e  a n y  c h a n g e  in  B I C - i n d u c e d  e p i l e p t i f o r m  a c t iv i t y  ( n = 6  o f  9 ) .  B .  In a  m in o r i t y  
o f  s l i c e s  ( n = 3  o f  9 )  s u b s e q u e n t  c o - a p p l i c a t i o n  o f  D M P P  p r o d u c e d  a  m o d e s t  b u r s t  
f r e q u e n c y  p o t e n t i a t i o n  o f  B I C - i n d u c e d  e p i l e p t i f o r m  a c t iv i t y  b u t  w h i c h  o v e r a l l  d id  n o t  
r e a c h  s t a t i s t i c a l  s i g n i f i c a n c e  {P=0.18, O n e - W a y  A N O V A ) .  C .  S u m m a r y  o f  t h e  e f f e c t s  
o f  a p p l i c a t i o n  o f  D M P P  o n  B I C - i n d u c e d  b u r s t  f r e q u e n c y  in  t h e  p r e s e n c e  o f  
C G P 5 5 8 4 5 A  a c r o s s  a ll s l i c e s  t e s t e d  ( n = 9 ) .  H o r iz o n t a l  b a r s  i n d i c a t e  P v a l u e s  b e t w e e n  
r e s p e c t i v e  c o l u m n s  a s  d e t e r m i n e d  u s i n g  A N O V A .
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6.2.3 Effect of GABAb receptor activation on 4AP-induced 
epileptiform activity
Application o f the GABAb receptor agonist baclofen (0.1-30pM) resulted in a 
concentration dependent reduction and eventual complete blockade o f 4AP- 
induced interictal activity (n=15, Figures 6.3 and 6.4). The effects induced by 
increasing concentration o f baclofen were analysed in 8 slices. With O.l-lOpM 
baclofen, a decrease in the rate o f occurrence o f interictal discharges occurred in 5 
o f 8 slices, whereas abolisliment was seen in the remaining 3 experiments. In 
slices in which interictal activity was not fully abolished by lOpM baclofen, 
frirther increasing the concentration to 30pM  caused a complete abolisliment (n=5 
o f 5). Complete blockade o f interictal discharges was also induced by application 
o f a single concentration o f baclofen (30 pM, n=7, Figure 6.4 A).
The suppressant actions o f baclofen upon epileptifonn bursting were fully 
reversible upon washout (n=3. Figure 6.3 A) or co-application o f GABAb receptor 
antagonist CGP55845A (IpM , n=3, Figure 6.3 B). We also analysed the 
concentration-response relationship o f the changes induced by baclofen with 
respect to the frequency o f 4AP-induced epileptiform activity (Figure 6.3 C). Data 
obtained in 7 slices in which increasing doses o f baclofen (0.1-30pM) were 
sequentially applied indicated an IC50 = 4.7pM, comparable with IC50 value o f 
other studies (Avoli et al., 2004; Braun et al., 2004).
Finally, in a minority o f slices tested 30 pM baclofen application resulted in 
abolishment o f interictal activity and the appearance o f  spontaneous ictal activity 
which was absent in control periods (n=2 o f 17, Figure 6.5 B).
6.2.4 Effect of nAChR activation on baclofen-induced 
suppression of epileptiform activity
In order to assess whether iiACliR activation could modulate baclofen-induced 
suppression o f  epileptiform activity, a series o f experiments were carried out in 
which DMPP was co-applied following a stable period o f baclofen application.
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Figure 6.3. Effect of GABAg receptor agonist baclofen on 4AP-induced epileptiform activity 
in area CA3 of tfie hippocampus.
A . S c a t t e r  p lo t  s h o w i n g  e f f e c t  o f  b a c l o f e n  o n  f r e q u e n c y  o f  in t e r i c t a l - l ik e  e v e n t s  i n d u c e d  b y  
4 A P  in  t h e  r a t  h i p p o c a m p a l  s l i c e .  A p p l i c a t io n  o f  b a c l o f e n  ( 1 - 3 0  p M ) r e s u l t e d  in  a  
c o n c e n t r a t i o n - d e p e n d e n t  d e c r e a s e  a n d  e v e n t u a l  c o m p l e t e  a b o l i t i o n  o f  t h e  4 A P - i n d u c e d  
in t e r i c t a l - l ik e  a c t iv i t y .  S h a d e d  h o r iz o n t a l  b a r s  i n d i c a t e  t h e  p e r i o d  o v e r  w h i c h  a n  in d iv id u a l  
c o n c e n t r a t i o n  w a s  a p p l i e d  t o  t h e  b a t h .  B. S im i la r  s c a t t e r  p lo t  in  w h i c h  t h e  e f f e c t  o f  3 0  p M  
b a c l o f e n  i s  r e v e r s e d  u p o n  c o - a p p l i c a t i o n  o f  t h e  GABAg r e c e p t o r  a n t a g o n i s t ,  C G P 5 5 8 4 5 A  
(1  p M ) .  C .  C o n c e n t r a t i o n - r e s p o n s e  c u r v e  f o r  t h e  d e c r e a s e  in  t h e  f r e q u e n c y  o f  4 A P - i n d u c e d  
in t e r ic t a l  a c t iv i t y ,  i n d u c e d  b y  d i f f e r e n t  c o n c e n t r a t i o n s  o f  b a c l o f e n  in  7  e x p e r i m e n t s .  T h i s  
d o s e - r e s p o n s e  c u r v e  r e v e a l s  a n  IC gg o f  4 . 7  p M .
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When the nAChR agonist DMPP (30 ]LiM) was applied to slices treated with 4AP 
+ baclofen, interictal activity reappeared upon DMPP application (n=10, Figure 
6.4 A-B). Although baclofen-induced suppression o f 4AP-induced epileptifonn 
activity was reversed upon application o f DMPP, the degree o f reversal varied 
between experiments. In 7 out o f 10 experiments, application o f 30 pM DMPP 
partially recovered the epileptiform bursting activity but the fi'equency recovery 
did not achieve pre-baclofen levels (39.3 ± 5% of control, Figure 6.4 A-B). In the 
remaining 3 slices application of DMPP resulted in a complete reverse o f baclofen 
effects to pre-baclofen fi'equency levels (95 ± 4.5% of control, Figure 6.5 A).
As it is mentioned above, baclofen application elicited ictal-like discharges 
(which were absent in control) in 2 out o f 17 experiments. In all these cases, 
subsequent application of 30 pM DMPP resulted in the subsequent reappearance 
o f interictal activity whereas the rate o f occurrence o f  the ictal-like events 
decreased (fiom 0.17 ± 0.02Hz during 30 pM baclofen to 0.08 ± 0.02Hz after 
adding DMPP, n=2; Figure 6.5 B). DMPP also reduced the duration o f the ictal- 
like discharges that occuned less fi'equently than with baclofen only (from 634.8 ± 
26 ms during 25 pM baclofen to 321 ± 19ms after adding DMPP, n=2).
6.3 Effect of DMPP on spontaneous IPSCs recorded in 
hippocampal intemeurones
To further investigate the effect o f nAChR activation on GABA transmission in 
the hippocampus and the possible involvement o f GABA receptors in iiAChR- 
induced burst frequency potentiation, we used whole cell path clamp 
configuration to record spontaneous IPSC events in hippocampal intemeurones 
and investigate the action o f subsequent nACliR activation.
Intemeurones with cell bodies located within stratum radiatum  were recorded in 
the whole cell formation under voltage clamp configuration and in the presence of 
the glutamate antagonists 4 pM NBQX and 50 pM CGP40116. Spontaneous
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Figure 6.4, Reverse of baclofen-induced effects on epileptiform activity by DMPP.
A . R a s t e r  p lo t  s h o w i n g  a  r e p r e s e n t a t i v e  e x p e r i m e n t  in  w h i c h  in t e r ic t a l  b u r s t in g  a c t iv i t y  
i n d u c e d  b y  4 A P  i s  c o m p l e t e l y  a b o l i s h e d  f o l l o w i n g  a p p l i c a t i o n  o f  b a c l o f e n  ( 3 0  p M , a r r o w  1 
o n w a r d s ) .  S u b s e q u e n t  c o - a p p l i c a t i o n  o f  D M P P  ( 3 0  p M , a r r o w  2 )  a n d  C G P 5 5 8 4 5 A  (1  
p M , a r r o w  3 )  r e c o v e r e d  a n d  t h e n  p o t e n t i a t e d  in t e r ic t a l  a c t iv i t y ,  r e s p e c t i v e l y .  B .  S c a t t e r  
p lo t  p r e s e n t a t i o n  o f  s a m e  e x p e r i m e n t  s h o w i n g  a p p l i c a t i o n  o f  a  s i n g l e  c o n c e n t r a t i o n  o f  
b a c l o f e n  ( 3 0  p M )  a b o l i s h e s  4 A P - i n d u c e d  in t e r ic t a l  a c t iv i t y  w h i c h  is  p a r t ia l ly  r e v e r s i b l e  
u p o n  c o - a p p l i c a t i o n  o f  D M P P  ( 3 0  p M , n = 7 ) .  F u r t h e r  r e v e r s e  o f  b a c l o f e n - i n d u c e d  e f f e c t s  
a c h i e v e d  f o l l o w i n g  c o - a p p l i c a t i o n  o f  C G P 5 5 8 4 5 A  t o  m e d i u m  c o n t a i n i n g  4 A P ,  b a c l o f e n  
a n d  D M P P .
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F i g u r e  6 . 5 .  Effect of DMPP on baclofen-induced effect on epileptiform activity.
A . S c a t t e r  p lo t  s h o w i n g  a n o t h e r  e x p e r i m e n t  in  w h i c h  in t e r ic t a l  b u r s t in g  a c t iv i t y  i n d u c e d  b y  
4 A P  i s  c o m p l e t e l y  a b o l i s h e d  f o l l o w i n g  a p p l i c a t i o n  o f  a  s i n g l e  c o n c e n t r a t i o n  o f  b a c l o f e n  
( 3 0  p M ) .  S u b s e q u e n t  c o - a p p l i c a t i o n  o f  D M P P  ( 3 0  p M )  a n d  C G P 5 5 8 4 5 A  (1  p M )  
r e c o v e r e d  a n d  t h e n  p o t e n t i a t e d  in t e r ic t a l  a c t iv i t y ,  r e s p e c t i v e l y .  B . In a  m in o r i t y  o f  
e x p e r i m e n t s  b a c l o f e n  a b o l i s h e d  in t e r ic t a l  e v e n t s ,  w h i l e  p r o m o t i n g  t h e  o c c u r r e n c e  o f  m o r e  
p r o l o n g e d  ic t a l - l ik e  a f t e r d i s c h a r g e s  ( n = 2  o f  1 7 ) .  In t h e s e  c a s e s ,  D M P P  a p p l i c a t i o n  
r e s u l t e d  in  t h e  r e a p p e a r a n c e  o f  in t e r ic t a l  a c t iv i t y  a n d  a  s h o r t e n i n g  in  t h e  d u r a t io n  a n d  t h e  
r a t e  o f  o c c u r r e n c e  o f  t h e  ic ta l  e v e n t s .  R ig h t  c o l u m n  p o i n t s  t o  e x p a n d e d  s e c t i o n s  o f  e a c h  
t r a c e  i l lu s t r a t in g  in d iv id u a l  f i e ld  p o t e n t i a l  e v e n t s .
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IPSCs (sIPSC) were recorded as transient inward currents with fast kinetics and a 
mean peak amplitude o f 20.42 ± 2.47pA (n=6). Perfusion o f the hippocampal 
slices with NBQX and CGP40116 blocked fast AMPA/kainate and NMDA 
receptors respectively and ensured the spontaneous PSCs recorded were 
GABAergic in nature (IPSCs). Bath application o f 30pM DMPP resulted in a 
significant increase in frequency o f sIPSC from 7.489 ± 1.93Hz to 13.5 ± 2.8Hz 
(n=6; P=0.0403; Figure 6.6). h i contrast, the amplitude o f sIPSPs was unaffected 
by DMPP application (from 20.4 2 ± 2.47pA to 23.41 ± 3.04pA, n=6, F=0.0836).
As well as the increase in IPSCs frequency, DMPP also elicited a pronounced and 
sustained inward current in 3 o f 6 intemeurones recorded (Figure 6.6 A). This 
slow nicotinic current was associated with action potential discharges as indicated 
by large and uncontrolled cunent transients (Figure 6.6 A).
6.4 Discussion
The main finding o f this chapter was the demonstration that preincubation o f 
slices with a GABAb receptor antagonist can prevent the ability o f the nAChR 
agonist DMPP to induce epileptiform burst frequency potentiation. This is 
consistent with the proposal that nAChRs might affect epileptiform activity 
through modulating GABAergic circuits. GABAergic intemeurones in the 
hippocampus are Imown to exhibit functional iiACliR-mediated responses 
(Alkondon et al., 1998; Frazier et al., 1998b; Jones and Yakel, 1997; McQuiston 
and Madison, 1999b). nACliRs are thus ideally placed to regulate neuronal 
excitability within hippocampal circuits. Strong neurochemical evidence indicates 
that presynaptic nAChRs are involved in the enhanced release o f a number of 
transmitters, including GABA (Alkondon et al., 1997; McMahon et al., 1994; 
Womiacott et al., 1989). Comparable to those reported by these authors, our group 
have found that iiACliR selective agonist DMPP increases the fi'equency o f 
spontaneous IPSPs recorded in the hippocampal CA l intemeurones (L.Ferrigan; 
personal communication). This result indicates that iiACliR agonists can
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F i g u r e  6 . 6 .  Effect of DMPP on spontaneous IPSCs (sIPSCs) in CA1 intemeurones 
A. R e p r e s e n t a t i v e  c u r r e n t  t r a c e  a n d  r a s t e r  p l o t s  i l lu s t r a t in g  s I P S C s  r e c o r d e d  f r o m  a  C A l  
i n t e r n e u r o n e .  N o t e  t h e  in w a r d  c u r r e n t  a n d  i n c r e a s e  in  s I P S C  f r e q u e n c y  in  r e s p o n s e  t o  D M P P  
a p p l i c a t i o n .  S u b s e q u e n t  c o - a p p l i c a t i o n  o f  t h e  s e l e c t i v e  G A B A ^  r e c e p t o r  a n t a g o n i s t  c o m p l e t e l y  
b l o c k s  s p o n t a n e o u s  in w a r d  c u r r e n t s  c o n f i r m i n g  t h e  G A B A e r g i c  n a t u r e  o f  t h e  e v e n t s .  B .  
R e p r e s e n t a t i v e  c u m u l a t i v e  p r o b a b i l i t y  p l o t s  s h o w i n g  (i)  s I P S C  i n t e r - e v e n t  in t e r v a l  a n d  (ii)  
s I P S C  a m p l i t u d e  b e f o r e  a n d  f o l l o w i n g  D M P P  a p p l i c a t i o n .  0 .  S u m m a r y  h i s t o g r a m s  s h o w i n g  
t h e  e f f e c t  o f  D M P P  o n  m e a n  s I P S C  f r e q u e n c y  a n d  a m p l i t u d e  ( n = 6 ) .  A  o n e - w a y  a n a l y s i s  o f  
v a r i a n t s  a n d  T u k e y s  p o s t  t e s t  p e r f o r m e d  o n  t h e  r a w  d a t a  i n d i c a t e d  a  s i g n i f i c a n t  i n c r e a s e  in  
s I P S C  f r e q u e n c y  ( P = 0 . 0 4 0 3 )  a n d  n o  c h a n g e  in  I P S C  a m p l i t u d e  ( P = 0 . 0 8 3 6 ) .
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depolarise CA l intemeurones and increase GABA release within the CA l region 
o f the hippocampus. Wliilst iiACliRs in the CNS are traditionally considered to 
exert a modulatory influence (Role and Berg, 1996; Womiacott, 1997), recent 
studies have demonstrated nACliRs to also mediate fast acetylcholine-mediated 
neurotransmission in hippocampus and neocortex (Alkondon et al., 1998; Frazier 
et al., 1998b; Jones and Yakel, 1997; McQuiston and Madison, 1999b). Given 
these evidences, it is likely that the pro-epileptogenic action o f nAChRs is 
mediated in part through GABAergic circuits. However, such an action o f 
nAChRs appears to be independent o f  fast GABAergic transmission. An 
important finding in this respect was that nACliR activation also resulted in a 
facilitation o f epileptifonn burst discharge in the bicuculline model (see chapter 4) 
in which GABAa receptors are blocked by high concentrations o f the specific 
GABAa receptor antagonist. This contrasts with a previous report that cholinergic 
modulation o f bicuculline-induced epileptiform activity is exclusively mediated 
through mACliRs (Sutor and Hablitz, 1989). However, this study was earned out 
in neonatal tissue and developmental differences may therefore account for such 
discrepancies. We believe that this is unlikely however, and indeed have shown 
that nACliRs potentiate bicuculline-induced epileptifonn bursts in both neonatal 
and juvenile rats (2-5 weeks old). Furthermore, nACh receptors show complex 
developmental expression profiles but important subunits such as the a7 subunit 
are generally expressed in hippocampus tliroughout postnatal development and 
into adulthood (Adams et al., 2002). The present results suggest that the primary 
means by which iiACliR activation are facilitating epileptifonn activity is tlnough 
mechanisms other than affecting fast GABAergic transmission. Indeed, this 
agrees well with a recent report showing the ability o f nicotine to potentiate 
paroxysmal depolarising shifts following GABA withdrawal syndrome (Silva- 
Barrat et al., 2001).
Previous in vitro works have shown that antagonising GABAb receptor is not 
sufficient per se to cause epileptiform synchronisation (McCormick, 1989; Sutor 
and Luhmann, 1998), but it can potentiate epileptiform responses induced by 
GABAa receptor antagonists (Karlsson et ah, 1992; McCoimick, 1989; Scanziani
1 2 2
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et al., 1994; Sutor and Lulnnann, 1998). These data suggested that weakening or 
abolishing GABAa receptor-mediated inliibition should be a sine qua non 
condition for expressing the proepileptogenic effects o f GABAb receptor. On the 
other hand, Motalli et al, 2002, have demonstrated that similar effects can be 
obtained by blocking GABAb receptors in the 4AP model in which GABAa 
receptor inliibition is potentiated as the result o f an increased release o f GABA 
hom  interneurone terminals (Perreault and Avoli, 1991; Perreault and Avoli, 
1992; Rutecki et al., 1987). Overall, these data suggest that the capacity o f 
GABAb receptor-mediated mechanisms to modulate epileptifonn synchronisation 
in cortical networks maintained in vitro does not depend on GABAa receptor 
antagonism but rather on the ability o f ambient GABA to activate type B 
receptors. This condition can be achieved by increasing neuronal excitability, and 
thus GABA release, either by blocking the GABAa receptor function (Karlsson et 
al., 1992; McCormick, 1989; Scanziani et a l , 1994; Sutor and Luhmann, 1998) or 
by applying dmgs capable o f augmenting transmitter release (e.g., 4AP) (Motalli 
et a l ,  2002). It has been hypothesised that the facilitation o f ictal activity by 
GABAb receptor antagonist is mainly caused by the blockade o f presynaptic 
GABAb receptor, leading to an increase in GABA release and subsequent larger 
[K'^jo elevations (Motalli et a l , 2002). However, in our experiments, application of 
a specific GABAb receptor antagonist, CGP55845A produced a very modest burst 
frequency potentiation in the BIC model and also did not change frequency o f 
epileptiform activity in 4AP model. It is reported that 5-10 fold higher 
concentration o f GABAb receptor antagonists are required to block presynaptic as 
opposed to postsynaptic receptors when these are activated by synaptically release 
GABA (Pozza et a l , 1999). It is likely therefore that this negative finding is 
attributable to the concentration of CGP55845A (1 pM) added to perfusing 
medium in our experiments being not high enough to substantially block 
presynaptic GABAb receptors.
Moreover, it has been reported that GABAb receptors exist as subtypes having 
distinct neuronal locations, functions and pharmacological properties (For review 
see Bonanno and Raiteri, 1993; Mott and Lewis, 1994). Thus, the different
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GABAb receptor antagonists may reflect different competitive interaction 
between different receptor subtypes and exhibit different pharmacology at pre and 
post-synaptic GABAb receptors (Pozza et a l ,  1999). Indeed, different subtypes o f 
GABAb receptors have been found at pre-and postsynaptic sites within the rat 
dorsolateral septal nucleus (Yamada et al., 1999). If  this distinct phamiacology 
and GABAb receptor distribution also extends to other CNS structures, such 
differences may therefore account for the findings described here.
As detailed in chapters 3 and 4 o f this thesis, the frequency o f 4AP and BIC- 
induced epileptiform activity were potentiated by subsequent co-application o f the 
selective nAChR agonist DMPP. In 4AP model, application o f DMPP (10-30 pM) 
resulted in a mean burst frequency potentiation o f 37 ± 5%. In contrast, slices pre- 
incubated with the GABAb receptor antagonist CGP55845A (IpM ) were not able 
to exhibit burst frequency potentiation upon DMPP application. Similarly, in the 
presence o f IpM  CGP55845A, slices exhibited negligible burst fi-equency 
potentiation o f bicuculline-induced (20pM) epileptifonn activity upon DMPP 
application (27.6 ± 18%), in comparison to those observed in the absence o f 
CGP55845A (248 ± 76 %). A comparison o f the effects o f DMPP upon these two 
models o f epileptiform bursting in the absence and presence o f GABAb receptor 
antagonist is summarised in histogram format in figure 6.7. As illustrated in figure 
6.7 C, the maximal burst frequency potentiation to DMPP application in 4AP and 
BIC models in the absence o f CGP55845A is 45 and 220% higher in comparison 
to those in the presence o f this antagonist.
These data suggest that GABAb receptor activation is necessary or at least an 
important element in the nAChR-induced burst frequency potentiation effect and 
nAChRs may regulate the excitability o f hippocampal networks through GABAb 
receptor-mediated mechanisms.
Overall the data presented in this ehapter are robust and reproducible. However, 
the data at the same time appears paradoxical and defy any simple mechanistic 
explanation. One possible explanation for this result is that increased nACliR
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A . H i s t o g r a m  s u m m a r i s i n g  1 0 - 3 0  | iM  D M P P - i n d u c e d  b u r s t  f r e q u e n c y  p o t e n t i a t i o n  in  4 A P  
a n d  B IC  m o d e l s  n o r m a l i s e d  t o  c o n t r o l  ( p r e - D M P P )  f r e q u e n c y .  In t h e  a b s e n c e  o f  G A B A g  
r e c e p t o r  a n t a g o n i s t ,  a c t i v a t i o n  o f  n A C h R s  b y  D M P P  r e s u l t s  in  a  s i g n i f i c a n t  i n c r e a s e  in  
b u r s t  f r e q u e n c y  in  b o t h  m o d e l s  ( W i l c o x o n - m a t c h e d  p a ir  t e s t ,  P < 0 . 0 1 ) .  B .  Q u a n t i t a t iv e  
s u m m a r y  o f  t h e  e f f e c t  o f  D M P P  o n  4 A P  a n d  B I C - i n d u c e d  e p i l e p t i f o r m  a c t iv i t y  in  t h e  
p r e s e n c e  o f  G A B A g  r e c e p t o r  a n t a g o n i s t ,  C G P 5 5 8 4 5 A  ( 1 - 3  p M ) .  A p p l i c a t io n  o f  
C G P 5 5 8 4 5 A  b l o c k e d  t h e  a b i l i t y  o f  D M P P  t o  p o t e n t i a t e  4 A P - i n d u c e d  b u r s t in g  ( n = 1 1 )  a n d  
a l s o  s u b s t a n t i a l l y  d e c r e a s e d  D M P P - i n d u c e d  m a x i m a l  b u r s t  f r e q u e n c y  p o t e n t i a t i o n  in  B IC  
m o d e l  ( n = 9 ) ,  O n e - W a y  A N O V A  in d i c a t e d  n o  s i g n i f i c a n t  c h a n g e  in  b u r s t  f r e q u e n c y  u p o n  
a p p l i c a t i o n  o f  D M P P  in t h e  p r e s e n c e  o f  C G P  5 5 8 4 5 A  in  4 A P  ( P = 0 . 4 5 )  a n d  B IC  m o d e l s  
( P = 0 . 1 5 ) .  C .  H i s t o g r a m  s u m m a r i s i n g  D M P P - i n d u c e d  c h a n g e  in  b u r s t  f r e q u e n c y  in  t h e  
a b s e n c e  a n d  p r e s e n c e  o f  C G P 5 5 8 4 5 A .  N o t e  t h e  m a x i m a l  b u r s t  f r e q u e n c y  p o t e n t i a t i o n  in  
B IC  m o d e l  in  t h e  a b s e n c e  o f  C G P 5 5 8 4 5 A  i s  2 0 0  f o ld  h i g h e r  in  c o m p a r i s o n  t o  t h o s e  in  t h e  
p r e s e n c e  o f  t h i s  a n t a g o n i s t .
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function leads to an increase in GAB A release from GABAergic interneurones.
This leads to a subsequent recruitment o f  GABAg receptors, which in turn can
modulate neuronal excitability via several mechanisms including:
• Activation of GABAg receptors induces an increase in conductance 
(Gahwiler and Brown, 1985; Newberry and Nicoll, 1984; 1985) which 
modulates seizure activity in both in vivo and in vitro preparations (Traynelis 
and Dingledine, 1988; Zuckermann and Glaser, 1968). Hence the 
proconvulsant action o f GABAg receptors activation may have resulted from 
changes in [K'^jo homeostasis. Indeed, GABA-mediated [K"^ ]o elevations have 
been shown to initiate ictal discharges in the 4-AP model (Avoli et al., 1996). 
However, [K"^ ]o recordings reported by Motalli et al (1999) indicated that the 
proconvulsant action o f  GABAg receptors is not accompanied by any 
measurable change in either [K’^ jo baseline or [K' J^o transient elevations 
(Motalli et ah, 1999).
• Activation o f GABAg receptors induces presynaptic inhibition o f G ABA 
release in turn leading to a depression o f IPSPs and subsequent increases in 
network excitability [e.g., GABAg mediated inhibition o f GABA release from 
inhibitory interneurones leading to a disinhibition (Mott et al., 1989; Watts 
and Jefferys, 1993)].
• Another possibility is that increased GABA release by nAChRs activates 
postsynaptic GABAg receptors. Activation o f postsynaptic GABAg receptors 
can induce a membrane hyperpolarisation o f inhibitory intemeurones again 
leading to disinlribition o f pyramidal cells and increase in excitability.
However, such a disinhibitory action must be associated with the ability of 
excitatory terminals to release transmitter, this being essential for 
proconvulsant activity. An important mechanism underlying the proconvulsant 
action o f GABAg receptors has been suggested to be related to activity-
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dependent changes in CA3 area network excitability that occur during GABAg 
receptor activation (Motalli et a l ,  1999). It is possible that an accumulation of 
glutamate-containing vesicles docking at presynaptic terminals results hom  
the block o f interictal activity and asyncln'onous excitatory synaptic potentials 
caused by GABAg receptors activation (Motalli et a l ,  1999). This should lead 
to an increased availability o f excitatory transmitter. Presynaptic factors 
controlling glutamate release have been proposed to regulate the probability 
and duration o f synchi'onous discharges generated by the CA3 network (Staley 
et a l ,  1998).
Application o f the GABAg receptor agonist baclofen decreased and eventually 
blocked the 4AP-induced interictal activity in all experiments. In our study most 
baclofen effects were antagonised by CGP55845A, thus indicating that they were 
mainly caused by the activation o f GABAg receptors, h i particular, we propose 
that baclofen abolishes 4AP-induced interictal activity by decreasing the release o f 
transmitter from excitatory and inliibitory terminals. This may be caused by 
activation o f presynaptic GABAg receptors iidiibiting both GABA and excitatory 
transmitter release (Lambert and Wilson, 1993; Lanthom and Cotman, 1981) and 
by a postsynaptic GABAg-mediated hyperpolarisation that decreases excitability 
o f principal cells (Newbeny and Nicoll, 1984; 1985) and intemeurones (Mis geld 
et a l ,  1989; Williams and Lac aille, 1992). Reappearance o f interictal activity by 
DMPP following application to medium containing 4AP and baclofen, could be as 
a result o f effect o f iiAChR activation in enhancing neurotransmitter release from 
presynaptic terminals (Gray et a l ,  1996; Role and Berg, 1996; Woimacott et a l, 
1989). However, this effect o f DMPP can not completely overcome the inhibition 
o f transmitter release exerted by baclofen since the effect o f baclofen was only 
partially reversible upon application o f DMPP in most experiments. Subsequent 
application o f CGP55845A blocked baclofen-induced inhibition o f 
neurotransmitter release and produced additional enliancement o f neurotransmitter 
release.
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111 simimary, whilst we have found robust evidence that GABAg receptor 
activation is an important element in the iiACliR-mediated burst frequency 
potentiation effect, the precise mechanistic detail is unclear and requires further 
investigation.
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CHAPTER 7 
GENERAL DISCUSSION
The major outcome o f this study was the demonstration that activation o f nACliRs 
has pro-epileptogenic actions within hippocampal circuits. This was obseiwed 
across a range o f different forms o f pharmacologically-induced epileptiform 
activities including 4AP, bicuculline and low magnesium models suggesting that 
nACliRs may have a general action in exacerbating epilepsy-like discharges. The 
mechanisms by which this exacerbation o f epileptiform activity occurs does not 
significantly compromise the mechanisms responsible for the precise firing o f 
action potentials and fast activity within individual bursting events as represented 
by the relatively small effect o f iiACliR agonists on high frequency aspects of 
burst waveform recorded in the presence o f 4AP. Our findings o f this study 
suggest that activation o f nACliRs potentiates pre-established epileptiform 
bursting activity in the hippocampus without demonstrating any overt 
epileptogenic activity p er se. This has to be viewed with caution since it is likely 
that the actions o f iiACliR activation may be more pronounced in the intact 
hippocampal structure in vivo. Wliilst the hippocampal slice retains many of the 
transverse pathways including the trisynaptic circuit, longitudinal pathways are 
lost and recurrent connections reduced. The exact subtypes o f  iiACliRs mediating 
the pro-epileptogenic actions can not be fully established in this study. It was our 
experience that relatively high concentrations o f nACliR ligands were necessary 
to obtain reliable effects within the interface-type recording chamber. 
Nevertheless, it is apparent that at least a7 and probably a4p2 subunit containing 
receptors are involved.
It has been shown that pharmacological activation o f nAChRs can potently 
modulate the induction o f synaptic plasticity including hippocampal long-term
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potentiation (Ji et a l ,  2001; Maim and Greenfield, 2003). Indeed several aspects 
o f the data presented in this thesis support potential plasticity that may occur at 
synapses in the network as a result of the activation o f nAChRs. For example, the 
inability o f iiAChR antagonists to fully reverse the effects o f DMPP (Figure 3.15) 
and the lack of hill reversibility of DMPP effects upon wash out (Figure 4.3) 
support the possibility that plasticity events may be an important factor in the 
action o f iiACliRs in epileptogenesis. Depending on the distributions o f various 
nAChR subtypes and the timing o f nAChR activity, cellular and synaptic events 
can be modified in many different ways (Ji et ah, 2001). Presynaptic nAChRs can 
increase the probability o f neurotransmitter release this increasing the fidelity o f 
synaptic transmission at any given excitatory synapse. Postsynaptic iiAClxRs can 
further increase the depolarization and calcium signal associated with successful 
transmission, helping to initiate intracellular cascades. On the other hand, 
nAChRs can have a potent impact upon the activity of interneurone populations 
which themselves are important regulators o f network excitability and synaptic 
plasticity (Davies et ah, 1991).
That said, the question still remains as to the precise mechanistic detail by which 
iiACliRs enliance epileptifomi activity? It is not possible from this study to 
identify the precise means by which nAChRs facilitate epileptiform activity 
although it is likely that a number o f factors may contribute to their pro- 
epileptogenic actions. An important locus o f action is likely to be that o f the 
calcium-dependent signalling pathways. Classically iiACliRs are considered to 
participate in fast signalling (Frazier et ah, 1998a; Hefft et ah, 1999). However, 
recent reports in the autonomic neiwous system suggest that iiACliR agonists, 
including nicotine, can produce sustained calcium spiking in presynaptic nerve 
tenninals (Brain et ah, 2001) during prolonged periods o f agonist application. It is 
possible that this type o f neuromodulatory effect at recurrent glutamatergic 
terminals may be responsible for generating the potentiation o f epileptiform 
activity reported here. Relevant to the hippocampus there is a precedent for 
nAChRs exhibiting a slow neuromodulatory action (McGehee and Role, 1996; 
Role and Berg, 1996; Wonnacott, 1997) with the strongest evidence for
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modulation of neurotransmitter release (Albuquerque et al., 1997; Gray et al., 
1996; Ji and Dani, 2000) and/or regulation o f  synaptic plasticity (Ji et al., 2001). 
In both cases transient activation o f nAChRs can potentially trigger either a 
transient or persistent effect that, by analogy to the autonomic nervous system, 
could possibly involve calcium-mediated pathways within neiwe terminals.
The data presented in this thesis provide some additional insight into the potential 
mechanisms underlying nAClrR-induced frequency facilitation. Although the 
mechanisms underlying the pro-epileptogenic action of iiACliRs are complex and 
not simply due to activation o f nACliRs, clearly involve the modulation o f both 
GABAergic and glutamatergic circuits (see Figure 7.1). In experiments devised to 
investigate the action o f iiACliRs on basal glutamatergic transmission, application 
o f DMPP resulted in a sustained yet reversible enhancement o f glutamate afferent 
evoked field EPSP amplitude in the CA3 region o f the hippocampus suggesting 
that nACliRs enliance glutamate release from presynaptic terminals. Whilst we 
can not rule out a possible postsynaptic sensitisation-type action on glutamatergic 
transmission we feel that this is unlikely. Instead, we hypothesise that activation 
o f nACliRs by DMPP enliances glutamate release, which in turn can strengthen 
recurrent excitatory connections in area CA3 and thus facilitate polysynaptic 
reverberations tliroughout the network. The strength o f such recurrent connections 
have been proposed to be critical in the generation and regulation o f  bursting 
activity within the CA3 network (Bains et ah, 1999; Staley et al., 1998; Traub, 
1991) and recent studies have shown acetylcholine to modulate these synapses 
directly (Vogt and Regeln*, 2001). The experiments using glutamate receptor 
antagonists (Chapter 5) further confirm the involvement o f glutamate receptors in 
pro-epileptogenic effect o f nAChRs. In agreement with previous studies, our 
results have shown that nAChRs unlikely to have a direct postsynaptic effect in 
principal cells.
On the other hand, in experiments devised to investigate whether iiAChRs 
regulate GABAergic cells and circuits, application o f DMPP revealed an inward 
cuiTent and increased the frequency o f spontaneous IPSCs in a subpopulation o f
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Figure 7.1. Sum mary o f possible loci and mechanisms for nAChR-m ediated pro- 
epileptogenic action.
A. Schematic drawing showing the possible sites at which nAChRs may influence 
hippocampal microcircuits including (1) postsynaptic sites on GABAergic 
intemeurones (including interneurone-selective cells), (2) pre-synaptic GABAergic 
terminals and (3) glutamatergic terminals. B. Flow chart indicating possible routes 
by nAChR modulation may ultimately result in pro-epileptogenesis (see text for 
details). Abbreviations: int - interneurone; PC - pyramidal cell.
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C A l intemeurones suggesting that nACliR agonist can directly depolarise CA l 
intemeurones and increase GABA release within the C A l region of the 
hippocampus.
Together, these results suggest that activation of nACliRs may produce pro- 
epileptogenic actions tlirough regulating both glutamatergic and GABAergic 
circuits, resulting in both direct excitatory and modulation o f GABAergic 
(probably via GAB As receptors) inliibition respectively. This is consistent with 
studies suggesting the involvement o f either glutamatergic or GABAergic 
transmission in the mechanisms underlying nicotine-induced seizures in vivo 
(Damaj et al., 1999). However, despite the functional expression o f iiACliRs on 
hippocampal GABAergic intemeurones (Alkondon et ah, 1997; Frazier et ah, 
1998a; Frazier et ah, 1998b; Jones and Yakel, 1997; McQuiston and Madison, 
1999b) it is unlikely that nAChRs are significantly affecting GABAergic circuits 
to promote epileptiform activity since h'equency facilitation is obseiwed in the 
presence o f the GABAa receptor blocker bicuculline. Indeed, a somewhat 
surprising finding was that nAChR-mediated burst frequency potentiation was 
particularly pronounced in the bicuculline model. However, an action on GABAg 
receptor mediated synaptic inputs camiot be excluded since GABAg receptor- 
mediated mechanisms are involved in the generation o f focal seizures and in 
epileptogenesis (McLean et ah, 1996; Scanziani et ah, 1994; Veliskova et ah, 
1996) and also in facilitating epileptiform activity (Motalli et ah, 1999; 2002). hi 
experiments to identify possible contribution o f the GABAg receptors in the 
iiACliR-induced effect, application o f GABAg receptor antagonist prevented 
DMPP-induced burst fi-equency potentiation o f 4AP and bicuculline-induced 
epileptifomi activity suggesting that iiAChRs may regulate the excitability o f 
hippocampal networks tlirough GABAg receptor-mediated mechanisms. This has 
important consequences for investigating network dynamics in that suggests the 
basal neuromodulatory tone o f transmitters and their interacting may be a 
significant consideration.
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Wliilst we hypothesise that activation o f nicotinic acetylcholine receptors has pro- 
epileptogenic actions within hippocampal circuits through regulating either 
glutamatergic, GABAergic or both circuits further effort is required to establish 
(a) how different iiACliR subtypes impact on this cellular process and (b) the 
precise nature o f their interaction. Furthermore, it is also necessary to establish 
whether iiACliR activation may indirectly modulate epileptiform activity thiough 
other transmitter systems. The hippocampus is reach in a variety o f 
neurotransmitters (Reviewed by Vizi, 1998) and ACh is known to modulate the 
release o f many o f these.
A key requirement is to establish whether discrete subtypes o f iiACliRs are 
implicated in epileptogenesis. The limited pharmacopea has hampered progi'ess in 
this area to date. However, introducing novel significantly more selective ligands 
would be useful to address this issue.
The hypothesis that choline as a selective agonist at certain nAChRs has a role in 
modulating epileptiform activity is significant. Despite acetylcholine being broken 
down and inactivated by acetylcholinesterase rapidly, it is possible that the 
sustained presence o f choline may have a longer lasting neuromodulatory 
influence. An interesting study would be to examine plasma choline levels across 
a large bank o f epilepsy patient volunteers to assess the possible potential 
contribution o f brain choline levels to epileptogenesis.
Another avenue in attempting to elucidate the mechanisms underlying pro- 
epileptogenic actions o f nAChR activation would be to take a calcium imaging 
approach. Recent studies using confocal imaging have shown nACliRs to be an 
important regulator o f spontaneous neurotransmitter release in the peripheral 
nervous system (Brain et al., 2001). Similar studies using a cell imaging approach 
whereby discrete cells and circuits are labelled with a fluorescent calcium 
indicator could be useful to assess the action o f the cholinergic system on cellular 
processes and importantly, calcium transients within nerve terminals at discrete 
circuits.
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Studies are on going with respect to identifying the precise inhibitory circuits 
under modulation by nAChR activation. These findings may reveal potentially 
more selective pharmacological means by which to regulate specific GABAergic 
circuits and this avoid the side effects associated with cun'ent anticonvulsant 
drugs which potentiate the entire GABAergic system without discrimination.
Despite these unresolved questions, the observation that brain nAChRs regulate 
synchronised neuronal activity suggests that nAChRs may represent a potential 
target in developing novel treatments for the control o f epilepsy. Since many 
epilepsies are resistant to current drug therapies which influence neuronal activity 
by affecting ion chamiels responsible for cell excitability or acting to potent 
GABAergic synaptic transmission, there is a push to identify new therapeutic 
agents based upon novel mechanisms o f action. As a result, nACliRs are currently 
the subject o f intense research interest with respect to their therapeutic potential in 
a series of neui'ological and psychiatric conditions including epilepsy. It has been 
reported in animal seizure models that preferential nicotinic acetylcholine receptor 
antagonists are potent anticonvulsants in the maximal electroshock seizure test 
(Loscher et al., 2003) and against nicotine-induced seizures (Damaj et al., 1999). 
The anticonvulsant potency in the maximal electro shock seizure test was 
decreased by injection o f a subconvulsant dose o f nicotine, suggesting the 
contribution o f nACliR mechanisms (Loscher et al., 2003). In conclusion, it may 
be suggested that nicotinic acetylcholine receptor antagonism might be a valuable 
future therapeutic approach to treat epileptic seizures. The work in this thesis has 
gone some way to providing a basis upon which future studies to this aim can be 
based.
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